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Summary  
 
The mean life expectancy of humans has increased continuously over the last 200 years. Since 
longevity is of little value in the absence of health, it is a central request to prevent the increas-
ing burden of age-related diseases. As shown by long-living populations in Okinawa and the 
Mediterranean, nutrition plays a prominent role in extending the healthspan. It is suggested that 
phytochemicals in plants, specifically the polyphenols (PPs), are important factors to support the 
overall well-being. However, the precise mechanisms that can explain, in full, the magnitude of 
impact remains elusive. It has still not been established whether certain PPs use common, over-
lapping or exclusive mechanisms, whether antioxidative properties, energy re-allocation effects 
or hormesis-based action modes are responsible and which genetic players are involved. This 
knowledge gap can only be plugged by in vivo model organism approaches that integrate life-
span assays with physiological, and genetic parameters following the ingestion of PPs.  
In this study, three PPs with life-extending properties in C. elegans were identified: Quercetin 
(Q), Caffeic acid (CA) and Rosmarinic acid (RA). After ruling out that the longevity effect is pro-
voked by experimental artifacts, like antibacterial properties of the PPs against the E. coli feed-
ing strain or direct caloric restriction (CR) effects due to gustatory repulsion, the underlying 
mechanisms were systematically studied by a broad spectrum of functional and genetic investi-
gations. For all three compounds, life extension was characterized by hormetic concentration-
response curves, but stress-response induction, a hallmark of hormetin action, was restricted to 
Q and RA, at least when assessed at the level of gene expression of heat shock proteins. A 
reallocation of resources in a disposable soma-like pattern could be shown for all three PPs, 
because the exposure to Q, CA and RA resulted in variations in body size, altered lipid-
metabolism and a tendency towards a delay in reproductive timing. However, not all physiologi-
cal parameters were affected by PPs, since, for example, the total number of offspring was un-
altered. While direct CR effects arising from reduced food uptake could be rejected, an indirect 
CR effect cannot be excluded for CA and RA, as these PPs failed to provoke longevity in sir-2.1 
mutants. Furthermore, the in vitro versus in vivo antioxidative properties were evaluated, 
through lifespan assays with endogenous ROS stressed mev-1 mutants, an oxidative stress test 
with paraquat, a total antioxidative capacity (TAC) assay, and by determining the intestinal lipo-
fuscin fluorescence, a marker for the amount of oxidative damaged macromolecules. While all 
three PPs could prolong mev-1 lifespan, only Q and CA were shown to increase the TAC in vivo 
and reduce oxidative damage in the nematodes. To define the genetic pathways of PP action, 
lifespan and thermotolerance assays were performed in mutant animals devoid of aging-
relevant genetic players. These experiments revealed that the health gaining properties of CA 
and RA both rely on osr-1, sek-1, sir-2.1 and unc-43, plus daf-16 in the case of CA. The me-
chanisms of Q action are partly distinct and were analyzed in more detail by integrating own 
mutant lifespan assays and DNA-microarray studies with an extensive meta-analysis of pub-
lished gene expression profiles obtained under aging-relevant conditions. Quercetin is proposed 
to act through a complex interplay of conserved genetic pathways, for example Insulin-like sig-
naling (ILS), TGF-beta signaling, p38 MAPK, CaMKII, and possibly also due to germline and 
somatic gonad signaling.  
Taken together, hormesis, in vivo antioxidative/prooxidative properties, modulation of genetic 
players, as well as the re-allocation of resources all contribute (to some extent and dependent 
on the polyphenol) to life extension. 
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Zusammenfassung  
 
Die mittlere Lebenserwartung des Menschen ist über die letzten 200 Jahre kontinuierlich ge-
stiegen. Da Langlebigkeit ohne Gesundheit wenig Wert besitzt, ist es ein zentrales Anliegen, 
das Auftreten altersbedingter Krankheiten zu mindern. Wie durch langlebige Populationen in 
Okinawa und dem mediterranen Raum gezeigt, spielt die Ernährung dabei eine wichtige Rolle. 
Besonders pflanzliche Phytochemikalien, im speziellen Polyphenole (PPs), sollen erheblich an 
der Gesundheitsförderung mitwirken. Die exakten Mechanismen jedoch, welche die Wirkvielfalt 
erklären könnten, sind nicht im Detail bekannt. Weder ist ermittelt, ob bestimmten PPs diesel-
ben, überlappende oder jeweils eigene Wirk-Wege zugrundeliegen, ob antioxidative in vivo Ei-
genschaften, Energie-Umverteilungs- oder Hormesis-basierte Effekte verantwortlich sind, noch 
welche Gene daran beteiligt sind. Diese Fragen können nur durch in vivo Studien an Modelor-
ganismen beantwortet werden, die sowohl die Lebensdauer, sowie physiologische und geneti-
sche Parameter einschließen. 
In dieser Studie wurden drei PPs mit lebensverlängernden Eigenschaften in C. elegans identifi-
ziert: Quercetin (Q), Kaffeesäure (CA) und Rosmarinsäure (RA). Nachdem experimentelle Arte-
fakte als Grund für die Langlebigkeit ausgeschlossen waren (wie z. B. antibakterielle Wirkungen 
der PPs gegenüber den Futterbakterien oder direkte Kalorien-Restriktions (CR)- Effekte ausge-
löst durch eine verminderte Futteraufnahme), wurden zugrundeliegende Mechanismen mit ei-
nem breiten Spektrum an funktionellen und genetischen Analysen systematisch untersucht. Für 
alle drei PPs wurden hormetische Konzentration-Wirkungs-Kurven gefunden, dennoch war die 
Hormetin-typische Aktivierung einer Stressantwort (gemessen als Geneexpressions-Level von 
Hitzeschock-Proteinen) auf Q und RA beschränkt. Eine Umverteilung von Ressourcen nach 
dem Prinzip der „Disposable Soma Theorie“ konnte anhand von Abweichungen in der Größe, 
verändertem Lipid-Metabolismus und verzögerter Reproduktion (bei gleichbleibender Anzahl 
der Nachkommen), für alle drei PPs gezeigt werden. Während direkte CR-Effekte ausgeschlos-
sen wurden, ist dies nicht möglich für durch CA und RA ausgelöste indirekte CR-Effekte, da 
beide die Lebensspanne von sir-2.1 Mutanten nicht verlängern konnten. Darüberhinaus wurden 
in vitro und in vivo antioxidative Eigenschaften mittels Lebensdauertests mit endogen gestress-
ten mev-1 Mutanten, einem oxidativen Stresstest mit Paraquat, einer Messung der Totalen 
Antioxidativen Kapazität (TAC) und über die Bestimmung der intestinalen Lipofuscin-
Fluoreszenz als Marker für die Menge an oxidativ geschädigten Makromolekülen bestimmt. Alle 
drei PPs verlängerten die Lebensspanne von mev-1 Mutanten, jedoch wurde eine erhöhte TAC 
in vivo und eine reduzierte oxidative Schädigung, nur durch Q- und CA- Gabe erreicht. Die ge-
netischen Wirkwege der PPs wurden durch Lebensdauer- und Thermotoleranztests mit in al-
ters-relevanten Genen mutierten Nematoden definiert. Die gesundheitsfördernden Eigenschaf-
ten von CA und RA konnten so osr-1, sek-1, sir-2.1 and unc-43, sowie daf-16 im Falle von CA, 
zugeschrieben werden. Die Mechanismen von Q wurden in größerem Umfang, durch die Integ-
ration von durchgeführten Lebensdauertests und DNA-Microarray-Studien einerseits und einer 
umfassenden Meta-Analyse von veröffentlichten, alters-relevanten Genexpressions-Profilen 
andererseits, analysiert. Q wirkt vermutlich durch ein komplexes Zusammenspiel von konser-
vierten genetischen Signalwegen, im Speziellen dem Insulin-ähnlichen (ILS), TGF-beta, p38 
MAPK, CAMKII und möglicherweise auch über eine von der Keimbahn und somatischen Gona-
de ausgehenden Signalwirkung.  
Zusammenfassend lässt sich sagen, dass sowohl in vivo antioxidative und prooxidative Eigen-
schaften, die Modulation auf Genebene, sowie eine Umverteilung von Ressourcen zu gewissen 
Teilen (abhängig vom PP) zur Lebensverlängerung beitragen.  
 
Abbrevations 
7 
 
Abbrevations 
 
AA    Ascorbic acid 
ACL    Antioxidative capacity of lipid-soluble substances 
ACW    Antioxidative capacity of water-soluble substances 
ADPKD Autosomal dominant polycystic kidney disease 
ANOVA Analysis of Variance 
BP    Biological Process 
CA    Caffeic acid 
CaMKII   Ca2+/ Calmodulin-dependent kinase  
CAT    Catalase 
CC    Cellular Component 
cDNA   Complementary DNA 
CeMM C. elegans Maintenance Medium 
CR    Caloric Restriction 
CVD    Cardio vascular disease 
CYP    Cytochrome P450 
cyps    Cytochrome P450 genes 
d    Day 
DAVID Database for Annotation, Visualization and Integrated Discovery 
DEGs Differential regulated genes 
DMSO Dimethylsulfoxid 
dsRNA double stranded RNA 
EGCG Epigallocatechin-3-Gallat 
F1    1st filial generation 
F2    2nd filial generation 
FDR False discovery rate 
FRTA Free Radical theory of aging 
GEPAS   Gene Expression Pattern Analysis Suite 
GFP    Green-fluorescence protein 
GO    Gene Ontology 
GST Gluthadion s-transferase 
gsts Gluthadion s-transferase genes 
HSP    Heat shock protein 
hsps    Heat shock protein genes 
IGF-1   Insulin-growth factor 1 
ILS    Insulin-like Signaling 
IP InterPro 
IVT In vitro transcription 
KEGG Kyoto Encyclopedia of Genes and Genomes 
L1    First larval stage 
L2    Second larval stage 
L3    Third larval stage 
L4    Fourth larval stage 
LPS Lipopolysaccharide 
LROs   Lysosome related organells 
MF    Molecular Function 
msps major sperm protein 
MTA    Mitochondrial theory of aging 
MW    Molecular Weight 
n Sample size 
NAD(P)H   Reduced form of nicotinamide adenine dinucleotide phosphate 
NGM    Nematode growth medium 
OD    Optical density 
p Statistical significance 
-p Without paraquat 
+p    With paraquat 
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P0    Parental generation 
p38 MAPK   Protein 38 mitogen activated protein kinase  
p53    Tumor protein 53 
PCA    Principal Component Analysis 
PI3K    Phosphoinositide 3-kinase 
PIP2 Phosphatidylinositol-3,4-diphosphate 
PIP3 Phosphatidylinositol-3,4,5-triphosphate 
PP    Polyphenol 
PQ+    Stable paraquat radical 
Q    Quercetin 
Qall    DEGs commonly regulated in 50, 100 and 200µM Q 
Qlongevity   DEGs commonly regulated in 100 and 200 µM Q  
qRT-PCR Real-time quantitative reverse transcriptase polymerase chain Reaction 
RA    Rosmarinic acid 
RF Representation Factor 
RNA Ribonucleic acid 
RNAi    RNA interference 
RNS    Reactive nitrogen species 
ROS    Reactive oxygen species 
SAM Significance of microarray 
SDR    Short-chain dehydrogenase/reductase 
SEM Standard error of the mean 
SIR2 Silent Information Regulator 2 
SOD    Superoxid dismutase 
T    Trolox 
TAC    Total Antioxidant Capacity 
TGF-beta   Transforming Growth Factor-beta 
TOR    Target of rapamycin 
UGT    UDP glucuronosyltransferase 
ugts    UDP glucuronosyltransferase genes 
UV    Ultra violet 
vWF Von Willebrand factor 
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1 Introduction 
 
1.1 Background 
 
Since the beginning of time, humans have searched for the “Fountain of Youth”, as the desire to 
live forever is neither new nor particularly Western, but rather a universal dream (Minois, 1987). 
Barely a week goes by without the media bringing up new and plausible hopes that we are just 
a technical breakthrough away from eternal youth or at least the extension of lifespan.  
 
Indeed, aging and the increase of life expectancy demonstrates one of the most impressive 
success stories in human history. In the last 200 years the mean life expectancy of humans has 
increased continuously such that in the last century lifespan has enhanced by approximately 2 
years every decade and this trend is expected to persist (Dominguez et al., 2009). Initially, the 
reasons for increased life expectancy included improvements in sanitation, housing and educa-
tion, which produced a decline in early and mid-life mortality due to the prevention and treat-
ment of infectious diseases. The further increase in life expectancy in the second half of the 
past century referred predominantly to medical advances and resulted in a decline in late-life 
mortality (Kirkwood, 2008). Consequently, the proportion of people aged over 60 years is grow-
ing fast. However, longevity is of little value in the absence of quality of life. All industrialized 
countries face a growing prevalence of chronic age-related conditions. Hence, huge social in-
terest in the civilized world exists, to extend the “health-span” of the individual. Beside caloric 
restriction, hormesis and genetic manipulations, which in fact could be shown to delay aging 
and death in model organisms (reviewed in Olsen et al., 2006), but with yet rare evidence for 
transferability to humans, a balanced nutrition and lifestyle remain today the simplest and only 
proven “Fountain of Youth” (Dominguez et al., 2009).  
 
Nutrition affects aging: “We are what we eat.” (taken from Pérez-López et al., 2009). In this con-
text, the popularity of the Mediterranean as well as the traditional Okinawan diet, which both 
share many of the same composition characteristics, has grown worldwide during the last 20 
years, due to their link with greater longevity, higher numbers of centenarians and lower rates of 
cardiovascular disease, cancer and age-associated cognitive decline (Trichopoulou et al., 2005; 
Serra-Majem et al., 2006). People on a Mediterranean diet for example, had more than a 20% 
lower risk of dying during a 10-year period compared to those with a differing food composition, 
independent of their age, body weight and gender (Knoops et al., 2004). The health and longev-
ity effect is in parts attributed to fruits and vegetables containing biologically active phytochemi-
cals, particularly the antioxidant polyphenols (PPs) (Willcox et al., 2009), that are likely to inter-
act in a number of ways to prevent disease and promote health (Liu, 2004).  
 
 
1.2 Phytochemicals in plant-based food  
 
Plant-based foods are prominent features of healthy dietary patterns. Despite all of the contro-
versy surrounding the optimal components of a healthy diet, there is little disagreement among 
scientists regarding the importance of fruits and vegetables (including legumes, whole grains 
and nuts; National Academy of Sciences, 1982, 1989; Liu, 2003).  
 
Evidence and future directions: So far results of numerous epidemiological studies and recent 
clinical trials provide consistent proof that diets rich in plants have significant protective effects 
and can reduce the risk of chronic disease (Block et al., 1992; Lock et al., 2005). Up to 2.635 
million deaths per year are attributable to an inadequate intake of plant-based food. Increasing 
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individual fruit and vegetable consumption up to 600 g per day could reduce the total worldwide 
burden of cardiovascular disease (CVD) and various types of cancer considerably (Lock et al., 
2005). 
 
In addition to providing energy and essential micronutrients, fruits and vegetables contain thou-
sands of biologically active phytochemicals that are likely to interact in a number of ways to pre-
vent disease and promote health (Liu, 2004). While there is ample evidence to support the 
health benefits of plant-based food, evidence that these effects are due to specific nutrients or 
phytochemicals is limited and exact mechanisms need to be deciphered. Therefore, it is rea-
sonable for scientists to precisely scrutinize phytochemical mixtures extracted from edibles and 
identify the bioactive compounds responsible for the health beneficial effects of plant-based 
foods. The driving force behind this approach is the hope to find the magic bullet to prevent 
chronic diseases and thereby provide a convenient long-lasting life. Hence, current great effort 
focus on the identification of molecules of herbal origin, which are able to significantly deceler-
ate deleterious impacts of aging in vivo and on the study of underlying physiological and genetic 
mechanisms to finally find new targets for pharmacological interventions (Wu et al., 2002; 
Viswanathan et al., 2005; Brown et al., 2006; Wilson et al., 2006; Kampkötter et al., 2007a, b, 
2008; Saul et al., 2008, 2009, 2010; Wiegant et al., 2008; Pietsch et al., 2009, 2011).  
 
Classification of phythochemicals: So far approximately 5000 individual phytochemicals have 
been identified in fruits, vegetables, and grains, but a large percentage still remain unknown. 
Phytochemicals can be classified as carotenoids, phenolics, alkaloids, nitrogen-containing com-
pounds, and organosulfur compounds. Supplementary Table 1 summarizes phytochemicals 
contained in food. Phenolics are among the best-studied phytochemicals (Liu, 2004) and pos-
sess one or more aromatic rings with one or more hydroxyl group and generally are categorized 
as phenolic acids, flavonoids, stilbenes, coumarins, and tannins. In plants phenolics are prod-
ucts of secondary metabolism, providing functions in reproduction, growth and colour and acting 
as defence mechanisms against pathogens, parasites, and predators. In addition to these abo-
riginal roles in plants, phenolic compounds ingested with our diet may provide health benefits to 
the consumer, due to adaptation processes in our metazoan ancestors (Stevenson and Hurst, 
2007).  
 
 
1.2.1 Polyphenols 
Most promising in the efficacy of reversing age-related declines and preventing CVD and cancer 
seem to be polyphenols (PPs, characterized by two or more phenolic hydroxyl groups), as evi-
denced by multiple in vivo studies (Joseph et al., 1999, 2005; Aggarwal et al., 2004; Neuhouser, 
2004; Manach et al., 2005a; Roginsky et al., 2005; Hodgson and Croft, 2006; Wilson et al., 
2006). The bioavailability and bioefficacy of certain PPs have already been proven for humans 
(Rechner et al., 2002; Nielsen et al., 2003; Manach et al., 2004, 2005b). Antioxidant properties 
were believed to be the reason for the denoted beneficial effects, however, recent indications 
point towards antioxidative-independent mechanisms (Akagawa et al., 2003; Nakagawa et al., 
2004; Galati et al., 2006; Maeta et al., 2007). PPs have been shown to alter gene expression 
patterns and act via different signaling cascades, involved in the regulation of cell growth, in-
flammation and many other processes (Williams et al., 2004; Narayanan, 2006; 
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Wilson et al., 2006; Pietsch et al., 2009, 2011). Under certain circumstances PPs appear to act 
as prooxidants which induce cellular stress responses and thereby reduce sensitivity to oxida-
tive stress. For detailed review see Stevenson and Hurst (2007). 
 
 
It is estimated that flavonoids account for approximately two thirds of the phenolics in our diet 
and the remaining one third are from phenolic acids (Liu, 2003). More than 4000 distinct flavon-
oids have been identified. They commonly have a generic structure consisting of two aromatic 
rings (A and B rings) linked by 3 carbons that are usually in an oxygenated heterocycle ring, or 
C ring. Differences in the generic structure of the heterocycle C ring classify them as flavonols, 
flavones, flavanols (catechins), flavanones, anthocyanidins, and isoflavonoids.  
The flavonoid Quercetin 
Quercetin (Q, Fig. 1 A) belongs to the subclass of flavonols and is an important dietary flavonoid 
that is present in herbal food like apples, broccoli, onions and many more herbal diets. Within 
the flavonoid family, Q is the most potent scavenger of ROS (Reactive oxygen species; Hana-
saki et al., 1994; Cushnie and Lamb, 2005), RNS (Reactive nitrogen species; van Acker et al., 
1995; Haenen and Bast, 1999) and peroxynitrite (Haenen et al., 1997; Heijnen et al., 2001). 
These antioxidative capacities of Q are attributed to the presence of two antioxidant pharmaco-
phores within the molecule, i.e. the catechol group in the B ring and the OH group at position 3 
of the AC ring (Heijnen et al., 2002). Q is also known to possess strong anti-inflammatory ca-
pacities, by inhibition of LPS induced cytokine production (Read, 1995; Manjeet and Ghosh, 
1999; Orsolic et al., 2004; Geraets et al., 2007; Bureau et al., 2008). Beyond above mentioned 
traits Q also possesses anti-fibrotic (Lee et al., 2003), anti-coagulative (Bucki et al., 2003), anti-
bacterial (Cushnie and Lamb, 2005), anti-atherogenic (de Whalley et al., 1990; Perez-Vizcaino 
et al., 2006), anti-hypertensive (Duarte et al., 2001; Perez-Vizcaino et al., 2006) and anti-
proliferative properties (Kuo, 1996; Orsolic et al., 2004; Gulati et al., 2006). Additionally, Q is 
reported to directly modulate the gene expression of enzymes involved in biotransformation 
(Walle et al., 1995; Pacifici, 2004; Schwarz et al., 2005; Moon et al., 2006) and to inhibit cell 
proliferation by interacting with estrogen binding sites (Piantelli et al., 1995; Caltagirone et al., 
1997). Q reduces oxidative DNA strand break formation and the decrease in apoptotic cell 
death by oxidative stimuli (Wätjen et al., 2005). Altogether, these studies indicate that Q may 
exert health-beneficial capacities through various damage modulating effects. Toxic effects of Q 
were only observed in vitro. These effects are most likely associated with the formation of poss-
ible toxic products (like ROS) by autoxidation and redox-cycling (Ochiai et al., 1984; Hodnick et 
al., 1986; Gaspar et al., 1994; Metodiewa et al., 1999; Yoshino et al., 1999). Genotoxic effects 
have been also reported, but are predominantly shown in bacteria (Vrijsen et al., 1990; Jurado 
et al., 1991; Rueff et al., 1995; Silva et al., 2000). However, most of the studies performed so far 
have involved the use of immortalized or cultured cell lines and are thus not easy to extrapolate 
to the whole animal, in vivo, situation. For a detailed overview be referred to Boots et al. (2008). 
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Fig. 1 Chemical structure of (A) Quercetin (MW: 302.236 g/mol), (B) Caffeic acid (MW: 180.16 g/mol), 
(C) Rosmarinic acid (MW: 360.31 g/mol) 
 
 
Two classes of phenolic acids can be distinguished: derivatives of benzoic acid and derivatives 
of cinnamic acid. The hydroxycinnamic acids are more ubiquitous than the hydroxybenzoic ac-
ids and consist mainly of p-coumaric-, caffeic-, ferulic-, and sinapic- acids. They are found in 
almost every plant (Herrmann, 1976; Kuhnau, 1976).  
The phenolic acids: Caffeic acid and Rosmarinic acid 
 
Caffeic acid (CA, Fig. 1 B), in its free as well as esterified form, is the major representative 
phenolic acid and depicts between 75% and 100% of the total hydroxycinnamic acid content of 
most fruits (Manach et al., 2004). It occurs in edibles chiefly as an ester with quinic acid, called 
chlorogenic acid. Coffee is a major source of chlorogenic acid in the human diet; other sources 
include apples, pears, berries, artichoke and aubergines (Clifford, 1999). The absorbance of CA 
in humans could be shown by Olthof et al. (2001). It presents antioxidant properties in vitro 
(Castelluccio et al., 1995; Rice-Evans et al., 1996), as well as inhibitory activities against Gram-
positive and -negative microorganisms (Lee and Lee, 2010). Furthermore it might inhibit the 
formation of mutagenic and carcinogenic N-nitroso compounds (Kono et al., 1995). CA exhibits 
antiproliferative effects in various cancer cellines (for review see Jaganathan and Mandal, 
2009), antiviral activities (for review see Arakawa et al., 2009), as well as antifungal drug poten-
tial (Pukkila-Worley et al., 2009). Moreover CA and derivatives prevent acute and chronic liver 
injury by inhibition of NF-kappaB (Muriel, 2009); it inhibits DNA methylation (a common charac-
teristic in tumor cells) in cultured MCF-7 and MDA-MB-231 human cancer cells (Vucic et al., 
2009). The in vivo impact on whole animal models is rarely investigated.  
 
Rosmarinic acid (RA, α-O-caffeoyl-3,4-dihydroxyphenyl lactic acid; Fig. 1 C) is a polyphenol 
antioxidant carboxylic acid found in many Lamiaceae herbs, used commonly as culinary herbs 
such as lemon balm, rosemary, oregano, sage, thyme and peppermint. RA is an ester of caffeic 
acid and 3,4-dihydroxyphenyllactic acid (Scarpati and Oriente, 1958), and therefore belongs to 
the cinnamate conjugates (Clifford, 1999). A multitude of biological activities have been de-
scribed, such as anti-depressive (Takeda et al., 2002), hepatoprotective (Osakabe et al., 2002), 
anti-inflammatory (Osakabe et al., 2004), anti-angiogenic (Huang and Zheng, 2006), antitumor 
(McKay and Blumberg, 2006), HIV-1-inhibiting (Dubois et al., 2008) and anti-mutagenic proper-
ties (Vattem et al., 2006; Furtado et al., 2008). RA is also known to possess marked antioxidant 
properties as a reactive species scavenger and lipid peroxidation inhibitor 
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(Kosar et al., 2008). The anti-inflammatory impact is thought to be at least partially based on the 
interference of RA with the complement cascade (Rampart et al., 1986; Englberger et al., 1988; 
Peake et al., 1991). Baba et al. (2004) found in a study with RA orally administered rats that the 
majority of fed RA was absorbed and metabolized as conjugated and/or methylated forms. So 
far most studies focus only on single outputs, but whole animal studies are missing. 
 
 
1.3 The model organism Caenorhabditis elegans 
 
 
 
Fig. 2 Caenorhabditis elegans, hermaphrodite on the 7th day of adulthood. 
 
 
History: Sydney Brenner introduced Caenorhabditis elegans (C. elegans; Caeno, recent; rhabdi-
tis, rod; elegans, nice; Fig. 2) 1963 as a convenient model organism for development and neu-
rology in biological research (Brenner, 1974). Since then C. elegans has been used as a re-
search tool around the world (Wood, 1988) and a broad knowledge infrastructure has 
developed (e.g. WormBase, a database of C. elegans genetic and genomic information, curated 
by a consortium of researchers; wormbook.org, and others). Discoveries made with C. elegans 
have been awarded with Nobel Prizes in 2002 (genetics of organ development and pro-
grammed cell death), in 2006 (RNA interference) and in 2008 (work on GFP, some of it in C. 
elegans).  
 
Biology: C. elegans is an originally free living, soil-dwelling, bacteriovorous (Byerly et al., 1976), 
non-parasitic, small (adult size about 1 mm) nematode. It has a short life span of approximately 
18–20 days depending on the temperature (due to its ectothermie, Klass, 1977) and a rapid 
generation time (3 days at 22°C), thus, can be easily and cheaply cultured and preserved (cryo-
genically at -80°C) in large numbers in the laboratory. Adult wild type C. elegans hermaphro-
dites constantly contain 959 cells (cell constance), exactly 302 of which are neurons. The situa-
tion in males is somewhat different (Sulston and Horvitz, 1977; Sulston et al., 1980). Due to its 
transparency in all life-stages, it is easy to track cells and follow cell lineages, as the complete 
cell-lineage is well-established (Sulston and Horvitz, 1977). Hence, research on development 
and morphology of a single cell and how genes influence cell fate, can be done within a living 
organism (Kenyon, 1988; Wood, 1988; Donald, 1997; Horvitz, 2004). Furthermore, many green-
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fluorescence protein (GFP) reporter-gene strains have been developed, enabling researchers to 
visualize signaling pathways, developmental processes and structures of anatomy (Gruber et 
al., 2009).  
 
Genetics: As the first animal, C. elegans’ whole genome was sequenced at the end of 1998 and 
striking similarities to human genes have been found (around 60-80%; Sonnhammer and Dur-
bin, 1997; The C. elegans Sequencing consortium, 1998; Lai et al., 2000; Kuwabara and O’Neil, 
2001; Harris et al., 2004), what made C. elegans a popular model for human diseases (e.g. di-
abetes and obesity, aging, cancer, Alzheimer’s disease, Parkinson’s disease, Huntington’s dis-
ease, depression, neuronal regeneration/pain, autosomal dominant polycystic kidney disease 
(ADPKD), muscular dystrophy, ionchannelopathie and innate immunity (for excellent review see 
Kaletta and Hengartner, 2006)). Even though a direct translation of human pathology into C. 
elegans phenotypes is not possible, this model system approach helps to enlighten molecular 
mechanisms which contribute to find new therapeutics.  
 
The size of the genome is around a hundred million base pairs (20x bigger than in E. coli, 1/30 
of humans; www.wormclassroom.org), which codes approximately 18 000 genes. It has five 
pairs of autosomes and one pair of sex chromosomes. The distinction in two sexes (males and 
hermaphrodites) results from the ratio of sex chromosomes to autosomes (6th chromosome pair 
XX: hermaphrodite; X0: male). On one hand hermaphrodites can self-fertilize or mate with 
males, but hermaphrodites cannot fertilize each other. In case of mating with males, the ratio 
between males and hermaphrodites will be 50:50. In nature and under laboratory standard con-
ditions, hermaphrodites are the most common sex (> 99%). To produce certain desired geno-
types for genetic studies in the laboratory, reproduction can be channeled either to self-
fertilization or crossing with males. By self-fertilization the diversity of individual genotypes can 
be neglected, thus populations can be maintained isogenic (clonal), which bears many advan-
tages. A self-fertilizing hermaphrodite can produce up to 350 progeny during the first week of 
adulthood, a number which is even higher when mated with males. All of these characteristics 
contribute to the ease in producing various geno- and phenotypes for research issues (Klass, 
1977; Wood, 1988; Horvitz, 1997). Worms can additionally be manipulated by the use of RNA 
interference (RNAi). Altered bacteria, producing dsRNA from a desired C. elegans gene, can be 
simply fed to the worms, what produce loss-of-function phenotypes in the nematode (Timmons 
and Fire, 1998).  
 
Advantages of research in C. elegans: Due to the contribution of the whole C. elegans research 
community an extensive library of mutant- and GFP strains, as well as RNAi bacterial strains 
have been generated, which can be ordered (C. elegans Genetic Center and e.g. under 
www.lifesciences.sourcebioscience.com). Furthermore, many protocols and methods for genetic 
manipulations have been developed and are easy to access through databases. Hence, re-
search in C. elegans bears the potential to bridge the gap between in vitro and in vivo ap-
proaches by combining the use of high-throughput technologies (e.g. genome-wide RNAi stu-
dies, microarrays) in a multicellular, whole animal setting (Kaletta and Hengartner, 2006) and 
therefore is also a feasible model for the pharmaceutical industry to identify new drug targets.  
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1.3.1 C. elegans in aging research 
C. elegans undoubtedly gained its popularity in aging research due to the findings of single 
gene mutations, which dramatically prolonged the lifespan of the nematodes. By then, the aging 
research area was predominantly circulating around the underlying genetics, while now many 
more approaches are used, e.g. environmental manipulations such as caloric restriction (CR) 
and hormetic treatments, evolutionary and population studies, models of age-related diseases, 
and drug screening for compounds that extend life span (reviewed in Olsen et al., 2006).  
 
Qualifications for being an aging model: Age-related changes in C. elegans resemble those in 
other organisms: nematodes are less active, display uncoordinated movements and eventually 
completely stop moving, likely due to muscle degeneration. Furthermore, they accumulate lipo-
fuscin, dark-pigments and vacuole-like structures (Herndon et al., 2002) and display enhanced 
levels of oxidized proteins (Adachi et al., 1998; Nakamura et al., 1999; Yasuda et al., 1999). 
Although C. elegans populations are comparatively clonal, the variability of age-related changes 
between individuals are still very high, which leads to the assumption that stochastic events play 
a prominent role in C. elegans’ aging (Herndon et al., 2002). 
 
Similar to several other species, in C. elegans there is a mechanistic connection between stress 
resistance and longevity that is well established. It is probable that all long-lived mutant strains 
are armed with a robust resistance to oxidative stress, hypoxia, heat shock, UV radiation and 
heavy metal stress. Accordingly, it is possible to enhance longevity in wild type animals by a 
range of manipulations that enhance stress resistance, e.g. overexpression of certain heat 
shock proteins (hsps). Furthermore, longevity in wild type animals can be triggered by the short-
term application of stressors such as increased heat, high oxygen and gamma irradiaton, (re-
viewed in Olsen et al., 2006). These aspects all contribute to the feasibility of C. elegans as a 
model organism for aging research. 
 
Genetic pathways affecting aging in C. elegans: The existence of stress-resistant, long-living 
dauer larvae formed as a result of stressful conditions such as low nutrition or high population 
density, is of great interest for aging research (Anderson, 1978; Larsen, 1993; Riddle and Al-
bert, 1997). It has been found that many mutations with effects on dauer formation are also 
players of the evolutionary conserved insulin/IGF-I signaling pathway (Insulin-like signaling; ILS; 
Fig. 3) and affect adult longevity (reviewed in Kenyon, 2011). Many ILS pathway mutations have 
been shown to influence lifespan in flies and mice and recently new links to human longevity 
have been reported (Kenyon, 2011). Key genes in ILS are daf-2, age-1 and daf-16. daf-2 en-
codes a homolog of the mammalian insulin/IGF-I receptor (Brown, 1979) and age-1 encodes 
the catalytic p110 subunit of phosphoinositide-3-OH kinase (PI3K) found downstream of DAF-2 
(Garigan et al., 2002). Mutations in age-1 and daf-2 cause large increases in the nematodes’ 
lifespan as well as enhanced stress resistance, both dependent on daf-16. daf-16 encodes the 
central FOXO forkhead transcription factor of the ILS pathway and is the major downstream 
effector of DAF-2 (Tatar et al., 2003). Its transcriptional targets include stress response, antimi-
crobial, and metabolic genes, as well as many genes of unknown function (for detailed review 
see Landis and Murphy, 2010), some of which in turn impact aging (Murphy et al., 2003). Genes 
which also play a role in ILS are sgk-1, aap-1, daf-18, pdk-1, akt-1/2, hsf-1 (reviewed in Schaf-
fitzel and Hertweck, 2006). 
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Fig. 3 Model for ILS Signaling. Upon DAF-2 activation, AGE-1 and PIP3 activate PDK-1. PDK-1 phos-
phorylates AKT-1, AKT-2, and SGK-1 that form a kinase complex to antagonize DAF-16 by direct phos-
phorylation. The major importance of AKT-1 and AKT-2 to prevent DAF-16 from inducing the dauer pro-
gram is indicated. SGK-1, but not the AKT kinases, inhibits DAF-16-induced longevity and stress 
tolerance. (Reprinted from Hertweck et al. (2004), with permission from Elsevir). 
 
 
Beside the ILS and its molecular players, more genes and genetic signaling pathways have 
been discovered related to lifespan variations (Fig 4). To mention a few: germline signaling (daf-
12 glp-1, mes-1), CR, SIR2 deacetylase activity (probably with importance in CR), JNK-
signaling (jnk-1, jkk-1) , TOR (let-363, daf-15, pep-2) and TUBBY signaling (tub-1), mitochondri-
al mechanisms (isp-1, clk-1), oxidative stress signaling (gsk-3, skn-1) and others (aak-2, eat-2). 
For detailed review be referred to Schaffitzel and Hertweck (2006). 
More recently, the identification and analysis of compounds that delay aging and extend lifes-
pan became an important aspect of gerontology research. Besides testing theories of aging, it 
leads to the identification of endogenous mechanisms which underlie the aging process and 
provides a basis for treatments, which are able to slow down senescence. A good overview 
about the procedure of testing and a good review about so far conducted studies are provided 
in Collins et al. (2006). 
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Fig. 4 Regulation of lifespan in C. elegans. Several evolutionary conserved mechanisms contribute to 
the complex regulation of lifespan in C. elegans. Decreased activity (indicated in blue) and increased 
activity (indicated in orange) of the following signaling pathways and processes lead to longevity in the 
animal. In some of these mechanisms, including ILS-, germline-, TOR-, TUBBY-, JNK- signaling, and 
SIR2 activity, lifespan extension occurs in a DAF-16-dependent manner. (Reprinted from Schaffitzel and 
Hertweck (2006), with permission from Elsevir). 
 
 
1.4  Aging 
 
 “The situation borders on ludicrous. We have landed on the moon and sequenced the human genome but there is 
still no scientific agreement on even the nature of aging.” (Goldsmith, 2008) 
Aging, also called organismal senescence, is due to the accumulation of changes in an organ-
ism over time (Bowen and Atwood, 2004). These changes affront the healthy functioning and 
survival of the organism; however, it has proved difficult to deduce the relative importance of the 
manifold processes that leads to aging (Murphy and Patridge, 2008). Commonly aging is cha-
racterized by a declining ability in stress response, decreased homeostatic balance and an in-
creasing risk of aging-associated diseases, which finally leads to death. Species-specific maxi-
mum lifespan correspond to inherited differences in the rates of aging and therefore a human is 
considered elderly at 80 years, while a mouse is considered elderly at 3 years of age. From a 
more generalized view, organismal aging could be summarized as the result of two contrarian 
forces: (i) destabilization processes that increase the probability of death of an organism, and (ii) 
longevity assurance mechanisms that prevent, repair, or embank damage (Zimniak, 2008). 
Processes of the first group are often chemical and physico-chemical in nature and are either 
inevitable or only under marginal biological control. Unlike protective mechanisms, which are 
genetically determined and are subject to natural selection. Lifespan is therefore largely depen-
dent on the investment into protective mechanisms, which evolved to optimize reproductive fit-
ness. Senescence of the organism gives rise to the Gompertz-Makeham law of mortality, which 
postulates that mortality rate increases exponentially with age. It is composed of an age-
independent component (Mekeham term, Makeham, 1860) and an age-dependent component 
(the Gompertz term, Gompertz, 1825). Where the age-independent component is negligible 
(e.g. laboratory conditions, low mortality countries), the function simplifies to the Gompertz law 
of mortality. 
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1.4.1 Why do we age? - Selected Aging theories 
Why aging occurs has been debated for 150 years and still remains a mystery in the scientific 
world, with yet no consensus over the general nature of aging. Two general directions of 
thoughts exist, which can be summarized by following questions:  
1. Is aging an evolved characteristic of organism’s design, programmed by the organisms’ 
genetics and thus the active result of this pro-aging design, because a limited life-span 
confers some advantage? 
2. Or is aging not an evolved characteristic but rather a fundamental limitation that apply to 
all living things, a defect that confers no benefit and displays rather the passive result of 
forces acting upon the organism?  
 
Around 300 different scientific aging theories have arisen so far (Medvedev, 1990) but all of 
them either fail to fully explain observed animal characteristics or conflict with the widely ac-
cepted evolution theory. Some of these theories may be a result of other theories and some are 
interlinked.  
 
The existing aging theories can be crudely classified in three categories 
(http://www.programmed-aging.org/): 
- Mechanistic theories 
1. Simple deterioration theories (“wear and tear”) 
- Evolutionistic theories 
2. Programmed theories, also known as adaptive or active theories 
3. Non-programmed theories, also known as non-adaptive or passive theories 
Below follows a selection and short overview of single theories. 
 
 
Biological aging could be simply the result of universal deteriorative processes, such as oxida-
tion or wear and tear, as is the cause in machineries and other inanimate objects. Some theo-
ries assume that aging is just a process of increasing entropy and over a certain time results in 
deterioration. However, entropy can be reversed by application of energy and living organisms 
routinely reverse entropy using food energy in order to grow and live. But why is the body able 
to use energy to antagonize this deterioration for a certain time, but fails in old age? And how is 
it possible, that two closely related species, like naked mole rats and mice for example, display 
huge variations in their maximal lifespan (30 and 2 years, respectively)? Furthermore these 
theories fail to explain, why some organisms apparently do not age (Negligible Senescence, 
e.g. Hydra; Martinez, 1998) and why other organisms die suddenly after reproduction. Conse-
quently, few scientists believe in simple deterioration theories and more complex explanations 
for aging evolved. Nevertheless, many scientists do still believe in oxidative and other molecular 
damage to be involved in the aging process, but beyond additional factors probably determine 
whether this damage is repaired. 
Simple deterioration theories (“wear and tear”) 
 
ROS and aging: Oxygen is essentially required for aerobic life, but also may play a prominent 
role in aging (for a detailed review of causes and effects of ROS and a summary of experiments 
in the worm C. elegans that have examined the relationship between ROS and aging see Van 
Raamsdonk and Hekimi, 2010). Following the aging theories associated with Reactive oxygen 
species (ROS) are scarcely described: 
 
Introduction 
21 
 
In the early 1900s observations by Rubner pointed towards a role for oxygen in determining 
lifespan. He found an inverse relationship between metabolism and lifespan: large animals tend 
to have longer lives, than small animals and small animals have a higher metabolic rate (Rubn-
er, 1908). Hence, the basis for the Rate-of-living theory of aging was born, which postulates 
that the lifespan is dependent on the metabolic rate (Pearl, 1928). Furthermore this theory tried 
to include the idea of a delimited amount of energy which each individual own when starting life. 
The lifespan is therefore determined by the speed of energy consumption (for review of the rate-
of-living theory see Speakman, 2005). 
 
The Free radical theory of aging (FRTA), proposed by Harman (1956), provided a possible 
mechanism for the rate-of-living hypothesis: it suggested that the progressive process of aging 
results from the accumulation of molecular damage caused by ROS, by-products of normal me-
tabolism. During energy generation from food and oxygen, a small percentage of oxygen is 
converted to ROS. ROS causes oxidative damage to DNA, proteins, and lipids, which accumu-
lates over time. The free radical theory of aging suggests that the accumulation of oxidative 
damage is the cause of aging. According to this theory, the accumulated oxidative damage 
eventually leads to cellular dysfunction and increases the probability of death. Hence, a species 
with a higher metabolic rate, produce more ROS, thereby more molecular damage arise faster, 
the rate of aging increase, thus the lifespan decreases (for review see Van Raamsdonk and 
Hekimi, 2010). 
 
In 1972 Harman refined his theory to highlight the role of mitochondria in the aging process (Mi-
tochondrial theory of aging (MTA), also called Oxidative stress theory of aging). The energy 
providing mitochondria are the main producers of free radicals and also the primary sites for 
free radical damage. The production of free radicals at the level of the electron transport chain 
subsequently results in the formation of various ROS species in the mitochondria of all tissues 
(Lapointe and Hekimi, 2010) and damage in mitochondrial and cytosolic constituents occur 
which lead over time to aging. Furthermore it is suggested that the oxidative damage to mito-
chondrial constituents results in a deterioration of mitochondrial function. The resulting mito-
chondrial dysfunction leads to more ROS generation and the global (also non-mitochondrial) 
oxidative damage will progressively accumulate.  
 
In the last decades, both the FRTA and the MTA has attracted much interest and hence are 
presumably the broadest tested theories of aging. Numerous experiments were conducted, both 
supporting and refuting the assumptions of these theories (reviewed in Muller et al., 2007; La-
pointe and Hekimi, 2010). Nevertheless, there is unquestionable evidence for the age-
dependent accumulation of ROS damaged products (Epstein et al., 1972; Adachi et al., 1998; 
Gerstbrein et al., 2005;), abnormalities and dysfunction of mitochondria as well as a decreased 
metabolic capacity (Epstein et al., 1972; Melov et al., 1995; Van Voorhies and Ward, 1999; Ya-
suda et al., 2006; Braeckman et al., 2002) in C. elegans (reviewed in Gruber et al., 2009). Rea-
sons to refute these theories arose due to discoveries of ROS not just as damaging species, but 
also as important signaling molecules in intracellular pathways and as effectors in pathogen 
resistance (Lamb and Dixon, 1997). Hence, a consensus on whether or not oxidative damage is 
responsible for aging has not yet been achieved.  
 
The FRTA states that ROS are the major cause of aging. If this is true, the modulations of en-
dogenous antioxidant defense systems or a supplementation with exogenous antioxidants seem 
to be promising strategies for delaying aging (Gruber et al., 2009). Indeed, a number of studies 
have examined the effects of compounds that influence ROS levels on C. elegans lifespan (re-
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viewed in Collins et al., 2006 and Ramsdoonk and Hekimi, 2010) and also mutations which re-
sult in increased or decreased antioxidant defense (reviewed in Ramsdoonk and Hekimi, 2010). 
 
Mutations affecting the endogenous defense: C. elegans mutants which support the FRTA are 
e.g. mev-1, daf-2, eat-2 and age-1. The mev-1 mutation affects the mitochondrial complex II, 
ROS production is increased and levels of oxidative damage are elevated. mev-1 are hypersen-
sitive to oxidative stress and short-lived (Senoo-Matsuda et al., 2001). On the other hand long-
lived daf-2, age-1 and eat-2 display elevated levels of antioxidant enzymes like catalases (CAT) 
and superoxide dismutases (SOD) and possess an enhanced resistance to oxidative stress 
(Larsen, 1993; Vanfleteren, 1993; Houthoofd et al., 2002; Murphy et al., 2003; McElwee et al., 
2004; Panowski et al., 2007). Further examples of mutants with an inverse relationship of lifes-
pan and sensivity to oxidative stress are prdx-2, trx-1 and gst-10 (reviewed in Van Ramsdoonk 
and Hekimi, 2010). Hints against the FRTA comes from experiments with sod deletion mutants: 
the deletion of sod genes, alone or in combination, has little or no impact on lifespan despite the 
clear increase in sensitivity to oxidative stress (reviewed in Gruber et al., 2009 and Van Rams-
doonk and Hekimi, 2010). All results from mutant strains have to be interpreted carefully, since 
some of these antioxidant defense genes have multiple roles within the cell (e.g. peroxiredoxin, 
TRX, glutaredoxin) whereas others have the only (known) function to detoxifying ROS (e.g. 
SOD and catalase). Thus, the effect on lifespan may not necessarily result from the gene’s ef-
fect on oxidative stress resistance. 
 
Studies with antioxidative acting compounds (exogenous antioxidative defense): Many studies 
examined the effects of so-called antioxidants (or compounds which influence ROS levels) on 
C. elegans lifespan (summarized in Collins et al., 2006; Saul et al., 2009; Van Ramsdook and 
Hekimi, 2010). While treatment of C. elegans with exogenous antioxidants predominantly pro-
voked an increased resistance to oxidative stress, there was some variability concerning the 
effects on lifespan (dependent on dose, experimental conditions, and method of delivery). Nev-
ertheless, most of the tested antioxidants could increase lifespan under at least one set of con-
ditions. Examples for such compounds are EGCG (Brown et al., 2006; Abbas and Wink, 2009; 
Zhang et al., 2009); Resveratrol (Gruber et al., 2007); Gingko Bilboa (Wu et al., 2002; Cao et 
al., 2007), Tocotrienol (Adachi and Ishii, 2000), coenzyme Q 10 (Ishii et al., 2004) and others. 
 
Recently some artifacts associated with the handling of C. elegans in testing of antioxidants and 
other agents have been discussed (Gruber et al. 2009; Pun et al. 2010). First, in vitro determi-
nation of antioxidants is not predictive to in vivo antioxidant properties. Second, in vivo antioxi-
dant properties as measured e.g. by protein carbonyl content were not predictive for lifespan 
extension (Pun et al., 2010). And third, Pun et al. suggests, the ability of (some in vitro) antioxi-
dants to increase lifespan is not solely explainable by their mediation of oxidative stress resis-
tance. Other mechanisms have to be considered to explain these findings. For example issues 
about the direct vs. the indirect antioxidative (triggering the endogenous antioxidative response; 
elevated expression of enzymes) actions of the compound in vivo. One argument for indirect 
actions recently was pointed out by Halliwell (2007): unconjugated polyphenols, which possess 
antioxidant properties, rarely exceed the low µM range in plasma, while total antioxidant capaci-
ty is often in the range of 1 mM. These pitfalls and the associated complexities can only be cir-
cumvented by choosing a broad spectrum of bioassays and adequate biomarkers for oxidative 
damage and protection. Furthermore methodological challenges have to be addressed which 
ensure the standardization of handling in the C. elegans community to circumvent variations of 
results due to variable test designs (information on methodological considerations, genetic in-
homogeneity and drift in C. elegans can be found in Collins et al. (2006), Patridge and Gems 
(2007) and Gruber et al., (2009)).  
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Finally it should be mentioned, that extensive studies addressing the supplementation of anti-
oxidants in humans have failed to support assumptions made by FRTA (Anghel, 2010). The 
current scientific consensus is rather that there is no health benefit when taking antioxidant 
supplements (Howes, 2006) or even more unexpected an article announced that antioxidants 
may actually prevent the health-promoting effects of physical exercise (Ristow et al., 2009). 
Howes (2006), who reviewed clinical studies with altogether 550 000 humans, which overwhel-
mingly have failed to confirm the FRTA, claims: “The free radical theory has fallen”. Probably 
studies with humans bear too many variables to get predictive results. For a critical review see 
Halliwell (2007). A new concept arose: the mitohormesis theory. 
 
Contrasting to assumptions made by the FRTA, mitohormesis (mitochondrial hormesis) de-
notes a biochemical process, in which an enhanced production of ROS in activated mitochon-
dria, induce the cell intern stress response against oxidative stress, thereby reduce net stress 
levels and hence, possibly prolongs lifespan in a hormetic way (Vanfleteren, 1993; Houthoofd et 
al., 2002; Johnson et al., 2002; Kharade et al., 2005; Sinclair, 2005; Zarse et al., 2007). Further 
support gains this theory by evidence of increased ROS production provoked by physical exer-
cise (Chevion et al., 2003), which has proved to prolong lifespan in humans (Lindsted et al., 
1991; Manini et al., 2006). Schulz et al. (2007) could show that increased glucose availability 
decreases C. elegans lifespan, while controversially, diminished glucose metabolism extends 
life by inducing mitochondrial ROS production and thereby stress resistance. Recently, a study 
by Ristow et al. (2009) in humans evaluated the influence of the antioxidants Vitamin C and E 
on the positive effect of physical exercise. They conclude that antioxidant supplements prevent 
the induction of molecular regulators of insulin sensitivity and endogenous antioxidant defense 
by physical exercise. Consistent with the concept of mitohormesis, they postulate that tempo-
rary enhanced oxidative stress levels are presumably a potentially health promoting event at 
least concerning insulin sensitivity and the prevention of insulin resistance and type 2 diabetes 
mellitus. Additionally, the meta-analysis of studies in humans with antioxidant supplements 
(Howes, 2006; Bjelakovic et al., 2007), could not confirm benefits, but rather neglects them. In 
summary, all these findings support the mitohormesis theory. 
 
Gems and McElwee (2005) postulated the Green theory of aging (Fig. 5) on the basis of find-
ings in DNA-microarray studies in long-lived daf-2 mutants (McElwee et al., 2003, 2004; Murphy 
et al., 2003). They found a major role in longevity assurance of the phase 1 and phase 2 detox-
ification system in daf-2 mutants, which involve cytochrome P450 (CYP), short-chain dehydro-
genase/reductase (SDR) and UDP glucuronosyltransferase (UGT) enzymes. This system is 
energetically costly and requires the excretion of its products out of the cell (unlike superoxide 
and hydrogen peroxide detoxification). Given that aging results from molecular damage by toxic 
products of the metabolism and xenobiotics (whereof ROS are just one component), the en-
hanced activity of detoxification processes can lead to an extended lifespan. A further compo-
nent of this theory is based on the conservation of existing proteins via molecular chaperones. 
Due to the accentuation in this theory on investment in cellular waste disposal and on protein 
conservation, Gems and McElwee (2005) named this longevity assurance mechanism the green 
theory. 
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Fig. 5 Broad spectrum detoxification and longevity assurance. It is proposed that a major contributor 
to the aging process is molecular damage resulting from toxins (mainly endobiotic and lipophilic) which 
are targets of the phase 1, phase 2 detoxification system. In this model, the smooth endoplasmic reticu-
lum functions as a longevity organelle, derivatising and excreting lipophilic toxins. However, this process 
is energetically costly, and most cells take the energy saving step of down-regulating the detoxification 
system, and dumping toxins within lipofuscin depots. The consequence of this is accelerated aging. Re-
versing this process means up-regulation of the biotransformation and hsp-response (Green theory of 
aging). CYP: cytochrome P450; GST: glutathionyl; Gluc: glucuronosyl/glucosyl; SDR:short-chain dehy-
drogenase/reductase; UGT:UDP-glucuronosyl-/glucosyl- transferases. (Reprinted from Gems and McEl-
wee (2005), with permission from Elsevier). 
 
 
These theories assume that organisms are designed with a genetically programmed limited li-
fespan because aging and consequently limited lifespan conduce to some evolutionary advan-
tage. According to this concept, aging is a necessary biological function and like other biological 
functions, can be directed by a lifespan regulation system involving hormones, signaling, genes, 
sensing of external conditions. A lifespan exceeding the species-specific value mediate disad-
vantages and therefore cause evolutionary motivation to develop the aging function. 
Programmed, adaptive, active theories 
 
Weismann (1882) suggested that aging and finally death was a genetically programmed, 
evolved characteristic due to natural selection, because it confers benefit to the species in spite 
of its negative effects on the fitness of the individual (Weismann’s Theory of Programmed 
Death). By removing older members, programmed death shifts resources (e.g. food and habitat) 
from less evolved, older animals to more evolved, younger animals and thereby improves the 
species’ general ability to evolve, especially its ability to adapt to changes in its external envi-
ronment. Because of two problems, current biologists have largely discounted Weismann’s 
theory: (i) If there was a genetically programmed characteristic, its mutation would possibly lead 
to immortal individuals, and therefore evolution would tend to infinite longevity, which obviously 
has not happened so far. (ii) Most animals in the wild essentially never lived long enough to die 
of old age. Therefore the potential benefit of programmed death could never have been realized 
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and thus could not have driven evolution. Programmed death therefore violates the theory of 
natural selection.  
 
 
Main focus of these theories is embedded in the assumption that aging does not serve an evo-
lutionary goal. Aging is rather an inevitable adverse side-effect of some useful biological func-
tions. These theories assume that organisms do not have an evolutionary need to live longer 
than the species-specific lifespan and therefore did not develop or even lost the trait to live 
longer.  
Non-programmed, non-adaptive, stochastic passive theories 
 
Medawar (1952) postulated that the evolutionary effect of adverse conditions declines to the 
point of being negligible, beyond the age at which an organism is initially capable of reproduc-
tion. Therefore, random, detrimental mutations which only cause late-life negative effects would 
not be ruled out efficiently by natural selection and can accumulate over time and with each 
generation (Mutation accumulation theory). Hence they would cause the decline and damage 
that we associate with aging (Edney and Gill, 1968). Among other aspects, this theory cannot 
explain, why a number of diverse organisms (e.g. salmon, octopus, marsupial mouse and bam-
boo) also display death closely following an act of sexual reproduction. Death in these species 
appears to be controlled by the reproductive function or controlled by factors triggering repro-
duction as opposed to calendar age. 
 
Pleiotropy is defined as a situation in which a single gene controls more than one trait. Williams 
(1957) proposed that aging was caused by the combined effect of many pleiotropic genes that 
each displayed beneficial effects in an animal’s youth but also had an adverse side effect at 
older age (Antagonistic pleiotropy theory). If evolution is a race to have the most offspring the 
fastest, then enhanced early fertility could be selected even if it is associated with trade-offs that 
included deterioration, senescence and death later on. The antagonistic pleiotropy theory con-
sidered any alteration of the aging process as impossible, because aging is held for a side ef-
fect of necessary functions. One example on which this theory is applicable is p53, which sup-
presses cancer during lifetime, but also suppresses stem cells, which recreate worn-out tissue 
and thereby causing aging (Rodier et al, 2007). Contrary examples brought breeding experi-
ments with Drosophila. Leroi et al. (1994) inbred flies which lived twice as long as their parental 
generation, but nevertheless laid more eggs, thereby invalidating antagonistic pleiotropy. 
 
Proposed by Kirkwood and Holliday (1979), the Disposable soma theory assumes that aging 
occurs due to the accumulation of damage over time, which results in failures of repair and de-
fense mechanisms (Kirkwood, 1977; Kirkwood and Holliday, 1979; Kirkwood, 2000). They pre-
sumed that certain gene mutations save energy for reproduction in an antagonistic pleiotropic 
manner, by partially disabling molecular proofreading and other maintenance mechanisms in 
somatic cells (reviewed in Ljubuncic and Reznick, 2009). That means an organism has to deal 
with delimited resources, which have to be rationed between maintenance and reproduction. 
Thus, an optimal balance between somatic repair and maintenance on one hand versus repro-
ductive success on the other hand is to be aspired by each organism. The germ line (reproduc-
tive cells) must be maintained to preserve the viability throughout many generations, whereas 
the soma serves only one single generation. Therefore, the disposable soma theory links me-
chanistic and evolutionary theories of aging by stating that aging results from progressive ac-
cumulation of molecular and cellular damage, as a direct consequence of evolved limitations in 
the genetic settings of maintenance and repair functions. Supporting evidence for this theory 
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comes from studies in mice and Drosophila melanogaster, where a reduction in body size corre-
lates with longevity (Flurkey et al., 2001; Nielsen et al., 2008) but also in C. elegans, where Har-
rington and Harley (1988) observed a reduction of offspring in response to Vitamin E mediated 
longevity. Similarly, Saul et al. (2009, 2010) discovered that Catechin and Tannic acid mediated 
longevity was associated with an attenuation of growth. 
 
 
1.4.2 Modulation of lifespan: Caloric restriction and Hormesis 
In 1935 McCay et al. found, that rats fed a restricted diet show diminished age-associated phy-
siological deterioration and partly age-associated diseases, and display enhanced lifespan. 
Since that time CR (also called dietary restriction) has been grown to a major research area in 
gerontology and it has been shown that application of a 30-50% restricted diet is able to extend 
lifespan in multiple species and model organisms (rats, mice, fish, flies, nematodes, water fleas, 
yeast, dogs, spiders; Masoro, 2000). Some side-effects of CR have been reported e.g. limita-
tions in the reproductive capacity (Holliday, 1989; Vanfleteren & Braeckman, 1999; Martin et al., 
2008) and the growth (McCay et al., 1935; Mörck & Pilon, 2006). Until now many reviews focus-
ing on CR have been published (to cite a few: Weindruch and Walford, 1988; Masoro, 2000; 
Speakman et al., 2002; Heilbronn and Ravussin, 2003; Ingram et al., 2004; Anson et al., 2005; 
Gredilla and Barja, 2005; Sinclair, 2005; Wolff and Dillin, 2006; Bishop and Guarente, 2007 and 
Piper and Bartke, 2008).  
Caloric restriction (CR)  
 
Experimental induction of CR: A number of methods exist to restrict nutrients, all of which pro-
voke longevity (Goodrick et al., 1990; Mair et al., 2005; Masoro, 2005; Dilova et al., 2007; Mair 
and Dillin, 2008; Piper and Bartke, 2008; Skorupa et al., 2008). Considering C. elegans there 
are eight different protocols (genetic mutation in the eat-2 gene, two different methods to dilute 
the bacteria in liquid cultures, axenic medium, chemically defined medium, dilution of peptone in 
the agarose plates, absence of bacteria on the plates and serially diluted bacteria on plates; 
Greer and Brunet, 2009). Moreover, a few chemical compounds have to be proposed to act as 
CR mimetics without actually restricting food (Ingram et al., 2006). In this context resveratrol 
was claimed to mimic CR in yeast (Howitz et al., 2003), worms (Wood et al., 2004; Viswanathan 
et al., 2005; Gruber et al., 2007), flies (Wood et al., 2004), fish (Valenzano et al., 2006) and 
mice (Baur et al., 2006), although some studies could not find any life extension in flies (Bass et 
al., 2007) and mice (Pearson et al., 2008). At present, studies with primates and humans are 
ongoing and will give final results in a few years. So far humans on a CR diet were found to dis-
play a reduction in blood pressure, glucose levels, insulin levels, body mass index, body fat per-
centage, C-reactive protein and other markers (Fontana et al., 2004). Thus, risk factors for age-
related diseases like diabetes and arterioscleroses are lowered and it appears possible that CR 
extends life span also in these species (Fontana et al., 2004; Heilbronn et al., 2006; Ingram et 
al., 2006a; Weindruch, 2006 and Fontana and Klein, 2007).  
 
General mechanisms underlying CR-induced longevity: Many hypotheses regarding the under-
lying mechanisms have been postulated (reviewed in Sinclair, 2005), which include develop-
mental delays (McCay et al., 1935), reduced metabolic rate (reviewed in Krystal and Yu, 1994), 
laboratory artifacts (Cutler, 1982; Hayflick, 1994), attenuated glucocorticoid pathways (Spindler 
et al., 1991; Nelson et al., 1995; Masoro, 1996), diminished fat levels (Berg and Simms, 1960), 
decreased ROS (reviewed in Barja, 2004; Merry, 2002), increased rate of cell survival (Koubova 
and Guarente, 2003; Cohen et al., 2004), changes in protein turnover rates (Lewis et al., 1985; 
Tavernarakis and Driscoll, 2002; Del Roso et al., 2003), diminished glucose and insulin levels 
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(reviewed in Kalant et al., 1988), diverse endocrinological changes (subject of debate in Mobbs 
et al., 2001; Miller et al., 2002; Bluher et al., 2003; Masternak et al., 2004) and hormesis (Maso-
ro and Austad, 1996; Rattan, 2004; Turturro et al., 2000; Masoro, 2000; Lithgow, 2001; Mattson 
et al., 2002; Anderson et al., 2003). The hormesis hypothesis (for general introduction to hor-
mesis section below) of CR embrace many of aforementioned events by making four key pre-
dictions (Sinclair, 2005): (i) CR induce signaling pathways that respond to biological stress and 
a low nutritive status; (ii) these pathways contribute in defending against causes of aging; (iii) 
these pathways regulate glucose, fat, and protein metabolism to enhances the chance of sur-
vival during times of stress; and (iv) these pathways act in a coordinated manner due to endo-
crinological regulation.  
 
Genetic basics of CR: Recent research uncovered genes which mediate longevity by different 
CR regimes or resveratrol in invertebrates (Lakowski and Hekimi, 1998; Wood et al., 2004; 
Hansen et al., 2005; Viswanathan et al., 2005; Wang & Tissenbaum, 2006; Bishop & Guarente, 
2007; Greer et al., 2007; Hansen et al., 2007; Panowski et al., 2007; Steinkraus et al., 2008). 
Possibly the one that gained the most attention was the NAD-dependent deacetylase of the Sir2 
family (Greer and Brunet, 2009). It was found to be necessary for longevity in various CR re-
gimes and resveratrol (Lin et al., 2000; Rogina & Helfand, 2004; Wood et al., 2004; Chen et al., 
2005; Viswanathan et al., 2005; Wang & Tissenbaum, 2006). Controversially, Kaeberlein et al. 
(2004, 2006), Lee et al. (2006), Bass et al. (2007) and Hansen et al. (2007) found no evidence 
for the involvement of Sir2 in CR or resveratrol-mediated longevity. Additionally the TOR path-
way was identified in yeast, worms and flies as involved in CR action (Kapahi et al., 2004; Kae-
berlein et al., 2005; Hansen et al., 2007), but apparently not in C. elegans (Henderson et al., 
2006). More genetic mediators for CR are discussed in Greer and Brunet (2009). 
 
 
"All things are poison, and nothing is without poison; only the dose permits something not to be poisonous." 
Hormesis  
 (Paracelsus, (1493 - 1541)) 
In 1888 hormesis was first described by Schulz, a pharmacologist who observed the stimulation 
of yeast growth after treatment with small concentrations of poisons. Together with Arndt, who 
studied the effect of a low drug exposure in animals, they formulated the Arndt-Schulz law. The 
rule was discredited in the 1920s and ‘30s due to Arndt’s advocacy of homeopathy (Kaiser, 
2003). 1943 the term hormesis was first coined by Southam and Ehrlich, but is recently revived 
due to the work of Calabrese on peppermint plants (Calabrese, 2004).  
 
Concept of hormesis: Hormesis (from Greek hórmēsis "rapid motion, eagerness," from ancient 
Greek hormáein "to set in motion, impel, urge on") is a term that denotes adaptive non-linear, 
biphasic dose-response effects at low concentrations of otherwise toxic agents (Oberbaum and 
Cambar, 1994). It is characterized by low dose stimulation and high dose inhibition, typically 
resulting in either a J-shaped or an inverted U-shaped dose response (Fig. 6). It has been es-
tablished in various fields of biology and proposed to have no taxonomic limitation. Any agent, 
be it physical, chemical or biological, may be expected to be stimulatory when it is given in 
much smaller doses than found to be harmful (irradiation, food limitation, heat stress, hypergrav-
ity, reactive oxygen species and other free radicals, chemical or natural compounds in food 
(hormetins) and others; Rattan, 2008). However, hormesis as a concept is controversially de-
bated (Kaiser, 2003). 
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Fig. 6 U-shaped dose–response (hormetic) curves illustrating apparent (A) reduced dysfunction and 
(B) enhanced function. (Reprinted from Calabrese and Baldwin (2001a), with permission from Elsevir). 
 
 
Mechanisms of hormesis: The beneficial effects of mild stress on aging and longevity have been 
studied for several years (Le Bourg, 2009). Mild stress appears to slightly increase longevity, 
delay aging, and increase resistance to adjacent severe stresses. It is suggested that these 
stimulatory effects can be generally explained by (i) a direct response to the stimulus or by (ii) 
an overcompensation response after exposure to a toxic agent which disturbs homeostasis (Ca-
labrese and Baldwin, 1998; Calabrese, 2001). Detailed molecular actions of hormesis are be-
coming increasingly understood, and comprise a cascade of stress response and other path-
ways of maintenance and repair (Rattan, 2008). It is suggested, that during the long path of 
evolution organisms have developed complex mechanisms to cope with environmental hazards 
in order to protect themselves from becoming extinct: the hormetic response pathways (Matt-
son, 2008), which involve proteins such as ion channels, kinases, deacetylases, transcription 
factors for cytoprotective proteins, chaperones, antioxidant enzymes and growth factors (Math-
ers et al., 2004; Mattson et al., 2004; Young et al., 2004). Rattan (2008) suggests that the 
“chain of events following initial hormesis leads to biologically amplified effects, synergistic and 
pleiotropic.” This phenomenon is termed “the homeodynamic space” (by means of an increased 
defense capacity and reduced load of damaged macromolecules) that is enhanced and pre-
vents disease and diminishes the rate of aging. For a review of previous results concerning 
hormesis in various fields, e.g. radiation hormesis, caloric restriction hormesis, nutritional hor-
mesis and hormetins, hypergravity hormesis, thermal and exercise hormesis, refer to Rattan 
(2008). 
 
A 
B 
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Hormesis and risk-assessment: In a literature search Calabrese and Baldwin uncovered few 
studies demonstrating hormesis (Calabrese and Baldwin, 2001b), e.g. plants exposed to herbi-
cides or metals grow amply, bacteria prosper better in the presence of tiny doses of antibiotics, 
and arsenic treatment cause immune cells to proliferate faster (summarized in Kaiser, 2003). 
Some proponents of the concept of hormesis animate it should be attended as the norm, not the 
exception and claim that the risk-assessment guidelines should be reassessed. They propose it 
applies to all toxicants in the absence to the contrary (Axelrod et al., 2004). However, Axelrod et 
al. announced that the data on which this concept is based, shows no evidence that it is neither 
universally adaptive nor widespread. Rather, it is suggested that even if few chemicals have 
low-dose beneficial effects, it would be unjustifiable to incorporate these effects into risk-
assessment, as is argued by Renner (2004) and Calabrese and Baldwin (2003). Experimental 
studies are mostly based on the use of mature and homogenous animals and therefore results 
cannot be extrapolated on a heterogeneous population (Axelrod et al., 2004). Opponents of the 
hormesis concept also postulate that even if the effect seems to be beneficial, it is not necessar-
ily a good thing (Vom Saal, 2007).  
 
Counterexamples of hormesis: Negative side-effects are rarely investigated and opponents of 
the hormesis concept accuse hormesis proponents that they focus on single endpoints such as 
cancer, while ignoring other endpoints (Kaiser, 2001). For example cyclophosphamide, a cancer 
drug that stops cell-divisions, protected rats from flu viruses at low doses, but injected with tu-
mor cells, these animals displayed a higher probability to develop cancer (Portier, 1993). Fur-
thermore, endocrine disruptors (hormones and chemicals mimicking hormones), although dis-
playing a biphasic dose-response, contradict the assumptions made by the hormesis concept 
(Vom Saal, 2007): at high toxicological doses hormones (e.g. estradiol) down-regulate their re-
ceptors and bind to other members of the nuclear receptor superfamily. Thus, they induce and 
inhibit different gene sets in low and high dose treatments; hence, they provoke different biolog-
ical effects. For example, fetuses or babies exposed to low concentrations of estrogenic chemi-
cals, formerly assumed to display no effect, reveal genetic imprinting with adverse effects on 
cell functions, which can lead to cancer. For an overview of the controversy and counterexam-
ples of hormesis be referred to Kaiser (2001), Axelrod et al. (2004) and Vom Saal (2007). 
 
The xenohormesis-concept: Originated by Lamming et al. (2004) to explain the favorable effect 
of resveratrol on Saccharomyces cerevisiae lifespan, the Xenohormesis hypothesis argues 
that plants which are exposed to stress produce molecules that can prolong the lifespan of the 
consumer. Resveratrol, a polyphenol built in plants after injury or infection (Langcake and Pryce, 
1976) activates Sir2, which may underlie the health benefits of CR. Baur and Sinclair (2008) 
postulated that to a yeast cell growing on a grape, an increase in the concentration of resvera-
trol might be a useful indicator that the food supply is coming to a limit. Therefore the yeast cell 
might gain a selective advantage by responding to resveratrol in the same way it would to an 
actual deficit of calories, i.e. activation of sirtuin enzymes. Yun et al. (2005) further developed 
this theory by stating that stressful conditions in modern husbandry and agriculture lead to 
stressed food, which in turn can act as an illegitimate signal of chronic stress in the consumer 
and possibly lead to obesity, by erroneously biasing hosts towards caloric accumulation despite 
the abundance of energy. 
 
However, to date xenohormesis is a more speculative theory, in general suggesting that hetero-
trophs (animals and fungi) are able to sense chemical cues synthesized by plants and other 
autotrophs in response to stress. Thereby plants’ secondary metabolites (“xeno”- compounds) - 
produced under stressful conditions like drought, disease and weather - serve as a molecular 
warning when affiliated by the animal consumer, who in turn is able to prepare itself in prior to 
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unfavorable conditions. Moreover, the theory predicts that ‘xenohormetic’ molecules bind to 
conserved domains in proteins, both, as agonist on one enzyme and as an antagonist against 
another (Howitz and Sinclair, 2008). This might explain the presumed variety of underlying ac-
tion mechanisms, which all serve to protect the animal consumer.  
 
 
1.5 Goals of this study 
 
The identification and analysis of compounds that delay aging and extend lifespan is an impor-
tant aspect of gerontology research. Besides testing theories of aging and the discovery of en-
dogenous systems that influence aging, it establishes the basis for treatments that might delay 
normal human aging. Therefore, the present study identified three polyphenols (PPs) with lifes-
pan extending and stress-tolerance enhancing properties in C. elegans, namely Quercetin (Q), 
Caffeic acid (CA) and Rosmarinic acid (RA), which belong to the two major subgroups within the 
PPs, the flavonoids (Q) and the phenolic acids (CA and RA). Investigations of these three PPs 
allows comparing the effects of PPs belonging to distinct classes on one hand (Q vs. CA and 
RA), and the effect of two structurally close related PPs (CA and RA) on the other. The broadest 
emphasis in this study was put on Q. Thereby insights were provided, whether PPs act through 
common or exclusive mechanisms. Furthermore, this study aims to contribute to a better under-
standing and enlightenment of underlying mechanisms at the physiological and genetic level, by 
answering following key questions: 
 
 
Are antimicrobial properties of the PPs responsible for life extension? Proliferating E. coli can 
produce deleterious metabolites for aging C. elegans which are grown on the bacterial layer. 
Antibacterial properties of the PPs could diminish the growth of the food source E. coli and thus 
reduce the negative impact on aged nematodes, hence extending their lifespan. Therefore it is 
reasonable to check the antimicrobial potential of each PP against E. coli. 
(i) Is the chosen test design adequate and does not produce artifacts in lifespan exten-
sion?  
 
Methods: 
- The growth of proliferating E. coli was monitored with and without PPs, to discover antibac-
terial properties. 
- The lifespan of wild type C. elegans was determined when grown on heat killed OP50 
mixed with respective PP from the 6th day of adulthood on, to evaluate the influence of the 
possible antibacterial properties on the lifespan.  
 
 
 
Is it possible that transgenerational effects of the PPs cause variations in life extension due to 
different exposure times? Certain compounds can lead to genetic imprinting (e.g. endocrine 
disruptors; Vom Saal, 2007) or provoke other epigenetic changes on the DNA, which lead to 
additive or adverse effects in the offspring of the exposed parental generation. To find out if it is 
adequate to use F1 nematodes which developed in treated P0 hermaphrodites, and therby ex-
clude associated artifacts, Q treated nematodes have exemplarily been investigated for all three 
PPs.  
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Methods: 
- To gain hints on possible transgenerational effects, lifespan assays with wild type nema-
todes treated with Q in four different exposure scenarios were conducted: P0 exposed to Q 
from L4 on, F1 descendent from treated P0 exposed to Q during the whole lifetime, F2 des-
cendent from treated P0 and F1 treated during the whole lifetime, F2 descendent from ex-
posed P0 and F1 but exposure was stopped at L4 and henceforth grown on non-PP-
containing plates.  
 
 
 
Since hormesis gains growing interest in the scientific community and a growing proportion of 
compounds have been identified displaying a hormetic action scheme, all three PPs were eva-
luated concerning the potential to be classified as hormetins. 
(ii) Do these three PPs promote longevity via hormesis? 
 
Methods: 
- Performance of lifespan assays over a broad concentration range to identify typical bi-
phasic, inverted J-shaped dose-response curves, characteristic for hormetins. 
- Further evidence of the hormetic character by evaluation of the gene expression levels of 
six hsp genes, as a marker for elevated repair responses and thus hormesis action. 
- Evaluation of the global transcriptional response in Q treated C. elegans, to identify expres-
sion changes in genes belonging to repair and biotransformation systems. 
 
 
 
CR is the only approach that is accepted to prolong lifespan in a broad range of species. Since 
the PP resveratrol is suggested to induce sirtuins and thereby activate an indirect CR response, 
it is conceivable that the PPs investigated in this study also act through this pathway. Further-
more it is possible that direct mechanisms, like the diminished affiliation of food triggered by 
respective PP - caused by either avoidance of food or a decreased pumping frequency – also 
lead to a CR response. 
(iii) Do direct or indirect CR effects contribute to lifespan extension? 
 
Methods: 
- Performance of lifespan assays with sir-2.1 mutants, to find a possible lack of response to 
respective PP. 
- An attraction assay was conducted, to find out whether or not nematodes are distracted by 
the PPs supplement in the bacterial diet and thereby displaying an indirect CR effect. 
- Monitoring of the pharyngeal pumping to exclude an alternative cause of CR by decreasing 
food ingestion. 
 
 
 
It is conceivable that the longevity phenotype of Q, CA and RA treated nematodes takes place 
on the expense of other physiological parameters, e.g. the reproduction capacity, the growth 
and others. To determine whether or not such reallocation events occur, different experiments 
were chosen. 
(iv) Does re-allocation of resources take place in a disposable soma like manner? 
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Methods: 
- The reproduction has been examined concerning the total amount of offspring per nema-
tode, and additionally for the time to start egg laying to detect potential developmental de-
lays. 
- The growth of the nematodes has been examined and variations between treated and un-
treated nematodes have been determined. 
- Differences in the fat deposits in Lysosome related organells (LROs) have been measured 
with a Nile Red fluorescence assay to reassess the presumed relationship between a de-
crease in staining and an enhanced stress-resistance (O’Rourke et al., 2009). 
 
 
 
Many PPs display antioxidant properties in vitro, which were formerly thought to be the only 
reason for the positive effects of PPs in organisms. Evidence from recent studies, argues that 
an in vitro antioxidant effect is not compulsory associated with in vivo antioxidant properties and 
furthermore is doubtable that the in vivo antioxidant property of a given compound is responsi-
ble for (all) observed positive effects in the organism (Pun et al., 2010). Thus, it is important to 
check both, the in vitro and in vivo antioxidant properties. 
(v) Are in vivo antioxidative properties of the PPs responsible for the longevity effect as 
proposed by the FRTA? 
 
Methods: 
- The total antioxidative capacity (TAC) of each PP was measured in hydrophilic and lipophil-
ic solvents to determine general antioxidative properties in vitro. 
- The TAC was measured in the hydrophilic and hydrophobic fraction of worm-homogenate, 
to determine the antioxidative status in vivo after treatment with each PP. 
- Lifespan assays with mev-1 mutants, which are hypersensitive to oxidative stress, have 
been conducted to investigate whether respective PP treatment has the potential to prolong 
lifespan, which suggests a lowering of internal oxidative stress. 
- The intestinal lipofuscin fluorescence – a marker for endogenous oxidative damaged ma-
terial, also called aging-pigment – was determined, to see a decrease in accumulation, pre-
sumably due to slowing of aging. 
- Paraquat - a herbicide, commonly used to generate oxidative stress in vivo by redox cycling 
- exposure from L4 on, with concurrent application of respective PP to see a reduction in 
oxidative stress susceptibility by means of matricidal prevention. 
 
 
 
PPs are expected to act through genetic players and signaling cascades to deploy their longevi-
ty and stress tolerance enhancing potential. In the past many genes have been identified in C. 
elegans research that have been connected to lifespan and stress resistance.   
(vi) Which genetic players are involved in PPs induced longevity and stress-resistance? 
 
Methods: 
- To find such genetic mediators, lifespan assays with mutant strains, lacking genes formerly 
described as important in lifespan regulation or stress response, have been conducted. For 
Q treated nematodes 13 strains have been chosen; in CA and RA exposure 8 mutant 
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strains have been utilized. Presumable players for longevity (no life extension due to PP 
treatment in respective mutant strain) were confirmed with thermal stress tests. 
- To further enlighten the genetic mechanisms, a DNA-microarray assay was performed with 
three concentrations of Q treated nematodes. In a database search overrepresented GO 
terms and KEGG pathways have been analyzed. Furthermore, an extensive literature com-
parison has been conducted in which overrepresented gene groups and gene expression 
mountains (according to Kim et al., 2001) have been identified. By further matching the Q 
data to previously published DNA-microarray data from mutants and immune challenged 
nematodes, the picture of underlying mechanisms of Q mediated longevity shapes clearer. 
 
 
 
By comparing findings from Q, CA and RA treated nematodes it is possible to see commonali-
ties or discrepancies between all three PPs. Hence, it is possible to get first insights if structural 
realted compounds, like these three PPs, share comparable basic action schemes in vivo or if 
they differ considerably.   
(vii) Do Q, CA and RA use common or exclusive mechanisms?  
 
 
 
The obtained results will be discussed in the light of current aging theories. This will in turn help 
to further understand the processes leading to aging. 
(vii) Which current aging theories can be applied to obtained results? 
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2 Materials and methods 
 
2.1 Strains and growth conditions 
 
All strains were maintained (unless otherwise stated) at 20°C in appropriate incubators on 
nematode growth medium (NGM) seeded with the Escherichia coli feeding strain OP50 accord-
ing to Brenner (1974). NGM plates were 35 mm or 96 mm in diameter and inoculated with either 
100 µl or 1000 µl OP50 (OD595 3.4 - 3.6), respectively. Strains used in this study were: N2, Bris-
tol (wild type); GR1307, daf-16(mgDf50); VC199, sir-2.1(ok434); AM1, osr-1(rm1); AU1, sek-
1(ag1); MT2605, unc-43(n498n1186); TK22, mev-1(kn1); DR1572, daf-2(e1368); VC8, jnk-
1(gk7); TJ1052, age-1(hx546); DR20, daf-12(m20); EU1, skn-1(zu67); VC204, akt-2(ok393); 
AE501, nhr-8(ok186). All C. elegans strains as well as the OP50 strain were obtained from the 
Caenorhabditis Genetics Center (CGC), University of Minnesota, USA. Q (Quercetin dihydrate; 
≥ 98%, Fluka NO. 83370 Sigma-Aldrich, Germany), CA (Caffeic acid ≥  99%, NO. C 0625, 
Sigma-Aldrich, Germany) and RA (Rosmarinic acid ≥97%, Fluka NO. 44699, Sigma -Aldrich, 
Germany) was dissolved in DMSO (Dimethylsulfoxid; Applichem, Germany) and added (final 
concentration as denoted in respective section) to the NGM medium and the OP50 bacterial 
feeding suspension. A final DMSO concentration of 0.3 % (v/v) was maintained in control and 
polyphenol containing plates. 
 
 
2.2 Life table parameters and other functional investigations  
 
2.2.1 Lifespan assays 
Lifespan of wild type C. elegans was tested in several exposure scenarios. The 1st generation 
(P0) started at L4 larval stage on either control or treatment plates. Eggs of the 2nd generation 
(F1) developed in the pre-exposed parent and hatched in the corresponding condition and were 
exposed during their entire lifetime. This approach was basically chosen for all three polyphe-
nols.  
 
Nematodes of the 3rd generation (F2) exclusively tested for Q, were either used to investigate 
the presence of additive or adaptive effects of this PP, or transferred (as eggs) onto control 
plates to determine transgenerational responses. The concentrations of Q, CA and RA were 0, 
50, 100, 200 µM, plus 250 µM for Q, and 300 and 600 µM for CA and RA treated wild type 
nematodes as well as 0, 200 (Q and RA), and 300 µM (CA) for the mutants. The mutant assays 
were conducted using the concentration that was deemed to be most effective in inducing life-
span extension (in wild type). Blinding of studies was not possible due to the colour of Q and 
RA, which stain the NGM agar.  
 
For each experimental condition at least two independent trials were performed, each compris-
ing ten small agar plates with at least 100 nematodes. The first day of adulthood was defined as 
day 1. During the reproductive period, adult nematodes were transferred daily to new treatment 
plates to avoid overcrowding. After reproduction ceased, transfer occurred every third day, until 
the impact of aging disallowed handling of the nematodes. Alive and dead animals were scored 
daily until all had died. Animals were considered dead when no response was observed follow-
ing a gentle touch by a platinum wire. Nematodes which had escaped the plates or died after 
internal hatch were subtracted from the total number. All lifespan assays were carried out at 
20°C, except where mentioned otherwise. Additional temperatures were 15°C and 25°C for Q 
treated nematodes. Usually lifespan assays were performed with F1 nematodes, yet, only for ad 
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libitum fed wild type worms, treated with Q, from all three generations. 
 
To verify if the PPs acts only via antibacterial effects or as CR mimetics, lifespan assays were 
also conducted with heat-killed (hk) E. coli (30 min at 65°C, according to Gruber et al. 2007) or 
– just for Q - without a bacterial lawn. To avoid excessive loss, only 6th days old C. elegans (F1 
generation) were transferred to hk-bacteria or bacteria-free plates, respectively. 
 
 
2.2.2 Reproduction 
Broodsize: 10 nematodes (L4 larvae of the F1 generation) per concentration were placed onto 
individual treatment plates. Nematodes were cultivated at 20°C and transferred daily to new 
plates until reproduction was completed. The total offspring of each individual nematode was 
counted once grown to L2 or L3 stage. 
 
Reproduction delays: Reproduction was assessed by plating nematodes (the P0 generation) 
onto control or treatment plates (Q 200 µM, CA 300 µM and RA 200 µM) and incubated at 20°C 
for 4 days. Subsequently, worms were synchronized through egg preparation according to 
Strange et al. (2007) with sodium hypochlorite (Sigma). Eggs (the F1 generation) were allowed 
to hatch and arrest at L1 stage by rotating (20 rpm) in M9 buffer over night at room temperature. 
Ten L1 larvae were transferred to respective control or treatment plates and cultured until adult-
hood. Approximately 21 h after reproduction commenced, adult nematodes were removed and 
the number of offspring determined after the nematodes had grown to the third larval stage. 
 
 
2.2.3 Growth alterations  
Volumetric area of living wild type worms from hatching up to day 8: Changes in the volumetric 
area (from hatching to day 8) were measured as follows: Synchronized F1 wild type nematodes 
were obtained as described above and the resultant L1s transferred to treatment plates. To 
avoid overcrowding, due to reproducing adults, worms were periodically moved to new plates 
using a platinum wire pick. Photos were taken with a standard upright microscope/camera sys-
tem (SMZ1500, Nikon UK Ltd., Kingston upon Thames, UK) every 24 h until day 8 (180 h). The 
volumetric area within the perimeter of the nematodes was measured with Image-Pro Express 
5.1 software (Media Cybernetics, Wokingham, UK). 
 
Length alterations of heat-killed nematodes at the 6th day of adulthood: The growth assay util-
ized a minimum of 30 nematodes of the F1 generation per concentration and trial. Nematodes 
were cultured at 20°C. On the 6th day of adulthood, nematodes were killed by heat exposure 
(150 minutes/45°C) and the length of each individual nematode was measured using a micro-
scope equipped with a graduated eyepiece. 
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2.2.4 Pharyngeal pumping rate 
At the 3rd, 6th and 10th day of adulthood the pharyngeal pumping rate was quantified under a 
microscope at high magnification. In detail, for every dose and age point, 10 (pre-treated) F1 
nematodes were randomly selected and the pumping frequency determined three times over a 
15 s time span.  
 
 
2.2.5 Stress resistance 
Thermotolerance: F1 generation nematodes were cultured as described above for lifespan as-
says and kept at 20°C on either control (0 µM) or PP (Q 200 µM, CA 300 µM, RA 200 µM) 
plates until the 6th day of adulthood. The thermal resistance test was performed with approx-
imately 120 nematodes for each concentration in each trial. At the 6th day of adulthood, plates 
were switched to 35°C. After 8 h for wild type N2 and unc-43(n498n1186), 9 h for age-1(hx546), 
10 h for daf-2(e1368), 7 h for sir-2.1(ok434), osr-1(rm1) and daf-16(mgDf50), and 6 h for sek-
1(ag1) dead and alive nematodes were counted.  
 
Oxidative stress resistance with 10 mM paraquat: Wild type C. elegans (L4 stage) were placed 
on control and treatment plates (0 µM, Q 200 µM, CA 300 µM, RA 200 µM) in the presence of 
10 mM paraquat (NN-dimethyl-44´-bipyridinium dichloride, ABCR GmbH & Co. KG, Karlsruhe, 
Germany) added to the agar and the OP50 food source. Survivors were counted after 72 h. 
 
 
2.2.6 Attraction assay 
NGM agar plates (92 mm) were prepared containing six alternating spots of bacteria around the 
peripheral region of the plate, lacking or supplemented respective PP (Q 200 µM, CA 300 µM, 
RA 200 µM). The bacterial spots on the agar surface were identical in size and quantity. Imme-
diately after air-drying one L4 juvenile F1 worm was placed on each of the six spots, incubated 
at 20°C for 24 h, and thereafter the number of next generation (F2) offspring on each individual 
spot was determined. The combined number of total F2 offspring present on the three control 
spots was set to 100% and compared to the F1 offspring counted on the three spots supple-
mented with PPs.  
 
 
2.2.7 Bacterial growth assay 
E. coli OP50 bacteria (OD595 = 0.2) were spiked with 0.3% (v/v) DMSO, Q 200 µM, CA 300 µM 
or RA 200 µM and the OD595 at this time point taken as the blank at time point zero. Tubes were 
incubated at 37°C on a shaker (240 rpm) and the OD595 was measured every 60 min until all 
samples reached an OD in excess of 1.0. 
 
 
2.2.8 Fluorescence measurements 
Synchronized wild type (F1 generation) nematodes were prepared by egg preparation as de-
scribed above. L1 larvae were transferred to control and treatment plates inoculated with OP50. 
To avoid overcrowding, worms were transferred daily during the reproductive period. On day 3 
and 6 of adulthood, 10-20 worms per condition (0 µM, Q 200 µM, CA 300 µM, RA 200 µM) were 
placed on microscope slides, prepared with 2% agarose pads and immobilized with 50 mM so-
dium azide (Sigma). The mean fluorescence intensity was quantified using Image ProExpress 
by determining the area of nematodes and the sum of fluorescence. 
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Nile red staining of intestinal fat deposits: OP50 was supplemented with Nile red to a final con-
centration of 6 µM. Pictures were taken at the 3rd and 6th day of adulthood. Individual nema-
todes were observed and photographed using an inverted fluorescence microscope with a 200x 
magnification (Nikon TE2000S).  
 
Intestinal lipofuscin fluorescence: Individual nematodes were observed and photographed at 
100x magnification fluorescence microscope (Nikon Eclipse E200). Pictures were taken at the 
7th day of adulthood.  
 
 
2.2.9 Total antioxidative capacity (TAC) 
For each condition (0 µM, Q 200 µM, CA 300, RA 200 µM) 40 staged L4 wild type C. elegans 
were grown on three 96 mm agar dishes (inoculated with 1 ml bacterial suspension) for 4 days, 
after which nematodes were rinsed off and washed with M9 buffer. The resultant worm pellets 
were homogenized in a “SpeedMill” (Analytik Jena, Germany). Sample disintegration was 
achieved by ten cycles of rapid shaking (30 s) followed by ice-cooling (1 min). The homogenate 
was centrifuged and the supernatant used to determine the antioxidative capacity of both aque-
ous- and lipid-soluble substances. Therefore, a PHOTOCHEM® (Analytik Jena, Germany) 
driven photochemiluminescence (PCL) approach (Popov and Lewin 1999) was applied to define 
the TACs of pure PP standard solutions.  
 
The results are presented in equivalent concentration units of ascorbic acid (AA) for water-
soluble substances or Trolox® (T) units for lipid-soluble substances. The PCL assay combines 
the fast photochemical radical generation with the sensitive luminometric detection. This reac-
tion is induced by optical excitation of a photosensitizer which results in the generation of the 
superoxide anion radical O2-. These radicals are partially eliminated from the sample by reac-
tion with the antioxidants present in the sample. In the measuring cell of the PHOTOCHEM® the 
remaining radicals cause the detector substance to luminescence. For more details, refer to the 
original description of Popov and Lewin (1999). The antioxidant capacity of the sample is de-
termined in a separate cell by means of a photomultiplier tube. The hydrophilic and lipophilic 
antioxidants were quantified using the ACW (by means of the lag phase for water-soluble water-
soluble substances) and ACL (by means of the area under the curve for lipid-soluble sub-
stances) kits (Analytik Jena, Germany), respectively. The preceding lipid extraction was per-
formed according to Bligh and Dyer (1959) and the measurements of the corresponding protein 
via a standard Bradford assay (Bradford, 1976).  
 
According to previous experiences with multiply challenged waterfleas (Steinberg et al. 2010), 
total antioxidant capacity of organisms reflects the deviation of the redox homeostasis more 
accurately than the sum of single antioxidants or the modulation of single antioxidant enzymes. 
These experiences were based on the gaschromatographic monitoring of ethylene development 
from a-keto-c-methiol-butyric acid, which is inhibited in the presence of antioxidants. Given that 
the method applied here exploits photochemiluminescence, it should be more sensitive (by a 
factor of at least 102) than any previously applied detection.   
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2.2.10 Data interpretation and statistical analysis  
All tests comprised of at least two - mostly more - independent experimental trials. Alterations in 
lifespan values of treated versus untreated nematodes were specified in percentage, both for 
mean and median lifespan. Statistical significance was calculated by means of the log rank test 
(Bioinformatics at the Walter and Eliza Hall Institute of Medical Research; 
http://bioinf.wehi.edu.au/software/russell/logrank/). Mean values were also calculated for repro-
duction, body length, growth rate alterations, Nile red staining, bacterial growth, hsp-levels and 
TAC, respectively. Statistical significance was evaluated by one way ANOVA (Sigma Stat 3.5, 
SPSS Inc., USA). For the thermotolerance and oxidative stress assay (paraquat), mean survival 
rates were calculated. Statistical significance in the thermotolerance, oxidative stress and attrac-
tion assays were identified by the Chi Square Test (Sigma Stat 3.5, SPSS Inc., USA). Variances 
were considered significant at *p < 0.05 and **p < 0.005. 
 
 
2.3 Molecularbiological experiments  
 
2.3.1 Expression levels of heat shock protein genes (hsps) quantified by reverse 
transcriptase –PCR (qRT-PCR) 
Sample generation: For qRT-PCR synchronized first-staged wild type animals were grown at 
20°C until the 1st day of adulthood at a density of about 500 animals/plate (90 mm in diameter), 
in the presence of either 0 µM PP, 200 µM Q, 300 µM CA or 200 µM RA. Animals were re-
moved from plates with a platinum wired worm pick, transferred into micro-centrifuge tubes with 
cold M9 buffer, allowed to settle on ice, then shock frozen in liquid nitrogen and stored at -80°C. 
For each condition worm samples were collected in duplicates. 
 
RNA preparation and cDNA synthese: The packed frozen worm samples were disrupted, using 
0.5 mm glass beads, in a SpeedMill homogenizer (Analytik Jena). Two 2 min cycles of shaking, 
were followed by 5 min of cooling on ice. RNA was prepared according to the TRizol® extraction 
protocol by Chomczynski and Sacchi (1987) with few modifications. After further purification with 
Chloroform and Isopropanol (Roth, Karlsruhe, Germany) the RNA was precipitated with ethanol 
and resuspended in sterile water. The cDNA synthesis was performed with M-MLV revertase 
(Promega, Madison, USA).  
 
RT-PCR: Real-time PCR was conducted in the MyiQ5 System (Bio-Rad, USA) using the fluo-
rescence dye EvaGreen (Bioscience, Jena, Germany) and green core qPCR polymerase (Jena 
Bioscience GmbH, Germany), 2 µl cDNA and 100 µM primers (Primerdesign is shown in Table 
1). Signals were normalized using the reference gene beta-actin (act-1) as an invariant internal 
control. The relative expression of the target genes has been calculated using the comparative 
2-∆∆Ct method (Livak and Schmittgen, 2001). Following gene-specific primers were used:  
 
Data interpretation and statistical analysis: Mean values were calculated. Statistical significance 
was evaluated by one way ANOVA (Sigma Stat 3.5, SPSS Inc., USA). 
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Table 1: Primersequences for hsp-gene expression measurement 
Gene Forward Primer Reverse Primer 
act-1 (T04C12.6) TCCAAGAGAGGTATCCTTAC CGGTTAGCCTTTGGATTGAG 
hsp-3 (C15H9.6) CCGTCACCATCCAGGTCTTC GGTTCCCTTATCCTCGGCAG 
hsp-12.6 (F38E11.2) AGTTGTCAATGTCCTCGACG CTTCAATGTGAAGAATTCCATGTG 
hsp-16.1 (T27E4.8) CTGAATCTTCTGAGATTGTTAAC TTTGTTCAACGGGCGCTTGC 
hsp-16.41 (Y46H3 A2) ATTGGGGAGATTGTAAATGATG GCGTTTCAAGTATCCATGTTCC 
hsp-17 (F52E1.7) ATGGCCGATTCTTCGATGAC GGACAAAGTGACGCTCTACC 
hsp-70 (F44E5.4) GAAAGGTTGAGATCCTCGCC CATCGAAACGTCGTCCAATC 
 
 
2.3.2 DNA-microarray analyses  
Sample generation: Untreated P0 nematodes were chunked out on control and treatment plates 
(96 mm in diameter; 0 µM, Q 50 µM, Q 100 µM, Q 200 µM) and incubated at 20°C for 4 days. A 
synchronous culture was generated by rinsing F1 nematodes from Q containing plates and sub-
sequently filtered through a 10 μm pore size membrane filter (SM 16510/11, Sartorius, Germa-
ny), which retains all but first-staged juveniles (L1). After filtering L1 nematodes were put again 
on treatment plates. Worms were grown to the young adult stage, harvested by rinsing off with 
M9 buffer and kept on ice until freezing in liquid nitrogen and stored at -80°C. Each condition 
was collected in triplicates. 
 
RNA preparation and conduction of DNA-microarray analyses: The packed frozen worm sam-
ples were disrupted by using a SpeedMill homogenizer (Analytik Jena) and special metal oxide 
beads in disintegration tubes. 2 min shaking followed by 5 min on ice was repeated twice to 
disintegrate samples. Subsequently the whole RNA was purified utilizing a Total RNA Isolation 
kit from Macherey-Nagel including a DNase step to remove genomic DNA. Samples were 
stored at -80°C until usage. Further procession of RNA was performed with MessageAMPTM 
Premier RNA Amplification Kit (Ambion). RNA sample preparation is based on the T7 in vitro 
transcription (IVT) amplification technology, also known as reverse transcription-IVT (RT-IVT) 
method (Van Gelder et al., 1990). First- and Second-Strand cDNA synthesis, aRNA synthesis, 
labeling, fragmentation, GeneChip hybridization, and scanning were performed according to 
specifications from Affymetrix. Triplicate chips were run for each condition (0, Q 50, Q 100, Q 
200 µM). 22548 transcripts were abundant on the chip. RNA and cDNA qualities were verified at 
each step using capillary electrophoresis (Bioanalyzer; Agilent Technologies). Quantities were 
measured photometrically (NanoDrop ND-1000 spectrophotometer, Thermo Fisher Scientific, 
Wilmington, DE, USA). 
 
Data interpretation and statistical analysis of DNA-microarray data: Pre-processing of DNA-
microarray raw data included probe-specific background correction, summarization of probe set 
values, and normalization using the GCRMA algorithm with CARMAweb 1.4, an R- and Biocon-
ductor-based web service for DNA-microarray data analysis (Rainer et al., 2006). Quality of the 
normalization was accessed by boxplot, and MA-graph analyses. Differences between treat-
ments were visualized by Principal Component Analysis (PCA) plotting with MeV (Saeed et al., 
2003). Data were initially filtered out for missing values and then subjected to a CLEAR-test that 
combines differential expression and variability using the GEPAS web server at 
http://www.gepas.org (Tárraga et al., 2008). The differential expressions of genes between the 
treatment group vs. reference control were compared using unpaired t-tests and significance 
analysis of microarray (SAM) testing; the latter includes a calculation that estimates the false 
discovery rate (FDR). Here the false discovery rate was set to a non-stringent level of <12.5%. 
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Differential expressed genes (DEGs) showing a fold change of 1.25 were further analyzed with 
regard to their molecular functions, biological processes, and biological pathways using informa-
tion provided by Wormbase (www.wormbase.org) with high throughput GoMiner software (Zee-
berg et al., 2005) and DAVID (http://david.abcc.ncifcrf.gov/). 
 
Representation Factor: As measurement of overlap between differing conditions (e. g. PPs and 
diverse gene expression mountains, gene groups or datasets in the literature), the Representa-
tion Factor (RF) was taken to definite the fold enrichment. It shows whether genes from one list 
(list A) are enriched in another list (list B). (Definition of RF: (number of genes in common be-
tween both lists)*(number of genes in the genome)/(number of genes in list A)*(number of 
genes in list B)). The choice of N (genome) was based on the values recommended by the au-
thors. Intersection p-values were calculated from the hypergeometric distribution. *p < 0.05, **p < 
0.005, ***p < 0.001 
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3 Results 
 
3.1 Possible artifacts: antimicrobial properties and transgenerational effects 
 
3.1.1 Q and RA dimish the bacterial growth of E. coli 
Given that some PPs possess antimicrobial properties, it was deemed important to investigate 
to what extent Q, RA and CA influence the growth of the gram-negative E. coli feeding strain 
OP50 and thereby cause advantages for life extension. In contrast to CA, which did not inhibit 
bacterial growth, RA and in particular Q both exerted significant effects over the 4.5 h cultivation 
period (Fig. 7).  
 
 
 
 
Fig. 7 Antibacterial properties. Bacterial growth test with pure OP50, OP50 containing 0.3% DMSO (0 
µM, control), or OP50 with 200 µM Q, 300 µM CA or 200 µM RA dissolved in DMSO. Graphs combine 
three biological replicates. Bars represent SEM. *p < 0.05, **p < 0.005 (One Way Anova).  
 
 
3.1.2 Growing on heat-killed E. coli does not prevent life extension 
To investigate if these antibacterial properties are linked to the observed lifespan extension, 
further assays were conducted with heat-killed bacteria. However, even after being fed with 
dead OP50 mixed with Q, CA or RA, nematodes exhibited PP induced average lifespan exten-
sions of 9%, 15 % and 22 %, respectively (Fig. 8 A, B, C). Thus, the hypothesis that longevity 
may be due to antibacterial-action of PPs was rejected. (Additional lifespan data for each indi-
vidual experimental trial can be found in Tables 3, 4 and 5.) 
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Fig. 8 Lifespan of wild type nematodes fed with heat-killed E.coli and Q 200 µM (A), CA 300 µM (B) 
or RA 200 µM (C). Detailed mean and median lifespan data, n and trial numbers, as well as single trial 
significances are listed in Tables 3 (Q), 4 (CA), 5 (RA). Bars represent SEM. *p < 0.05, **p < 0.005 (log-
rank test).  
 
 
3.1.3 Transgenerational effects of Q treatment are negligible 
It was also important to check, whether PPs could have adaptive or additive transgenerational 
effects which also provoke artifacts in life-extension, to find out if it is adequate to use whole life-
time PP-treated F1 nematodes for following experiments. To get first hints if PP treatments have 
the potential to cause types of epigenetic, additive or adaptive changes on lifespan throughout 
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generations, an experiment was conducted to determine (i) if the treatment through generations 
causes yet increased or diminished results, or (ii) if the lifespan of the untreated offspring of PP 
exposed worms is also enhanced. These tests are exemplarily for PPs performed with Q treated 
nematodes. 
 
Q enhanced lifespan in all generations tested (Fig. 9 A – C), an effect that was statistically sig-
nificant in the F1 and F2 generation, but not in P0. This may be a result of differing exposure 
times (the P0 generation was exposed only from L4 stage onwards) or an effect triggered during 
embryonic development, a question that clearly warrants further investigations. Nevertheless, 
lifespan extension was modulated in a Q dose responsive manner. In detail, the mean lifespan 
of the F1 generation was prolonged by 11 and 18% in the presence of Q 100 and Q 200 µM, 
respectively (Table 2). The median lifespan was expanded by up to 21% (Table 2). The experi-
mental setup was purposefully designed to test for additive (mean lifespan of F2 > mean lifes-
pan of F1) or adaptive effects (mean lifespan of F2 < mean lifespan of F1). Although the first 
experimental trials suggested that lifespan was extended in the F1 generation (compared to 
F2), further seven experimental trials could not confirm this perceived trend (compare Table 3). 
However, life extension of the F1 and F2 generation were comparable (Fig. 9 B and C, Table 2). 
Overall this suggests that Q displays no additive or adaptive effects in lifespan regulation. Simi-
larly, no beneficial transgenerational impact were observed, i.e., when the ancestor (P0 and F1) 
but not the offspring generation (F2) is treated with Q (Fig. 9 D, Table 2). These results justify 
the use of F1 nematodes in the other experiments. 
 
 
 
Fig. 9 Possible transgenerational effects. Q significantly extends the lifespan in C. elegans, shown are 
survival curves of nematodes of the first (P0) (A), second (F1) (B) and third (F2) (C) generation exposed 
to 0, 100, and 200 µM Q, respectively. Q treatment did not show transgenerational effects in the F2 gen-
eration, when nematodes were replaced to non-treatment plates as eggs (D). Graphs combine 2–3 inde-
pendent trials, for further details see Table 2, *p < 0.05, **p < 0.005 (log-rank test).  
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Table 2 Median and mean lifespan of Q treated wild type C. elegans in different application scenar-
ios. Refers to Fig. 9. 
Q  
(µM) 
Gene- 
ration 
Median lifespan 
(d) ± SEM 
Change 
± SEM 
Mean lifespan 
(d) ± SEM 
Change 
± SEM n Trials Change in single trials 
0 
P0 
14.90±1.03  17.10±0.72  102 
2 
 
100 16.60±0.38 1.11±0.07 18.40±0.16 1.08±0.04 103 1.13, 1.03 
200 17.70±0.54 1.19±0.17 18.70±0.10 1.09*±0.05 102 1.15*, 1.05 
0 
F1 
14.69±1.61  15.72±0.70  260 
2 
 
100 15.68±0.29 1.07±0.10 17.47±0.03 1.11**±0.06 258 1.06*, 1.17** 
200 17.79±0.30 1.21±0.12 18.54±0.15 1.18**±0.08 262 1.10**, 1.25** 
0 
F2 
16.40±2.05  17.11±1.22  363 
3 
 
100 18.64±1.59 1.14±0.06 16.73±1.11 1.08**±0.03 367 1.05, 1.08*, 1.13** 
200 19.39±2.50 1.18±0.04 19.05±1.54 1.11**±0.03 322 1.07, 1.14**, 1.11* 
0 
F2 
14.90±1.80  16.15±1.05  223 
2 
 
100→0 15.18±1.43 1.02±0.03 16.40±0.92 1.01±0.01 238 1.01, 1.03 
200→0 15.17±1.46 1.02±0.03 16.09±0.74 1.00±0.02 191 0.97, 1.02 
Statistical significance was calculated by log-rank test, changes in mean lifespan considered significant at 
*p < 0.05 or **p< 0.005 
 
 
3.2 Hormetic working modes 
 
3.2.1 PPs display concentration-dependent lifespan extension 
All three PPs exert a hormetic dose response that is defined by an inverted U-shaped curve 
(Fig. 10). Whilst 50 µM of Q evoked no significant change in life extension, 100 and 200 µM Q 
exerted an effect that was reversed at 250 µM Q (for more details see Table 3). Similarly, expo-
sure to 100 µM to 600 µM (but not 50 µM) of CA was found to significantly extend the lifespan of 
wild type C. elegans (Table 4). Indeed, the strongest effect was observed at 300 µM CA (11 % 
life extension). For RA, a significant life extension was induced at 200 µM and 300 µM RA, but 
notably not at 50 µM and 100 µM RA. Nematodes treated with 600 µM RA resulted in a signifi-
cant reduction in lifespan (Table 5). Based on these results, optimal concentrations for maximal 
lifespan extension were deemed to be 200 µM Q, 300 µM CA and 200 µM RA, thus these con-
centrations were used in all other experiments.  
 
 
 
Fig 10 Lifespan alterations in wild type nematodes treated with variable concentrations of Q, CA 
and RA. Shown are the mean lifespan variations in each condition compared to control. Appropriate data 
(mean and median lifespan, n and trial numbers, single trial significances) are listed in Tables 3, 4 and 5. 
Lines represent the inverted U-shaped dose-response relationships. Error bars represent SEM, *p < 0.05 
and **p < 0.005 (log-rank test).  
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Table 3 Median and mean lifespan of wild type C. elegans after treatment with differing Q concen-
trations (50, 100, 200, 250 µM) and two alternative feeding scenarios (heat killed OP50 and without 
OP50). Refers to Fig. 8 A and 10. 
Concen-
tration 
Q 
(µM) 
Median lifespan (d) 
± SEM Change 
± SEM 
Mean lifespan (d) 
± SEM Change 
± SEM 
n 
Control/ 
Treated 
Trials 
Mean 
lifspan 
change 
single 
trials 
Control Treated Control Treated 
50 16.20±0.40 16.79±0.29 1.04±0.01 16.45±0.62 16.84±0.63 1.02±0.01 186/180 2 1.02, 
1.03 
100 14.69±0.78 15.68±0.12 1.07±0.06 15.72±0.70 17.47±0.03 1.11**±0.06 260/258 2 1.06, 
1.17** 
200 16.09±0.72 17.64±0.77 1.10±0.04 16.43±0.77 18.05±0.84 1.10*±0.03 806/865 7 1.07*, 
1.25**, 
1.04, 
1.07, 
1.12**, 
1.03, 
1.06* 
250 17.20±0.13 16.11±0.94 0.94±0.06 17.22±0.05 16.04±0.50 0.93*±0.03 196/171 2 0.90*, 
0.96 
200a 28.45±1.08 30.68±2.27 1.08±0.04 26.57±1.35 28.76±1.33 1.09**±0.58 250/218 2 1.09, 
1.08* 
200b 23.80±4.22 27.93±4.67 1.17±0.08 28.91±7.13 32.24±9.31 1.10**±0.03 271/236 3 1.16**, 
1.05, 
1.09* 
a fed with heat-killed E. coli bacteria from the 6th day of adulthood 
b no food from the 6th day of adulthood (food deprivation) 
* p < 0.05 
** p <0.005 
all experiments are conducted at 20°C 
 
 
 
Table 4 Median and mean lifespan of wild type C. elegans after treatment with differing CA con-
centrations (50, 100, 200, 300, 600 µM) and an alternative feeding scenario (heat killed OP50). Ref-
eres o Fig. 8 B and 10. 
Concen-
tration 
CA 
(µM) 
Median lifespan (d) 
± SEM Change 
± SEM 
Mean lifespan (d) 
± SEM Change 
± SEM 
n 
Control/ 
Treated 
Trials 
Mean 
lifespan 
change 
single 
trials 
Control Treated Control Treated 
50 17.19±0.14 17.27±0.34 1.00±0.01 17.22±0.05 17.22±0.11 1.00±0.01 169/225 2 1.00, 
0.99 
100 13.26±1.70 14.64±0.64 1.10±0.05 14.07±1.44 15.30±0.85 1.09**±0.05 235/261 2 1.14**, 
1.05 
200 13.26±1.70 13.94±1.34 1.05±0.03 14.07±1.44 15.08±1.01 1.07*±0.04 235/239 2 1.04, 
1.10* 
300 13.56±0.79 15.39±0.94 1.13±0.03 14.43±0.76 16.08±0.94 1.11**±0.02 725/710 6 1.10**, 
1.09*, 
1.13**, 
1.03, 
1.15**, 
1.19** 
600 18.20±0.13 19.46±0.33 1.07±0.03 17.22±0.05 18.20±0.40 1.06**±0.03 169/162 2 1.03, 
1.08* 
300a 24.22±3.15 27.79±2.80 1.15±0.03 24.35±3.46 27.95±3.30 1.15**±0.03 234/324 2 1.12**, 
1.18** 
a fed with heat killed bacteria from the 6th day of adulthood 
* p < 0.05 
** p < 0.005 
all experiments are conducted at 20°C 
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Table 5 Median and mean lifespan of wild type C. elegans after treatment with differing RA con-
centrations (50, 100, 200, 300, 600 µM) and an alternative feeding scenario (heat killed OP50). Re-
fers to Fig. 8 C and 10. 
Concen
-tration 
RA 
(µM) 
Median lifespan (d) 
± SEM Change 
± SEM 
Mean lifespan (d) 
± SEM Change 
± SEM 
n 
Control/ 
Treated 
Trias 
Mean 
lifespan 
change 
single 
trials 
Control Treated Control Treated 
50 17.20±0.13 17.21±0.04 1.00±0.01 17.22±0.05 17.51±0.16 1.02±0.01 169/150 2 1.02, 
1.01 
100 14.98±2.77 16.74±3.89 1.12±0.06 15.60±3.54 16.56±3.75 1.06±0.01 208/256 2 1.08**, 
1.04 
200 15.21±1.27 16.86±1.76 1.11±0.04 15.80±1.17 17.45±1.52 1.10**±0.03 649/654 5 1.19**, 
1.10* 
1.13** 
1.05, 
1.04, 
300 14.75±2.25 16.67±2.76 1.13±1.48 15.70±1.56 17.03±2.14 1.08**±0.03 238/261 2 1.11** 
1.05 
600 17.20±0.13 15.81±0.19 0.92±0.02 17.22±0.05 16.14±0.20 0.94*±0.01 169/208 2 0.95, 
0.92* 
200a 25.34±1.00 29.41±0.42 1.16±0.06 22.84±1.89 27.84±2.47 1.22**±0.02 293/309 3 1.25**, 
1.21**, 
1.18 
a fed with heat killed bacteria from 6th day of adulthood 
*p < 0.05 
**p < 0.005 
all experiments are conducted at 20°C 
 
 
3.2.2 Induction of hsp expression levels is variable 
As a marker for elevated repair response and thus for hormetic action, the expression levels of 
six hsp-genes were measured with qRT-PCR. All 6 hsp-genes investigated are highly up-
regulated following an exposure to RA. Whilst Q treatment was able to induce 4 of 6 hsps, CA 
resulted in a down-regulation of five hsps and only hsp-12.6 was upregulated (Fig. 11). It should 
be noted that although the trends are apparent, not all results are statistically significant (due to 
the small sample size of just two biological replicates, each with two technical repeats). 
 
 
 
 
Fig. 11 Expression of six hsp-genes in PP treated nematodes on the 1st day of adulthood. Columns 
combine two biological and two technical repeats. Bars represent the positive SEM, controls are set to 1. 
*p < 0.05 and **p < 0.005 (One Way Anova). 
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3.3 Direct or indirect CR effects 
 
3.3.1 PPs enhance the pharyngeal pumping rate throughout the life 
To preclude the possibility that the observed longevity is the result of reduced food intake (sti-
mulated by Q, CA or RA exposure), pharyngeal pumping was quantified at the 3rd, 6th and 10th 
day of adulthood (Fig. 12 A). The pumping frequency declined over time in all conditions, re-
markable, however is the highly significant increase in pumping due to PP exposure (in particu-
lar Q). Taken together, these findings provide strong evidence that PPs increase food ingestion, 
thus calorie restriction is unlikely to be the cause of the observed longevity.  
 
 
3.3.2 C. elegans are not attracted nor repulsed by PPs  
 
If nematodes are repulsed by the PPs and hence avoid the bacterial food source it is conceiva-
ble that the overall food uptake decreases which would provoke a direct CR effect. A behavioral 
assay revealed the presence of a slight, but statistically non-significant, avoidance response 
towards Q and RA (control spots/spots with compound [%]: 100/84 for both PPs). The results 
from CA treatment (100/93) were similar to controls (100/94). Therefore, PPs seem to be, at 
large neither chemoattractive nor chemo-repulsive (Fig. 12 B). 
 
 
3.3.3 sir-2.1 lifespan can not be extended by CA and RA  
Hints towards indirect CR brought tests with sir-2.1 mutants. The sir-2.1 gene, which in the past 
has been suggested to mediate a genetic CR pathway (Lin et al., 2000; Rogina & Helfand, 
2004; Wood et al., 2004; Chen et al., 2005; Viswanathan et al., 2005; Wang and Tissenbaum, 
2006) – was identified in mutant lifespan and thermal resistance tests as a genetic player of CA 
and RA mediated longevity and thermal resistance (CA: Fig. 22 A, 23 A; Tables 8, 10; RA: Fig. 
22 B, 23 B; Tables 9,11). Hence it is conceivable that both PPs provoke an indirect CR effect, 
by activation of this sir-2.1 mediated CR response (for results and discussion see sections 3.6.2 
and 4.6.2). In the case of Q, lifespan assays with sir-2.1 mutants revealed that Q could extend 
the lifespan even in the absence of sir-2.1, and hence an indirect CR effect was excluded (Fig. 
14, Table 4). Further confirmation brought lifespan assays with wild type nematodes, grown on 
agar plates provided with Q, but without food from the 6th day of adulthood (to avoid excessive 
loss of worms due to “bagging”) on. If Q would provoke an indirect genetic CR program, it is 
suggested that no further extension of lifespan would be achieved by this test design. Since the 
gain in lifespan was significantly enhanced, indirect CR was excluded for Q action (Table 3). 
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Fig. 12 Direct dietary restriction effects. (A) Influence of PPs on the average pharyngeal pumping rate. 
Shown are the compiled graphs of two single trials (20 worms per condition). Pumping activity was moni-
tored at the 3rd, 6th and 10th day of adulthood; (B) PPs in the bacterial diet does not attract nor distract the 
nematodes. Shown are eight repeats, each repeat was conducted with n= 6 nematodes in each treat-
ment. Wild type C. elegans were used for both tests. Error bars represent the SEM. *p < 0.05, **p < 0.005 
(Chi Square test (A), One Way Anova (B)). 
 
 
3.4 Re-allocation of resources 
 
3.4.1 Reproduction: unchanged broodsize but delays in timing 
 
Worms produced on average 301 juveniles in (non-exposed) control conditions and 297, 285 
and 298 offspring when exposed to Q, CA or RA (Fig. 13 A). These statistically insignificant dif-
ferences in the total broodsize are in contrast to the observed drift in reproduction on days 2 
and 4 (Fig. 13 A), where CA and RA caused significant variations in offspring numbers, respec-
tively. These results could be underlined by the finding of delayed onset of reproduction, which 
was significant in the case of RA (Fig. 13 B).  
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Fig. 13 Reproduction. (A) Displays the mean total broodsize per nematode for control compared to 200 
μM Q, 300 μM CA and 200 μM RA treated animals. Three trials are compiled (n = 27/25/26). (B) PP 
treatment delays the onset of reproduction, results are significant for RA. Tests are conducted with wild 
type nematodes. Shown are two combined trials with n = 20 for each treatment; Bars represent the SEM. 
*p < 0.05, **p < 0.005 (One Way Anova). 
 
 
3.4.2 PPs influence the growth of young larvae and adults  
To test whether PPs influence the growth of wild type C. elegans the body size was measured 
using two different approaches: (i) the dynamics of growth were assessed by measuring the 
area of synchronized alive nematodes from 12 h until 180 h (~ 5th day of adulthood) after hatch-
ing with Image Pro Express software and (ii) the size of adults on their 6th day of adulthood was 
additionally quantified by measuring the length of heat-killed nematodes under a graduated eye 
pieced microscope. Both test designs demonstrate effects of PPs on nematode growth. 
 
In general, exposure to PPs increased the volumetric area of living wild type larvae (Fig. 14 A), 
an effect that was lost by the time the worms reached the L4/young adult stage (60 h). This in-
dicates that PPs may accelerate growth in early larval stages. Although this observation was 
deemed to be statistically robust, stage-specific differences in the magnitude of error bars may 
account for some, if not all, observed differences and calls for caution when interpreting the da-
ta set.  
 
Figure 14 B reveals that all three PPs diminished the length of 6 days old dead wild type ani-
mals, although only the effects of CA and RA reached statistical significance. The mean length 
of the control was 1309.30 µM, Q treated nematodes sized averagely 1286.94 µM (98%), whe-
reas CA treated worms measured 1267.20 µM (97%) and RA treated animals ranged around 
1216.55 µM (93%). Overall these findings demonstrate that PPs do impact the growth of C. ele-
gans although to varying extent, dependent on the developmental stage of the nematodes. 
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Fig. 14 Growth. (A) Impact of PPs on volumetric growth of living nematodes from 12 h after hatching until 
an advanced adult stage (180 h, 5th day of adulthood). Every 24 h worms were pictured and measured 
with Image Pro Express software. Pillars include two single trials, total number of n ranges between 22 
and 79 for each treatment and day; (B) shows the length of heat-killed nematodes on their 6th day of 
adulthood. Bars compile 2 trials for CA (with total numbers n control/treated: 79/67) and 3 individual re-
peats for RA (n = 127/130). Tests are conducted with wild type worms. Error bars represent the SEM. *p 
< 0.05, **p < 0.005 (One Way Anova). 
 
 
3.4.3 PPs change intestinal fat deposition  
Since reduced intestinal fat deposition has been linked to longevity, the fat status of nematodes 
was determined. Taking into account the area and the sum of fluorescence per nematode 
(measured from lips to vulva), obvious differences in Nile Red staining were observed (Fig. 15 
A). Q and CA exposed nematodes displayed reduced Nile Red fluorescence at days 3 and 6 of 
adulthood, a result that was significant for CA treated nematodes at day 3 and for Q treated 
worms at day 6 (representative images in Fig. 15 B and C, respectively). RA exposed C. ele-
gans caused the mean fluorescence to increase marginally, however this result was not signifi-
cant. Noteworthy, Nile Red fluorescence could not be reliably measured in young adult nema-
todes and 10 days old adults: in young adults the eggs seemingly are stained by Nile Red, thus 
excluding quantification of intestinal levels. In 10 days old adults the intestine structure obvious-
ly looses integrity in a large percentage of nematodes, which leads to misleading overstaining 
(representative images are displayed in Supplementary Fig. 1).  
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Fig. 15 Fat deposition. Nile Red staining of control and treated nematodes to detect possible PP-
induced variations in fat storage on the 3rd and 6th day of adulthood. (A) The histogram represents the 
sum of fluorescence per area of nematode. Shown are two combined trials with a total of between 25 and 
28 worms per treatment and day. Wild type C. elegans were used for. Bars represent the SEM. *p < 0.05 
and **p < 0.005 (One Way Anova). (B) Displays respresentative fluorescence images of nematodes on 
day 3 of adulthood, (C) on day 6. 
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3.5 Antioxidative Properties 
 
3.5.1 PP-distinct total antioxidative capacity (TAC) in vivo and in vitro  
To prevent free radical damage, living organisms possess a defense system, to a major extent 
displayed by enzymatic (e.g. superoxide dismutases, glutathione peroxidases and catalase) and 
nonenzymatic antioxidants (e.g. ascorbic acid, tocopherol, urinic acid, billirubin). The cellular 
state of oxidative stress results from the imbalance between the formation of ROS and the abili-
ty to detoxify oxidizing radicals (Valko et al., 2007) and plays an important role in pathological 
processes and aging (Droge, 2002). Exogenous supplied compounds, which possess in vivo 
antioxidant properties can interfere in this process. To check if Q, CA and RA have the potential 
to act as antioxidants and thereby cause the life extension, their in vitro and in vivo antioxidative 
potential have been determined. 
 
 
 
Fig. 16 Total antioxidative capacity (TAC) of PPs in hydrophilic (A) and lipophilic (B) solvents. TACs of 
water-soluble (C) or lipid-soluble (D) substances in homogenates obtained from PP treated and untreated 
wild type worms. Tests were repeated 3 times with a total of approximately 3000 worms per treatment in 
each single trial. Errors represent the SEM, differences were considered significant at *p < 0.05 (One 
Way Anova). 
 
 
The antioxidative properties of pure PPs dissolved in either a hydrophilic solvent (water) or a 
lipophilic solvent (methanol) were measured and normalized to Ascorbic acid (AA) or Trolox (T), 
respectively. Although all three PPs are poorly soluble in water, the hydrophilic (Fig. 16 A) and 
the lipophilic (Fig. 16 B) extracts showed strong antioxidative properties. In both solvents PPs 
exhibited the same pattern relative to each other: the highest TAC value was observed with CA 
Results 
53 
 
(which was 22 and 175 fold higher than AA and T, respectively), followed by RA (7 fold higher 
than AA and 18 fold higher than T) and finally Q (0.8 fold of AA, 0.9 fold of T). To confirm the 
antioxidative activity in vivo, we measured the TAC in the homogenate of control, Q, CA and RA 
treated nematodes. The water-soluble fraction (Fig. 16 C) revealed the presence of significantly 
enhanced activities in case of Q and CA exposure, but not for RA treated worms. The TACs of 
lipid-soluble fractions (Fig. 16 D) were elevated by Q, suppressed by RA and similar to controls 
in CA exposures; none of the PP effects reached statistical significance. 
 
 
3.5.2 Q prevents, RA enhances paraquat-induced matricidal 
Paraquat (1,1‘-dimethyl-4,4’-bipyridinium) dichloride – a herbicide commonly used to generate 
oxidative stress in vivo by redox cycling - is metabolically reduced to the stable paraquat radical 
(PQ+) in a NAD(P)H-dependent reaction catalyzed by NAD(P)H-cytochrome P-450 reductase. 
In turn the paraquat radical reduces molecular oxygen and thereby produces the superoxide 
radical (O2–) (Brigelius et al., 1986; Fukushima et al., 1993; Yamada et al., 1993). The exact 
mechanism by which paraquat acts in detail is yet not enlightened. Presumably several compo-
nents may contribute to the cytotoxicity of paraquat. However, strong evidence points towards 
ROS as main cause for the cytotoxicity of paraquat, which inflicts cellular injury by damaging 
biological macromolecules (Bus et al., 1976; Bagley et al., 1986; Chan and Weiss, 1987). This 
theory is supported by studies in diverse organisms, including bacteria (Greenberg et al., 1990; 
Hongo et al., 1994), Drosophila (Orr and Sohal, 1993; Parkes et al., 1993) and C. elegans (Van-
fleteren, 1993), where elevated antioxidant enzyme activity in response to paraquat have been 
demonstrated.  
 
 
 
Fig. 17 Prevention of paraquat-induced matricidal. Displayed are the survival of wild type C. elegans 
72 h after starting the treatment with 10 mM paraquat (+p) or a negative control (-p) combined with either 
0 μM, 200 μM Q, 300 μM CA or 200 μM RA. Shown are data from two single trials. Total numbers of ani-
mals tested: control 283, Q 273, CA 285, RA 223, negative control 167. Numbers represent the percent-
age of observed “bagging” phenotype ± SEM; **p < 0.005 (Chi Square test). 
 
 
Exposing control and PP treated nematodes for 72 h to paraquat caused severe levels of matri-
cidal death (“bagging”) (Fig. 17). In the absence of paraquat no “bagging” was observed 
throughout the whole time period. Nonetheless, a high degree of protection was provided by Q 
which was able to significantly increase the survival rate from 9.9 % (in control worms) to  
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47.1 %. Whilst increased survival by CA was statistically insignificant (to 12.1 %), RA imposed a 
negative effect, reducing the survival to 0.3 %. In conclusion, Q was shown to rescue a para-
quat induced “bagging” phenotype suggesting that Q may play an effective role in protecting 
against oxidative stress. 
 
So far, induction of matricidal hatching in C. elegans have been observed following starvation, 
due to placement in water without food, or caused by various stress conditions, as when ex-
posed to chitinase-producing bacteria or high salt concentrations (Chen and Caswell-Chen, 
2003). It is arguable, if the observed internal hatching observed in this study arises partly due to 
the inhibitory impact of paraquat on the bacterial growth (personal communication with Zeitoun), 
which may alter the food conditions for the nematodes towards a caloric restrictive diet, known 
to cause matricidal. But beside, paraquat doubtlessly acts in a direct oxidative way on the 
worms. 
 
 
3.5.3 All three PPs prolong the lifepan of mev-1 mutants 
The first mitochondrial mutation identified in C. elegans was mev-1(kn1). Ishii et al. (1998) cha-
racterized mev-1 as a missense mutation in the cytochrome b subunit of complex II. Electron 
chain transport studies with mitochondria from mev-1 nematodes (Senoo-Matsuda et al., 2001; 
Kayser et al., 2004) showed a decreased complex II activity and also decreased rates of oxida-
tive phosphorylation. mev-1 has been characterized to be sensitive to oxygen, to show in-
creased rates of oxidative damaged proteins, a diminished fecundity (Brand, 2000), an elevated 
production of superoxide (Senoo-Matsuda et al., 2001) and thereby a shortened lifespan, which 
can be extended to normal by add-on of superoxide dismutase/catalase mimetics (Sedensky 
and Morgan, 2006). Kondo et al. (2005) also reported that DAF-16 - a fork-head transcription 
factor which is negatively regulated by the ILS pathway - persists constitutively in the nuclei of 
mev-1 nematodes even under normal growth conditions, in contrast to the common situation in 
wild type animals, where DAF-16 remains in the cytoplasm until a translocation is triggered by 
diverse activating stimuli (e.g. environmental stressors, such as starvation, heat and oxidative 
stress; Henderson and Johnson, 2001). Kondo et al. (2005) assumed that the endogenously 
created high steady-state levels of oxidative stress caused the persistence of nuclear DAF-16 in 
mev-1 animals and overwhelm all resistance mechanisms mediated by the translocated tran-
scription factor. A reversal of the nuclear DAF-16 state could be achieved by supplementation of 
the antioxidant, radical scavenger coenzyme Q10 (Kondo 2005). All these findings point toward 
the heightened ROS production as origin of the diminished lifespan found in mev-1 nematodes, 
rather than the inhibited oxidative phosphorylation levels.  
 
Since Q, CA and RA were able to extend the mean survival time of mev-1 mutants by a highly 
significant 10 %, 10 % and 8% (Fig. 18 A, B and C, for more details see also Tables 6, 8, 9 in 
sections 3.6.1 and 3.6.2) suggests that all three PPs are able to enhance survival during oxida-
tive stress predominating in mev-1 mutants.  
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Fig. 18 Lifespan of mev-1 mutants treated with 200 µM Q (A), 300 μM CA (B) or 200 μM RA (C). Ap-
propriate data (mean and median lifespan, n and trial numbers, as well as single trial significances) are 
listed in Tables 6, 8 and 9; differences were considered significant at **p < 0.005 (log-rank test). 
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3.5.4 Intestinal lipofuscin fluorescence is decreased due to Q and CA  
One of the markers for oxidative damage during aging is the intensity of lipofuscin, which accu-
mulates gradually in the secondary lysosomes of aging organisms (Brunk and Terman, 2002) 
including C. elegans (Hosokawa et al., 1994). Lipofuscin consists primarily of lipid peroxidation 
products and oxidized proteins that resist proteolytic degradation (Berdichevsky et al., 2010). 
The quantification of lipofuscin fluorescence intensity (Fig. 19 A) demonstrates that Q, CA and 
RA exposure was able to reduce lipofuscin accumulation by a significant 16% and 34% and a 
nonsignificant 7%, respectively. Images in Fig. 19 B show representative images of treated and 
control nematodes. 
 
 
 
Fig. 19 Intestinal Lipofuscin fluorescence in wild type nematodes at the 7th day of adulthood. (A) 
Graphs of combined results of about 40 worms per treatment. Errors represent the SEM, differences were 
considered significant at *p < 0.05 (One Way Anova). (B) Representative lipofuscin fluorescence pictures. 
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3.6 Genetic background: mutant lifespan and thermotolerance assays  
 
To unravel the underlying genetics of Q, CA and RA action in vivo, lifespan assays were carried 
out with selected C. elegans mutant strains lacking genes previously implicated in stress re-
sponse or aging. Due to Q being the main focus of this study, 13 mutant strains are investigated 
with Q, whereas in CA and RA 8 mutant strains were used (detailes about mutated genes can 
be found in the discussion section 4.6.2, Table 25). Specifically, lifespan assays with CA and 
RA focused on mutants including the ones found to affect Q (Pietsch et al., 2009) and blueberry 
PP (Wilson et al., 2006) mediated longevity.  
 
 
3.6.1 Genetic players of Q mediated longevity  
Fig. 19 and Table 5 summarize results from mutant lifespan assays. It has been shown that the 
polyphenol resveratrol can increase lifespan via the sirtuin gene sir-2.1, which encodes a his-
tone deacetylase-like protein that integrates the metabolic status and lifespan (Tissenbaum and 
Guarente, 2001; Wood et al., 2004). Q treatment extended lifespan of sir-2.1(ok434), suggest-
ing that Q does not modulate this pathway. Several C. elegans transcription factors, including 
DAF-16, NHR-8 and SKN-1, promote the expression of antioxidant or detoxification enzymes. Q 
treatment was able to prolong lifespan of daf- 16(mgDf50), nhr-8(ok186) and skn-1(zu67) nema-
todes, indicating that Q may act independently of these genes as well. A similar result was ob-
tained for jnk-1(gk7). Activation of JNK-1, which is localized in the neuronal system, drives the 
nuclear translocation of DAF-16 within peripheral cells (Wolf et al., 2008). Furthermore, the li-
fespan of daf-12(m20) (daf-defective (daf-d) allel: mutants lack the ability to form dauers) could 
also be enhanced by Q. DAF-12, a member of the steroid hormone receptor superfamily, influ-
ences dauer formation downstream of the TGF-beta and ILS pathways, and affects gonad-
dependent adult longevity together with DAF-16 (Gerisch et al., 2007). In contrast to the afore-
mentioned mutants, Q treatment did not prolong the lifespan of two long-lived and oxidative 
stress-resistant mutants, namely daf-2(e1368) and age-1(hx546). Both genes are key players of 
the ILS pathway, and mutations result in a dramatic increase in longevity. DAF-2 is the only in-
sulin/IGF-1 like receptor in C. elegans, AGE-1 a catalytic subunit of a phosphoinositide 3-kinase 
(PI3K), is downstream of DAF-2. Both enzymes act at a similar point in the genetic epistasis 
pathway for dauer arrest and longevity and negatively regulate the activity of DAF-16. Given 
that DAF-16 was found to be non essential for lifespan regulation by Q, it is perhaps surprising 
to find other members of the ILS family to be involved in Q-mediated longevity. This issue will be 
addressed in finer detail concerning the DNA-microarray results. 
Genes required for Q mediated lifespan extension  
 
Furthermore, a disrupted calmodulin kinase II (CaMKII) pathway seems to prevent Q induced 
longevity. Survival in hyperosmotic environments requires the activity of several proteins of the 
CaMKII pathway, in which OSR-1 is coupled to SEK-1 (MAPKK) through UNC-43 (CaMKII) (So-
lomon et al., 2004). SEK-1 is also required for the resistance to pathogenic bacteria and oxida-
tive stress by assisting the translocation of cytoplasmic DAF-16 into the nucleus (Kim et al., 
2002; Kondo et al., 2005). All three genes were found to be essential for blueberry extract-
mediated longevity (Wilson et al., 2006). Similarly, Q treatment was not able to prolong the li-
fespan of unc-43(n498n1186) and sek-1(ag1) mutants, strongly suggesting that this flavonoid 
may act via this pathway. Noteworthy however, was that osr-1(rm1) nematodes continued to 
display robust Q induced longevity (Fig. 20, Table 6) 
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Fig. 20 Genetic modulators of Q mediated longevity. Lifespan alterations in 13 mutant strains follow-
ing the treatment with 200 μM Q. Shown are the mean lifespan variations compared to the respective 
untreated control. Mean and median lifespans, n and trial numbers, single trial significances are listed in 
Table 6. Error bars represent SEM, **p < 0.005 (log-rank test).  
 
 
Longevity is often coupled to stress resistance in C. elegans (Johnson et al., 2002), therefore 
the presumable genetic players for Q mediated lifespan extension were reassessed by thermo-
tolerance assays (Fig. 21, Table 7). The thermal resistance was significantly increased in wild 
type (N2) animals treated with 200 µM Q (according to Saul et al., 2008), a trend that could not 
be observed in age-1(hx546), daf-2(e1368), sek-1(ag1) and unc-43(n498n1186) mutants. 
These findings support the lifespan assays and strengthen the notion that Q mediated longevity 
is driven by age-1, daf-2, sek-1 and unc-43. 
Are the genes required for Q mediated lifespan extension also responsible for enhanced 
thermotolerance? 
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Fig. 21 Thermal stress resistance of wild type (N2) and selected mutant strains untreated (0 µM) or 
treated with Q 200 µM. Shown are the 8 h-survival rates for N2 and unc-43(n498n1186), 9 h-survival 
rates for age-1(hx546), 10 h survival rates for daf-2(e1368), and the 6 h-survival rates for sek-1(ag1) ex-
posed to 35°C. The experiment was conducted with 6th days old adult. Mean values, n, trial numbers, 
single trial results and significances are listed in Table 7. **p < 0.005 (Chi Square test). 
 
 
 
 
 
 
 
 
 
Table 7 Thermal resistance of Q 200 µM treated nematodes. Effect of 200 µM Q on thermal resistance 
of N2 and four different mutant strains compared to respective untreated control (refers to Fig. 21). 
Genotype 
Hours 
of 
heat 
stress 
Survivors (%) 
all trials pooled ± SEM 
n 
Con-
trol/ 
Treated 
Trials 
Survivors (%) 
single trials ± SEM 
n 
Control
/ 
Treated 
Control 
(0 µM) 
Treated 
(Q 200 µM) 
Control 
(0 µM) 
Treated 
(Q 200 µM) 
N2 8 h 40.31±8.12 51.95±8.53** 251/273 3 45.52±7.64 
24.39±8.84 
51.02±5.85 
56.19±0.84 
35.53±5.55 
64.15±9.16 
120/144 
82/76 
49/53 
age-1 (hx546) 9 h 55.91±3.78 49.09±2.14 303/337 3 62.07±3.92 
49.04±7.16 
56.63±2.13 
53.23±5.37 
46.09±2.34 
47.96±6.53 
116/124 
104/115 
83/98 
daf-2 (e1368) 10 h 65.42±1.58 61.80±3.33 305/309 3 68.47±3.41 
64.65±7.47 
63.16±5.80 
66.47±4.06 
63.30±9.02 
55.42±6.90 
111/117 
99/109 
95/83 
sek-1 (ag1) 6 h 51.14±2.63 48.78±4.82 98/111 3 46.15±0.00 
52.17±1.57 
55.10±8.94 
52.63±0.23 
54.55±4.08 
39.22±8.57 
26/38 
23/22 
49/51 
unc-43 
(n498n1186) 
8 h 44.67±5.44 48.86±0.79 299/341 3 55.00±7.31 
36.56±7.16 
42.45±5.06 
47.71±1.98 
48.48±4.94 
50.38±1.94 
100/109 
93/99 
106/133 
** p < 0.005 
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3.6.2 Genetic players of CA and RA mediated longevity  
 
Genes required for CA and RA mediated lifespan extension 
 
Fig. 22 Genetic modulators of CA (A) or RA (B) mediated longevity. Lifespan alterations in eight mu-
tant strains following the treatment with either 300 μM CA or 200 µM RA. Shown are the mean lifespan 
variations compared to the respective untreated control. Mean and median lifespans, n and trial numbers, 
single trial significances are listed in Tables 8 (CA) and 9 (RA). Error bars represent SEM, *p < 0.05; **p < 
0.005 (log-rank test).  
 
 
Since Q mediated longevity was specifically abolished in age-1, daf-2, sek-1 and unc-43 mu-
tants, the effects of CA and RA were analyzed in these as well as other mutants. CA and RA 
could not significantly extend lifespan in the four mutant strains (osr-1, sek-1, sir-2.1 and unc-
43) (Fig 22 A and B, Tables 8 and 9) This suggests that CA and RA both use comparable ge-
netic pathways for life extension which are, however, in parts distinct from those involved in Q 
action. Notably, lifespan was even reduced in CA exposed sir-2.1 and osr-1 and RA treated 
sek-1 and unc-43, however, it should be mentioned, that the individual trials of unc-43 resulted 
in highly variable, indeed sometimes contradictory results (changes: 0.85**, 1.00 and 1.10**). 
One difference prevailed throughout; in daf-16 lifespan extension was only achieved by RA and 
not CA.  
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The thermal resistance is significantly enhanced in CA and RA treated nematodes (Fig. 23 A 
and B). To support findings of genetic players for longevity thermotolerance assays with mutant 
strains that displayed no life extension due to respective PP treatment were also conducted. 
The results from different trials were somewhat variable, and in some cases contradictory (for 
detailed summary of results see Tables 10 and 9), however some valuable observations could 
be extracted which reflect general trends rather than firm mechanistic evidence. Taking all find-
ings together, strengthens the notion that daf-16, sek-1, sir-2.1, unc-43 and tentatively osr-1 
modulate the health gaining action of CA (Fig. 23 A). Results for RA are illustrated in Fig. 23 B. 
Independent repeats revealed that treated and untreated osr-1 showed almost equal numbers 
of survivors. The same holds true for unc-43 and sek-1. Treated sir-2.1 displayed in three inde-
pendent experiments moderate but statistically insignificant increased thermotolerance, a result 
that is analogous to the lifespan assays. In summary, osr-1, sek-1 and unc-43 seem to be ge-
netic mediators of RA in vivo responses, with sir-2.1 possibly playing an ancillary role. 
Verification of genetic palyers for CA and RA by thermotolerance 
 
 
 
Fig. 23 Thermal stress resistance of N2 and selected mutant strains untreated (0 µM) or treated with 
(A) 300 µM CA or (B) 200 µM RA, respectively. Shown are the 8 h-survival rates for N2 and unc-
43(n498n1186), 7 h-survival rates for sir-2.1(ok434), osr-1(rm1) and daf-16(mgDf50), and the 6 h-survival 
rate for sek-1(ag1) exposed to 35°C. The experiment was conducted with 6th days old adult. Mean values, 
n, trial numbers, single trial results and significances are listed in Tables 10 (CA) and 11 (RA). *p < 0.05, 
**p < 0.005 (Chi Square test). 
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Table 10 Thermal resistance of CA 300 µM treated nematodes. Effect of 300 µM CA on thermal resis-
tance of N2 and five different mutant strains compared to respective untreated control (refers to Fig. 23 
A). 
Genotype 
Hours 
of 
heat 
stress 
Survivors (%) 
all trials pooled ± SEM n Con-
trol/ 
Treated 
Trials 
Survivors (%) 
single trials± SEM n Control
/ 
Treated 
Control 
(0 µM) 
Treated 
(CA 300 µM) 
Control 
(0 µM) 
Treated 
(CA 300 
µM) 
N2 8 h 49.34±3.85 62.55**±4.07 494/466 6 67.86±3.48 
53.33±9.43 
69.05±2.99 
58.33±4.82 
26.94±8.36 
45.87±3.36 
77.32±5.58 
81.82*±5.51 
74.16±4.87 
75.44*±5.71 
38.03*±7.48 
57.85±4.95 
112/97 
30/33 
84/89 
108/114 
193/142 
109/121 
daf-16 (mgDf50) 7 h 22.54±3.31 14.07*±3.09 173/199 2 21.88±6.02 
23.38±4.06 
15.90±4.31 
12.61±5.37 
96/88 
77/111 
osr-1 (rm1) 7 h 61.95±2.85 67.08±2.64 205/240 2 58.63±4.50 
64.37±2.32 
68.03±3.04 
66.52±4.78 
108/123 
97/117 
sek-1 (ag1) 6 h 48.98±9.53 33.33±23.55 49/48 3 25.00±0.00 
53.85±0.00 
53.33±0.00 
10.00±0.00 
26.67±0.00 
87.50±0.00 
8/10 
26/30 
15/8 
sir-2.1 (ok434) 7 h 59.11±2.09 55.36±3.82 181/168 2 55.95±1.67 
61.86±3.34 
53.62±3.33 
56.57±7.52 
84/69 
97/99 
unc-43 
(n498n1186) 
8 h 47.41±3.26 39.12**±4.86 580/611 6 46.94±7.71 
40.48±4.36 
40.68±3.99 
50.00±7.91 
51.90±7.89 
61.73±6.71 
44.58±5.89 
14.39**±6.02 
44.54±13.28 
36.90±14.49 
60.87±15.00 
44.68*±6.96 
98/83 
126/139 
118/119 
78/84 
79/92 
81/94 
*p < 0.05 
**p < 0.005 
 
Table 11 Thermal resistance of RA 200 µM treated nematodes. Effect of 200 µM RA on thermal resis-
tance of N2 and four different mutant strains compared to respective untreated control (refers to Fig. 23 
B). 
*p < 0.05 
**p < 0.005 
Genotype 
Hours 
of 
heat 
stress 
Survivors (%) 
all trials pooled ± SEM n 
Control/ 
Treated 
Tri-
als 
Survivors (%) 
single trials ± SEM n 
Control/ 
Treated Control 
(0µM) 
Treated 
(RA 200 µM) 
Control 
(0 µM) 
Treated 
(RA 200 
µM) 
N2 8 h 59.64±3.45 68.54*±4.96 665/654 8 67.86±3.48 
53.33±9.43 
69.43±2.99 
55.96±3.03 
72.06±4.25 
45.28±4.35 
50.66±9.16 
62.56±9.34 
77.45±3.90 
74.42±1.73 
72.16±4.31 
65.66±6.49 
77.86±2.14 
35.21±4.89 
74.75**±5.96 
70.83±10.49 
112/102 
30/43 
84/45 
63/58 
111/118 
115/124 
86/102 
64/62 
osr-1 (rm1) 7 h 61.50±2.85 65.64±2.75 205/216 2 58.63±4.50 
64.37±2.32 
66.33±3.32 
64.94±4.89 
108/113 
97/103 
sek-1 (ag1) 6 h 44.06±9.53 43.13±11.83 49/53 3 25.00±0.00 
53.85±0.00 
53.33±0.00 
22.22±0.00 
44.00±0.00 
63.16±0.00 
8/9 
26/25 
15/19 
sir-2.1 (ok434) 7 h 63.45±3.92 71.43±4.15 279/184 3 55.95±1.67 
61.86±3.34 
71.84±10.63 
73.15*±4.70 
64.71±8.38 
78.82±6.81 
84/108 
97/85 
98/91 
unc-43 
(n498n1186) 
8 h 54.67±5.56 56.84±8.35 342/320 3 46.94±7.71 
40.48±4.36 
76.60±3.99 
56.25±1.78 
30.72±4.06 
83.93±4.79 
98/32 
126/153 
118/135 
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3.7 Global transcriptional profiling: DNA-microarray results from Q treated  
 nematodes 
 
To gain a deeper insight of how Q deploys its action by genetic regulation in vivo, global tran-
scriptional profiling has been performed using DNA-microarrays. Q has been applied in three 
different concentrations: Q 50, 100 and 200 µM. By investigation of this concentration range 
(spanning from pre-lifespan extending 50 µM, towards the life extending concentrations Q 100 
µM and 200 µM), it is possible to determine dose-dependent differences in the transcriptional 
output. By pooling the commonly regulated genes of the life extending concentrations on one 
hand (Qlongevity) and pooling of commonly regulated genes of all three concentrations on the oth-
er hand (Qall), it was furthermore possible to curtail life prolonging transcriptional outputs. Unfor-
tunately it was not possible to include an already toxic concentration, since at doses above 200 
µM Q the compound did not solve completely and aggregated in the agar.  
The whole dataset, with fold change values for all 22 548 transcripts and indicated significance 
can be found online in an excel spreadsheet (Online Supplementary 2) under following web 
address:  
https://docs.google.com/leaf?id=0B-
ebpwy-
wEV6MNGQ1MzU1ZGYtYjZhYS00ZGY2LWIwNTYtMjM5MGE1M2ZhMzJi&hl=en_US&authkey
=CNuBhcgP 
 
In addition to Q treatment, this spreadsheet contains DNA-microarray datasets from the litera-
ture which characterized various lifespan-prolonging conditions and will be discussed in the fol-
lowing sections. Genes belonging to gene expression mountains (according to Kim et al., 2001), 
as well as gene-classes and –groups are highlighted in the list ;thus, it is possible to filter for 
various conditions and gene categories with the autofilter function in microsoft excel, implying 
that the array analyses described in the following sections can be reproduced. For a short ma-
nual how to use the filter function in the Online Supplementary refer to the Supplementary in-
formation 1 in the Appendix. 
 
 
3.7.1 Transcriptional profiles  
Initial analysis of gene expression profiles using Venn diagrams (Fig. 24) revealed that gene 
expression patterns at different Q doses mirrored longevity effects: the differential regulated 
genes (DEGs), up- or downregulated more than 1.25-fold in Q 50 µM treated nematodes, differ 
strongly from the DEGs in Q 100 and 200 µM animals. In contrast, the expression profiles in 
response to the two latter concentrations resemble each other in the magnitude as well as in the 
majority of regulated transcripts. The total number of DEGs increase in Q 100 µM compared to 
Q 50 µM exposed C. elegans up to 3.3 fold, however, the increment in Q 200 µM surpass Q 100 
µM treated nematodes just about marginally 1.1 fold. A further discrepancy between the non-
longevity provoking concentration Q 50 µM and both longevity-mediating ones, is the proportion 
of up- and down- regulated transcripts. Whereas in Q 50 µM three times more genes are up- 
compared to down- regulated, the ratio reverses in the higher concentrations, where approx-
imately two times (2 fold in Q 100 µM and 1.7 fold in Q 200 µM) more genes were repressed 
contrasting to induced ones. Furthermore, the high percentage of exclusively Q 50 µM regulated 
transcripts (37%) points to a distinct mode of action, compared to the higher doses, which pre-
sumably lead to the observed variance in life extension.  
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Fig. 24 Number of significantly up- and down-regulated genes due to Q 50, 100 and 200 µM. Over-
view of significant DEGs (fold change > 1.25 or < 0.8) in response to Q 50, 100, 200 µM. Venn diagram 
showing the overlap of significantly either up- or down-regulated genes per concentration. 
 
 
3.7.2 Gene Ontology (GO) Analysis 
DEGs were classified using gene ontology terms to obtain functional insights into gene expres-
sion responses. Figures 25, 26 and 27 depict Gene Ontology trees (GO-trees) computed from 
DEGs; both up- and down-regulated genes were analyzed together, in Q 50, 100 and 200 µM 
treated nematodes, respectively. To keep better clarity these GO-trees are restricted to supe-
rordinated topics. While Q 50 µM affects solely anatomical structure morphogenesis (develop-
mental process) and structural molecule activity, Q 100 and 200 µM provoke a broad response 
in many fields, e.g. regulation of growth, reproduction, locomotion, cellular processes, develop-
mental processes (like embryonic development, larval development and also body morphoge-
nesis), nucleotide binding processes, as well as the formation of cell junctions. Importantly, only 
marginal differences are observed between both Q concentrations, reflecting the similar positive 
impact on lifespan. 
 
 
Fig. 25 Gene Ontology trees for overrepresented GO-terms in Q 50 µM treated nematodes out of 
the categories (A) Biological Process and (B) Molecular Function.  
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Fig. 26 Gene Ontology trees for overrepresented GO-terms in Q 100 µM treated nematodes out of 
the categories (A) Biological Process, (B) Cellular Component and (C) Molecular Function.  
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Fig. 27 Gene Ontology trees for overrepresented GO-terms in Q 200 µM treated nematodes out of 
the categories (A) Biological Process, (B) Cellular Component and (C) Molecular Function. 
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To further analyze the functional overlap between the single concentrations, commonly regu-
lated GO-terms have been determined. The Venn diagram in Fig. 28 shows the number of ex-
clusive and overlapping GO-categories in all three treatments (again concerning up- and down-
regulated genes together). A few GO categories are overrepresented in all three concentrations 
(e.g. body morphogenesis, oxidation reduction, oxidoreductase activity, DNA packaging, pro-
tein-DNA-assembly, nucleosome organization and assembly, chromatin assembly, monocar-
boxylic acid metabolic process, cuticle development, and cytoskeleton etc; cf. Supplementary 
Table 2). Comparing the mutual overlap between the Q concentrations, a strikingly similar regu-
lation of GO categories in lifespan prolonging conditions Q 100 and 200 µM can be observed. In 
contrast, the longevity-ineffective Q 50 µM concentration regulates only a few GO terms and 
shows little overlap with either Q 100 µM or Q 200 µM. Hence, longevity promoting concentra-
tions of Q induce longevity-specific, broadly overlapping gene expression responses as as-
sessed by GO terms. 
 
Nevertheless, some GO-terms differ also between both lifespan prolonging concentrations: One 
term (among others) which can just exclusively be found in Q 100 µM is “determination of adult 
lifespan” (genes in this term are: tir-1, ifta-2, ceh-20, gei-7, sod-3, dod-20, fkb-3, dod-22, unc-
112, dod-23, acdh-1, spp-1, cyp-35b1, cln-3.3, vha-12, che-11, alp-1, ftn-1, jnk-1, sodh-1, dod-
19, aqp-1, ife-2, elt-1, nuc-1, cyp-34a9, dod-3, unc-52, ifc-2, thn-1, elo-2, mdt-15). The involve-
ment of many dod-genes (means downstream of DAF-16) and sod-3, as well as sodh-1 which 
are also regulated by DAF-16, would point towards an involvement of this central FOXO-
transcription factor in Q induced logevity. However, it is not clear whether the observed differ-
ence between Q 100 µM and Q 200 µM is physiologically relevant or an experimental artifact 
that arises from technical variability in the array measurements. Of note, the putatively central 
“determination of adult life span” genes do not show up in the set of predicted aging-related 
genes, Qlongevity, which is defined based on overlaps of Q 100 µM and Q 200 µM. Additional in-
formation about regulated genes in all GO-terms of single concentrations can be found in Online 
Supplementary 1 and downloaded online under following link: 
https://docs.google.com/leaf?id=0B-
ebpwywEV6MNGIzODk4YWItMzYwNS00MTdjLWFmODEtNDI3NmYzOGUyMzcz&hl=en_US& 
authkey=CMDNr-8I 
 
 
 
Fig. 28 Overlap of overrepresented GO-categories in single Q concentrations. GO terms were de-
termined with DAVID software (p < 0.05, fold-change of statistically significant genes to reference control 
> 1.25 or < 0.8). Additional information about terms numbers and names can be found in Supplementary 
Table 2 and the Online Supplementary 1.  
 
 
To gain further insights into the mechanistic basis of the Q longevity effect, a cluster analysis of 
GO-terms was performed for different concentrations of Q. A cluster analysis groups GO-terms 
with similar inclosed genes, thereby revealing redundancies and allowing for complexity reduc-
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tion of the GO analysis output. Accordingly, only the most significant term of each GO cluster is 
given in the summary of the GO cluster analysis results (Tables 12 and 13). Since Q 100 and 
200 µM induce largely similar transcriptional responses, overlapping genes were pooled to a 
new group called Qlongevity, and the GO clustering analysis focused on a comparison of Qlongevity 
with the pre-life extension dose Q 50 µM (see Supplementary Tables 3 and 4 for Q 100 and 200 
µM results). Note that up- and down-regulated genes were treated separately and that slightly 
different results would be obtained when grouping together positively and negatively responding 
genes. The putatively lifespan-extending up-regulated transcripts in Qlongevity contained, among 
others, the following overrepresented GO-terms: (i) chromatin assembly, (ii) lipid metabolic 
process, (iii) monooxygenase activity and (iv) nucleosome. GO-terms revealed from down-
regulated genes included (i) nervous system development, (ii) regulation of muticellular organ-
ism growth, (iii) dauer entry, regulation (iv) -of transcription, (v) - of response to stimulus, (vi) -of 
cell communication, (vii) -of biological quality, (viii) -locomotion and (ix) -programmed cell death. 
All of these terms point towards a profund impact on signaling and development common to 
both longevity promoting concentrations. Moreover, the longevity-related transcriptional 
processes resemble parts of the dauer program. GO-terms in Q 50 µM revealed among others 
lysozyme activity and oxidoreductase activity acting on the CH-CH group of donors, what points 
toward an upgraded immunity and stress resistance, also in this pre-life prolonging concentra-
tion.  
 
 
Table 12 GO cluster analysis with significantly up- or down- regulated transcripts in Q 50 µM. Dis-
played is one significant GO-term per cluster. (DAVID, adjusted on "medium classification stringency", p < 
0.05). 
GO-term No. DEGs 
No. 
genes in 
GO-term 
p-value 
Fold 
Enrich-
ment 
Up-regulated overrepresented GO-terms in Q 50 µM 
Biological Process 
GO:0006082~organic acid metabolic process 17 217 2,13E-05 3,55E+00 
GO:0008152~metabolic process 120 3776 7,77E-08 1,44E+00 
GO:0040002~collagen and cuticulin-based cuticle development 6 89 4,57E-02 3,05E+00 
GO:0006725~cellular aromatic compound metabolic process 7 77 6,75E-03 4,12E+00 
GO:0008610~lipid biosynthetic process 8 104 7,79E-03 3,49E+00 
GO:0031497~chromatin assembly 4 32 3,24E-02 5,66E+00 
GO:0010171~body morphogenesis 20 582 5,28E-02 1,56E+00 
Cellular Coponent 
GO:0016021~integral to membrane 145 6596 1,35E-02 1,11E+00 
GO:0000786~nucleosome 4 30 2,06E-02 6,74E+00 
Molecular Function 
GO:0003796~lysozyme activity 4 8 8,18E-04 1,97E+01 
GO:0016627~oxidoreductase activity, acting on the CH-CH group of 
donors 9 67 2,71E-04 5,28E+00 
GO:0051213~dioxygenase activity 4 20 1,33E-02 7,87E+00 
GO:0016878~acid-thiol ligase activity 3 8 1,62E-02 1,47E+01 
GO:0016746~transferase activity, transferring acyl groups 9 162 5,35E-02 2,18E+00 
     Down-regulated overrepresented GO-terms in Q 50 µM 
Biological Process 
GO:0045449~regulation of transcription 16 817 5,65E-03 2,15E+00 
GO:0007399~nervous system development 6 107 2,71E-03 6,14E+00 
GO:0050789~regulation of biological process 43 3457 8,69E-03 1,36E+00 
Cellular Component 
GO:0005622~intracellular 31 3047 4,41E-02 1,35E+00 
Molecular Function 
GO:0043167~ion binding 26 1966 2,51E-02 1,50E+00 
GO:0043565~sequence-specific DNA binding 11 473 7,61E-03 2,65E+00 
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Table 13 GO cluster analysis with significantly up- or down- regulated transcripts in Qlongevity. Dis-
played is one significant GO-term per cluster. The cluster analysis of GO-terms in single concentrations 
can be found in Supplementary Tables 3 and 4. (DAVID, adjusted on "medium classification stringency", 
p < 0.05). 
GO-term No. DEGs 
No. 
genes in 
GO-term 
p-value 
Fold 
Enrich-
ment 
Up-regulated overrepresented GO-terms in Qlongevity 
Biological Process 
GO:0031497~chromatin assembly 7 32 8,42E-05 9,28E+00 
GO:0006629~lipid metabolic process 17 309 2,42E-03 2,33E+00 
GO:0006636~unsaturated fatty acid biosynthetic process 3 7 1,06E-02 1,82E+01 
GO:0019400~alditol metabolic process 3 15 4,70E-02 8,49E+00 
GO:0009451~RNA modification 4 25 2,00E-02 6,79E+00 
GO:0008152~metabolic process 105 3776 1,65E-02 1,18E+00 
Cellular Component 
GO:0000786~nucleosome 7 30 7,41E-05 9,47E+00 
GO:0016021~integral to membrane 175 6596 4,74E-02 1,08E+00 
GO:0005856~cytoskeleton 15 235 1,93E-03 2,59E+00 
Molecular Function 
GO:0016788~hydrolase activity, acting on ester bonds 26 467 1,32E-03 1,99E+00 
GO:0004497~monooxygenase activity 11 107 7,93E-04 3,67E+00 
          Down-regulated overrepresented GO-terms Qlongevity 
Biological Process 
GO:0007399~nervous system development 35 107 8,00E-15 4,77E+00 
GO:0007155~cell adhesion 21 64 4,16E-09 4,79E+00 
GO:0006928~cell motion 27 98 1,06E-09 4,02E+00 
GO:0009653~anatomical structure morphogenesis 124 1012 3,41E-11 1,79E+00 
GO:0040012~regulation of locomotion 32 224 1,24E-04 2,09E+00 
GO:0051239~regulation of multicellular organismal process 71 635 3,41E-05 1,63E+00 
GO:0065007~biological regulation 290 3514 1,70E-05 1,20E+00 
GO:0007167~enzyme linked receptor protein signaling pathway 9 32 1,11E-03 4,10E+00 
GO:0018991~oviposition 41 287 1,10E-05 2,09E+00 
GO:0045137~development of primary sexual characteristics 16 102 3,78E-03 2,29E+00 
GO:0001667~ameboidal cell migration 6 12 7,78E-04 7,30E+00 
GO:0050794~regulation of cellular process 156 1626 2,79E-06 1,40E+00 
GO:0009887~organ morphogenesis 42 377 1,94E-03 1,63E+00 
GO:0043053~dauer entry 7 28 1,03E-02 3,65E+00 
GO:0014018~neuroblast fate specification 3 3 1,34E-02 1,46E+01 
GO:0031344~regulation of cell projection organization 7 24 4,64E-03 4,26E+00 
GO:0008361~regulation of cell size 8 28 2,26E-03 4,17E+00 
GO:0006357~regulation of transcription from RNA polymerase II promo-
ter 13 85 1,25E-02 2,23E+00 
GO:0048583~regulation of response to stimulus 12 67 5,36E-03 2,61E+00 
GO:0010646~regulation of cell communication 19 152 1,56E-02 1,82E+00 
GO:0065008~regulation of biological quality 27 214 2,93E-03 1,84E+00 
GO:0045185~maintenance of protein location 5 16 2,04E-02 4,56E+00 
GO:0042464~dosage compensation, by hypoactivation of X chromo-
some 4 9 1,96E-02 6,49E+00 
GO:0048523~negative regulation of cellular process 18 132 8,37E-03 1,99E+00 
GO:0043067~regulation of programmed cell death 8 46 3,53E-02 2,54E+00 
GO:0043067~regulation of programmed cell death 8 46 3,53E-02 2,54E+00 
GO:0050793~regulation of developmental process 26 228 1,27E-02 1,66E+00 
GO:0007154~cell communication 14 107 3,03E-02 1,91E+00 
Cellular Component 
GO:0044459~plasma membrane part 36 256 1,06E-06 2,47E+00 
GO:0005622~intracellular 209 3047 6,71E-04 1,20E+00 
GO:0030054~cell junction 18 124 6,19E-04 2,55E+00 
GO:0005882~intermediate filament 5 12 3,54E-03 7,32E+00 
GO:0044421~extracellular region part 8 44 1,13E-02 3,19E+00 
GO:0005788~endoplasmic reticulum lumen 6 11 2,02E-04 9,58E+00 
GO:0005856~cytoskeleton 21 235 4,58E-02 1,57E+00 
Molecular Function 
GO:0030528~transcription regulator activity 76 685 1,01E-05 1,66E+00 
GO:0016864~intramolecular oxidoreductase activity, transposing S-S 
bonds 3 4 2,44E-02 1,12E+01 
GO:0016706~oxidoreductase activity, acting on paired donors, with 
incorporation or reduction of molecular oxygen, 2-
oxoglutarate as one donor, and incorporation of one 
atom each of oxygen into both donors 
4 9 1,84E-02 6,65E+00 
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3.7.3 Overrepresented KEGG pathways 
GO-terms provide useful information about biological functions, but often do not reveal compre-
hensive molecular mechanisms of action. DEGs (both up- and down-regulated together) were 
mapped on KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways to assign them to 
intracellular regulatory pathways. Table 14 gives an overview of overrepresented KEGG path-
ways in all three single concentrations and additionally for pooled datasets of commonly regu-
lated genes in Qlongevity and commonly regulated DEGs from all three concentrations (Qall). The 5 
overrepresented KEGG pathways in Q 50 µM clasps exclusively metabolic pathways, and main-
ly comprise induced DEGs (amino acid-, lipid- and xenobiotic – metabolism) (Table 15). In Q 
100 and 200 µM, nine and eight KEGG pathways are overrepresented respectively, a big pro-
portion (seven pathways) of which are overlapping as expected (Qlongevity). Besides metabolic 
pathways (amino acid-, lipid- and xenobiotic/drug – metabolism), also cellular processes (trans-
port & catabolism, lysosome), as well as environmental information processing (Signal transduc-
tion, Wnt- and TGF-beta- signaling) are affected. The fold change values for individual regulated 
DEGs in each KEGG-pathway from Qlongevity are shown in Table 16. (Q 100 µM, Q 200 µM and 
Qall can be found in Supplementary Tables 5, 6 and 7). Qlongevity DEGs from arginin- and prolin-
metabolism, as well as from the lysosome are up- as well as down-regulated. Genes of the 
TGF-beta- and Wnt-signaling pathway (both pathways include partly the same genes) are pre-
vailingly repressed, whereas genes represented in drug metabolism and metabolism of xeno-
biotics by cytochrome P450 are predominantly induced (Table 16). In the following a few as-
pects from this KEGG pathway analysis will be deciphered in closer detail. 
 
All proteins, and thus all enzymes and structural elements in living things are composed of ami-
no acids. Therefore the modulation of their metabolism is one the first steps to provoke changes 
in all kind of cellular processes. Qlongevity obviously interferes with arginine and proline, as well as 
with cysteine and methionine metabolism. Enhanced levels of arginine, for example, have been 
linked to an improved cellular immune response (Fürst et al., 2004; Landmesser, 2004). Fur-
thermore, the thiol side chain of cysteine is susceptible to oxidation (thereby possess antioxida-
tive properties) and often participates in enzymic reactions as a nucleophil 
(http://en.wikipedia.org/wiki/Cysteine). Cysteine partakes in numerous biological functions, e. g. 
as a precursor for the antioxidant gluthatione, in the formation of disulfide bonds (important for 
the cross-linking, folding and stability of extracellular proteins (Sevier et al, 2002)) and also in 
many post-translational modifications. Proline is important for the assembly of collagens. Since 
collagens are among the gene-groups which are highly overrepresented in Q treated nema-
todes (see chapter below), it is not suprising that prolin metabolism is affected. Interestingly, 
growing evidence from studies with methionine indicate that imbalance of methionine can lead 
to prolonged lifespan in some animals (Richard, 2009). Mice on a normal diet, but restricted for 
methionine, displayed enhanced lifespans (Miller et al., 2005). And application of methionine to 
Drosophila on a CR diet, restored egg-laying to normal, without reducing the lifespan (Grandi-
son et al., 2009). Hence, altering the amino acid metabolism by Q provides broad possibilities to 
trigger the physiological status of the nematodes. 
 
Lysosomes are membrane-delimited organelles in animal cells serving as the cell's main diges-
tive compartment. All kind of macromolecules are delivered for degradation into this acidic (pH = 
5) compartment, which contains more than 40 hydrolases (http://www.genome.jp/dbget-
bin/www_bget?map04142). The fact that some of the genes belonging to lysosome-related 
processes are up- while others are down-regulated, suggests that certain degradation 
processes are selectively targeted following Qlongevity treatment.  
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Wnt proteins are secreted morphogens that are involved in basic developmental processes, 
such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell 
division. There are at least three different Wnt pathways: (i) the canonical pathway, (ii) the pla-
nar cell polarity (PCP) pathway and (iii) the Wnt/Ca2+ pathway (http://www.genome.jp/dbget-
bin/www_bget?pathway:cel04310). Since jnk-1 (genetic player in the canonical pathway) is re-
pressed due to Qlongevity and unc-43 (CaMKII) was found in mutant lifespan assays to be re-
quired for Q mediated life extension, suggests that the canonical pathway as well as the 
Wnt/Ca2+ pathway are involved in Qlongevitys’ action. Both provide valuable tools for modulating 
the lifespan of the nematodes. 
Q also regulates signaling via the TGF-beta family of cytokines which control a wide spectrum of 
further cellular functions - such as proliferation, apoptosis, differentiation and migration TGF-
beta family members bind to their cognate receptor in the plasma membrane, which then in turn 
triggers phosphorylation of Smad transcription factors. These translocate into the nucleus and 
induce specific genes through cooperative interactions with other DNA-binding- and coactivator- 
(or co-repressor-) proteins and thereby provoke various outputs. 
All of these findings further underline the profound and complex impact of Qlongevity in vivo. By 
modulation of basic signaling pathways, up-grading of the biotransformation system, influence 
on the metabolism of certain aminoacids, as well as the selective regulation of cellular degrada-
tion processes, Q provides the basis for the longevity phenotype in C. elegans. 
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Table 14 KEGG pathways overview. According DEGs with fold change values, gene annotation and 
enrichement values can be found in Table 15 (Q 50 µM), Table 16 (Qlongevity) and Supplementary Tables 5 
(Q 100 µM), 6 (Q 200 µM) and 7  (Qall). 
Conditon KEGG pathway No. DEGs/ listed genes p-value 
Q 50 µM cel00330: Arginine and proline metabolism 6/30 0.002 
 
cel00062: Fatty acid elongation in mitochondria 4/13 0.007 
 
cel00480: Glutathione metabolism 5/35 0.022 
 
cel00270: Cysteine and methionine metabolism 4/25 0.041 
 
cel00980: Metabolism of xenobiotics by cytochrome P450 4/26 0.045 
Q 100 µM cel04142: Lysosome 15/68 0.000 
 
cel04350: TGF-beta signaling pathway 11/36 0.001 
 
cel00600: Sphingolipid metabolism 8/20 0.001 
 
cel04310: Wnt signaling pathway 14/60 0.001 
 
cel00980: Metabolism of xenobiotics by cytochrome P450 8/26 0.005 
 
cel00982: Drug metabolism 8/29 0.009 
 
cel00330: Arginine and proline metabolism 8/30 0.011 
 
cel00270: Cystein and methionine metabolism 6/25 0.033 
 
cel00350: Tyrosine metabolism 5/19 0.047 
Q 200 µM cel04350: TGF-beta signaling pathway 13/36 0.000 
 
cel04310: Wnt signaling pathway 15/60 0.001 
 
cel00982: Drug metabolism 9/29 0.005 
 
cel00480: Glutathione metabolism 9/35 0.015 
 
cel00330: Arginine and proline metabolism 8/30 0.020 
 
cel04142: Lysosome 14/68 0.026 
 
cel00980: Metabolism of xenobiotics by cytochrome P450 7/26 0.033 
 
cel00340: Histidine metabolism 3/9 0.048 
Qlongevity cel00330: Arginine and proline metabolism  9/30 0.000 
 
cel04350: TGF-beta signaling pathway 9/36 0.001 
 
cel04310: Wnt signaling pathway 11/60 0.004 
 
cel00982: Drug metabolism  7/29 0.008 
 
cel04142: Lysosome  11/68 0.009 
 
cel00270: Cystein and methionine metabolism 6/25 0.018 
 
cel00980: Metabolism of xenobiotics by cytochrome P450  6/26 0.022 
Qall Cel00330: Arginine and proline metabolism 4/19 0.005 
 
p < 1.0E-03 p < 1.0E-02 p < 5.0E-02 p > 5.0E-02 
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Table 15 Overrepresented KEGG pathways found in Q 50 µM treated nematodes. Further summa-
rized are the DEGs and statistical proven expression values (FC), p-values and the Fold Enrichment for Q 
50 µM. The numbers in italics in Q 100 and 200 µM show FC values without guarantee of statistical ro-
bustness and are just shown to see variances in single concentrations.  
Overrepresented KEGG pathways in Q 50 µM 
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cel00330: Arginine and proline metabolism 
0.002 6.261 T01B11.2a 1.48 1.06 1.20 Predicted alanine-glyoxylate aminotransferase 
  
dpy-18 1.26 0.85 0.77 prolyl 4-hydroxylase alpha subunit 
  
F44G3.2 1.53 2.18 1.89 Creatine kinases 
  
phy-2 1.33 0.71 0.71 Prolyl 4-hydroxylase alpha subunit 
  
smd-1 2.50 0.76 0.58 S-adenosylmethionine decarboxylase 
  
T22H6.2 1.29 0.73 0.69 1-pyroline-5-carboxylate synthetase  
cel00062: Fatty acid elongation in mitochondria 
0.007 9.633 ech-1 1.69 1.04 1.06 C.elegans cDNA clone yk5g6 
  
ech-8 1.82 1.16 1.00 
Hydroxyacyl-CoA dehydrogenase/enoyl-CoA 
hydratase 
  
hacd-1 2.68 0.84 0.86 3-hydroxyacyl-CoA dehydrogenase 
  
Y48A6B.9 1.96 1.01 1.20 Zn2+-binding dehydrogenase  
cel00480: Glutathione metabolism 
0.022 4.472 F26E4.12 1.37 0.97 1.02 Glutathione peroxidase 
  
gst-10 1.29 0.99 1.28 Glutathione S-transferase 
  
gst-38 0.58 0.64 1.23 Glutathione S-transferase 
  
gst-7 1.25 0.98 0.94 Glutathione S-transferase 
  
T25B9.9 1.37 0.95 1.00 6-phosphogluconate dehydrogenase 
cel00270: Cysteine and methionine metabolism 
0.041 5.009 sams-4 1.33 1.35 1.29 S-Adenosyl Methionine Synthetase 
  
F42D1.2 0.78 1.09 1.17 Predicted alanine-glyoxylate aminotransferase 
  
R03D7.1 1.60 1.24 1.22 S-adenosylmethionine synthetase 
  
smd-1 2.50 0.76 0.58 Tyrosine aminotransferase 
cel00980: Metabolism of xenobiotics by cytochrome P450 
0.045 4.816 gst-10 1.29 0.99 1.28 Glutathione S-transferase 
  
gst-38 0.58 0.64 1.23 Glutathione S-transferase 
  
gst-7 1.25 0.98 0.94 Glutathione S-transferase 
  
ugt-50 1.43 0.78 0.99 UDP-glucuronosyltransferase 
 
< 0.65 < 0.8 <…> > 1.25 > 2.5 
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Table 16 Overrepresented KEGG pathways found in Qlongevity treated nematodes. Further summa-
rized are the DEGs and statistical proven expression values (FC), p-values and the Fold Enrichment for 
Qlongevity. The numbers in italics in Q 50 µM show FC values without guarantee of statistical robustness 
and are just shown to see variances in single concentrations.  
Table continues on page 77 
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cel00330: Arginine and Proline metabolism 
0.0004 4.648 alh-1 1.14 1.45 1.42 Aldehyde dehydrogenase 2 
C10C5.4 1.15 1.68 1.95 
Aminoacylase ACY1 and related metalloexopepti-
dases 
T09B4.8 0.83 0.74 0.78 aminotransferase 
dpy-18 1.09 0.69 0.62 Prolyl 4-hydroxylase alpha subunit 
F44G3.2 1.53 2.18 1.89 Creatine kinases 
F55G1.9 1.17 1.29 1.32 Pyrroline-5-carboxylate reductase 
phy-2 1.33 0.71 0.71 Prolyl 4-hydroxylase alpha subunit 
smd-1 2.40 0.71 0.59 S-adenosylmethionine decarboxylase 
T22H6.2a 1.29 0.73 0.69 1-pyroline-5-carboxylate synthetase 
cel04350: TGF-beta signaling pathway 
0.0010 3.874 daf-1 0.89 0.79 0.73 abnormal DAuer Formation 
  
skr-10 0.99 0.68 0.56 SCF ubiquitin ligase, Skp1 component 
  
skr-12 / skr-13 1.01 0.63 0.58 SCF ubiquitin ligase, Skp1 component 
  
skr-13 1.03 0.72 0.62 SCF ubiquitin ligase, Skp1 component 
  
skr-14 1.04 0.80 0.67 SCF ubiquitin ligase, Skp1 component 
  
skr-15 0.95 0.76 0.65 SCF ubiquitin ligase, Skp1 component 
  
skr-21 0.78 0.73 0.54 SCF ubiquitin ligase, Skp1 component 
  
skr-7 1.02 0.68 0.61 SCF ubiquitin ligase, Skp1 component 
  
skr-8 0.99 0.70 0.57 SCF ubiquitin ligase, Skp1 component 
  
skr-9 0.95 0.67 0.56 SCF ubiquitin ligase, Skp1 component 
cel04310: Wnt signaling pathway 
0.0037 2.841 cwn-2 0.85 0.75 0.65 Wnt family of developmental regulators 
  
dsh-1 0.87 0.70 0.63 dishevelled-like protein 
  
jnk-1 0.71 0.74 0.62 MAP kinase 
  
skr-10 0.99 0.68 0.56 SCF ubiquitin ligase, Skp1 component 
  
skr-12 / skr-13 1.01 0.63 0.58 SCF ubiquitin ligase, Skp1 component 
  
skr-13 1.03 0.72 0.62 SCF ubiquitin ligase, Skp1 component 
  
skr-14 1.04 0.80 0.67 SCF ubiquitin ligase, Skp1 component 
  
skr-15 0.95 0.76 0.65 SCF ubiquitin ligase, Skp1 component 
  
skr-21 0.78 0.73 0.54 SCF ubiquitin ligase, Skp1 component 
  
skr-7 1.02 0.68 0.61 SCF ubiquitin ligase, Skp1 component 
  
skr-8 0.99 0.70 0.57 SCF ubiquitin ligase, Skp1 component 
  
skr-9 0.95 0.67 0.56 SCF ubiquitin ligase, Skp1 component 
cel00982: Drug metabolism 
0.0083 3.740 alh-5 0.73 1.95 2.28 Aldehyde dehydrogenase 
  
fmo-2 0.69 3.22 4.47 Flavin-containing monooxygenase 
  
gst-4 1.97 1.72 1.97 Glutathione S-transferase 
  
gst-5 1.13 1.27 1.53 Glutathione S-transferase 
  
sodh-1 1.78 2.32 1.83 Alcohol dehydrogenase, class V 
  
ugt-58 0.82 1.46 1.44 UDP-glucuronosyl and -glucosyl transferase 
  
ugt-50 0.89 0.71 0.60 UDP-GlucuronosylTransferase 
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< 0.65 < 0.8 <…> > 1.25 > 2.5 
 
 
3.7.4 Selected gene-groups and -classes 
Besides functional annotation by KEGG or GO analyses, it is important to identify groups of 
genes in order to gain insights into mechanistic principles governing global gene expression 
responses. To find specific gene classes regulated by each concentration of Q, the DEGs in Q 
50, 100, 200 µM, Qlongevity and Qall were matched to known gene-classes and –groups which 
were manually arranged by gene names or taken from Kim et al. (2001). Table 17 shows signifi-
cant RFs of gene groups in which at least one dataset displays overrepresentation. Several 
gene classes are overrepresented in all single conditions and thus also in both pooled datasets 
(Qall, Qlongevity): cell-adhesion and –structure, male- and sperm-enriched, msps, proteases, amino 
acid and lipid metabolism, collagens, and histone genes. The following gene classes appear to 
show distinct expression patterns for pre-life extension and life extension concentrations, and 
thus point to longevity-specific regulation: cyp-genes are overrepresented in all datasets, but not 
significant in Q 50 µM. gst-genes are overrepresented in all datasets except Qall, which points 
towards distinct gst-genes in Q 50 µM and the both lifespan prolonging concentrations. Lyso-
zymes are overrepresented in Q 50 and 100 µM as well in Qall (lys-4, -2, -10). Striking is the con-
trary lysozyme regulation in Q 50 µM (up) compared to the longevity mediating concentrations 
Q 100 and 200 µM (down). As also shown by the KEGG pathway analysis, genes for fatty acid 
oxidation, which are contained to a big extent in the groups of lipid metabolism, biosynthesis 
and dehydrogenases, are exclusively overrepresented in Q 50 µM. The striking difference be-
tween the longevity mediating concentrations Q 100 and 200 µM (and thus in Qlongevity) on one 
hand and Q 50 µM on the other hand, obviously lays in the exclusive  
Continuation of Table 16 
cel04142: Lysosome 
0.0092 2.507 apm-3 0.86 0.75 0.65 Clathrin-associated protein medium chain 
  
asm-2 1.20 1.38 1.79 
Acid sphingomyelinase and PHM5 phosphate meta-
bolism protein 
  
C33G3.4 0.89 0.73 0.68 Predicted beta-mannosidase 
  
cpr-2 1.56 5.83 8.28 Cysteine proteinase Cathepsin L 
  
cpr-3 0.70 0.64 0.73 Cysteine proteinase Cathepsin L 
  
F32H5.1 1.10 1.57 1.92 Cysteine proteinase Cathepsin L 
  
mig-23 0.88 0.73 0.78 Nucleoside phosphatase 
  
vha-15 0.87 0.77 0.75 Vacuolar H+-ATPase V1 sector, subunit H 
  
W07B8.4 2.61 3.57 4.11 thiol protease; C,elegans cDNA clone yk150b4 
  
Y4C6B.6 1.42 1.30 1.57 Beta-glucocerebrosidase 
  
Y40D12A.2 1.33 0.63 0.71 Serine carboxypeptidases (lysosomal cathepsin A) 
cel00270: Cysteine and methionine metabolism 
0.0183 3.719 T09B4.8 0.83 0.74 0.78 aminotransferase 
  
C06E7.3 1.33 1.35 1.29 S-adenosylmethionine synthetase 
  
ldh-1 1.14 0.78 0.70 Lactate dehydrogenase 
  
smd-1 2.40 0.72 0.59 S-adenosylmethionine decarboxylase 
  
tag-32 3.32 2.57 4.18 S-adenosylmethionine synthetase 
  
ZC373.1 0.67 0.63 0.64 Cystathionine beta-synthase and related enzymes 
cel00980: Metabolism of xenobiotics by cytochrome P450 
0.0216 3.576 alh-5 0.73 1.95 2.28 Aldehyde dehydrogenase 
  
gst-4 1.97 1.72 1.97 Glutathione S-transferase 
  
gst-5 1.13 1.27 1.53 Glutathione S-transferase 
  
sodh-1 1.78 2.32 1.83 Alcohol dehydrogenase, class V 
  
ugt-58 0.82 1.46 1.44 UDP-glucuronosyl and -glucosyl transferase 
  
ugt-50 0.89 0.71 0.60 UDP-GlucuronosylTransferase 
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Table 17 Representation Factors of overrepresented gene-groups and -classes in Q 50, 100 and 
200 µM treated nematodes and commonly regulated DEGs in pooled data sets of Qlongevity and Qall. Listed 
are only groups, in which at least one condition display significant overrepresentation (RF > 1). Dark grey 
fields mark groups, where all conditions are enriched; bright grey fields underline exclusive overrepre-
sented groups in Q 100 and 200 µM, Qlongevity. Non-marked fields with RFs display diffuse enrichment. 
Additional information in Supplementary Table 8. *p < 0.05, **p < 0.005, ***p < 0.001.  
Gene-class or -group Q 50 µM 
Q 100 
µM 
Q 200 
µM Qlongevity Qall 
amino acid metabolism 
3.00 1.50 1.60 1.57 2.44 
** * * * * 
aminoxidase 
  
3.10 
  * 
  
biosynthese 
2.00 1.30 1.20 1.09  
*** * * *  
cell adhesion 
4.10 2.90 2.50 3.18 4.51 
** *** *** *** * 
cell structure 
5.70 3.10 2.90 3.26 7.83 
*** *** *** *** *** 
collagen 
6.20 2.40 2.70 2.63 5.95 
*** *** *** *** *** 
cyps 
 
1.90 1.80 1.89 3.13 
* ** * * 
dehydrogenases 
3.10 1.30 1.40 
  *** * * 
  
fatty acid oxidation 
5.20 
  
  *** 
  
gsts 
3.70 2.10 2.00 1.76  
** ** * *  
histone genes 
3.80 2.30 2.30 2.33 5.34 
** ** *** ** *** 
hsps/chaperones/alpha crystallins 
  
1.80 
  * 
  
hydrolases 
 
1.60 
 
  
*   
lectins  
1.20 
   
 
* 
   
lipid metabolism 
2.80 1.70 1.60 1.46 1.94 
*** *** *** ** * 
lysozyme 
11.30 4.30 
 
 13.84 
*** **  ** 
male enriched 
2.00 1.50 1.60 1.54 2.82 
*** *** *** *** *** 
monooxygenases 
  
2.70 
  * 
  
msps 
12.90 6.00 5.40 6.56 21.21 
*** *** *** *** *** 
genes with PDZ domains 
 
1.80 1.60 2.00  
* * *  
peroxidases 
5.20 
 
2.30 
  * * 
  
phosphatases 
  
1.30  1.78 
*  * 
proteases 
1.90 1.60 1.40 1.45 2.25 
* * * * * 
sperm-enriched 
2.80 1.50 1.70 1.58 4.49 
*** *** *** *** *** 
transcription factors 
 
1.40 1.50 1.51  
* *** **  
ugts 
 
2.00 
 
1.90  
* *  
vitellogenin 
 
5.60 6.00 5.58  
*** *** *** 
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overrepresentation of pdz encoding genes (important for transport, localization and assembly of 
supramolecular signaling complexes; Harris and Lim, 2001), and the overrepresentation of tran-
scription factors and vitellogenins in the longevity mediating concentrations. Taken together, the 
analysis reveals several longevity-specific gene expression classes which likely underlie the 
beneficial effects of Q (more information for additional gene-groups and -classes, RFs and sta-
tistics in single concentrations and pooled datasets in Supplementary Table 8). Fold Change 
values for single genes in each gene-class and –group can be viewed in respective filter condi-
tion in the Online Supplementary 2 under 
https://docs.google.com/leaf?id=0B-
ebpwywEV6MNGQ1MzU1ZGYtYjZhYS00ZGY2LWIwNTYtMjM5MGE1M2ZhMzJi&hl=en_US&a 
uthkey=CNuBhcgP 
(The manual for the use of the filtertable in the Online Supplementary 2 can be found in Sup-
plementary Information 1 on pp. 179 - 181). 
 
 
3.7.5 Meta-analysis: comparison of global transcriptional patterns in Qlongevity and 
selected datasets in the literature 
To date, several DNA-microarray studies have been conducted to identify age-related transcrip-
tional changes in the nematode C. elegans (summarized in Golden and Melov, 2007). A syste-
matic comparison among these datasets that would potentially allow for the identification of 
common age-related pathways has not been performed so far. In this section, datasets from Q 
treated nematodes will be related to published expression profiles obtained in long-lived mu-
tants, dauers and worms treated with another life-extending PP (resveratrol). Questions to be 
addressed include: (i) Which aging-related perturbations share similar molecular mechanisms 
and are thus functionally related? (ii) What are the genetic players and molecular pathways un-
derlying the Q provoked longevity phenotype? As a control, the analysis will include studies ad-
dressing the gene expression changes during the C. elegans life-cycle. Moreover, gene expres-
sion in immune challenged nematodes will be related to Q studies to confirm the involvement of 
the innate immunity p38 MAPK pathway (e.g. by sek-1) in Q action, as suggested by results 
from mutant lifespan assays.  
 
Table 18 gives an overview about DNA-microarray studies which will be analyzed in the follow-
ing sections. The full comparison of all published array studies listed and all single concentra-
tions of Q can be found in Supplementary Tables 9, 10 and 11. In the main text, the focus will lie 
on the comparison between studies marked in grey in Table 18 and the pooled datasets of li-
fespan prolonging concentrations, namely Qlongevity. Notably, the study by Evans et al. (2008) is a 
meta-analysis addressing the expression output of daf-2 mutants (Murphy et al., 2003; McElwee 
et al., (2004); note: included are mutations in differing allels) and immune challenged nema-
todes (Shapira et al., 2006; Troemel et al., 2006). In this work, it was deemed adequate to show 
the comparison to the pooled meta-analysis data from this study, instead of showing compari-
son of single study results, since single results differ in marginal parts only (not shown).  
 
For meta-analysis, array studies were analyzed for similarities at the level of (i) overrepresented 
gene expression mountains (according to Kim et al., 2001) which characterize the global pat-
terns of a transcriptional response and (ii) DEGs, to identify conspicous genes. The significance 
of overlap between two gene lists has been assigned by calculating the representation factor 
(RF), and significances were determined using hypergeometric probability. The complete com-
parison can be reconstructed in the Online Supplementary 2. 
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Table 18 DNA-microarray studies addressing age- and immune-related issues, which have been 
compared to datasets obtained from Q treated nematodes. Grey fields mark studies on which will be re-
sponded in the comparison to the pooled dataset Qlongevity in the following sections. Henceforth, to each 
study will be refered by the nomenclature in red. RF- and p- values for the comparison of all studies with 
Q 50, 100 and 200 µM, as well as Qlongevity and Qall, can be found in Supplementary Table 11.  
Reference /  
DNA-microarray study Genotype / condition 
Studies addressing the age dependent expression changes in wild type C. elegans 
Hill et al. (2000) 
8 ages, 2 of which were adult, pools used, single array per age; 
Output: life-cycle changing genes; gene expression course during life cycle from 
oocytes until 2 weeks old adults; 
Lund et al. (2001) 
sterile mutant strains (fer-15, spe-9;fer-15, and spe-9;emb-27); 6 adult ages, pools 
used, three sterile mutant strains, 3-6 biological replicates per age group; 
Output:
aging genes (expression changes after day 4); 
 defining of maturity genes (expression changes on days 3 & 4) and 
Studies addressing the genetic background of longevity mutants and dauers 
McElwee et al. (2003) 
1st day adults, daf-2(e1370) vs. daf2(e1370); daf-16(m27). Pools used, 2 biological 
replicates, 2 technical replicates of each; 
Output: putative daf-16 targets 
Murphy et al. (2003) 
Young adult daf-2 or age-1 vs. control, N2, or daf-2; daf-16, 1-4 replicates per compar-
ison. Pools used. Time course of sterile mutant strain treated with daf-2, or daf-2 +daf-
16 RNAi, or control vector, one array per condition per time point; 
Output:
down in daf-2, longevity suppressors class II; 
 up in daf-2, longevity mediators class I; 
Wang and Kim (2003) 
N2 dauers 
Output: expression profile of dauer larvae 
McElwee et al. (2004) 
1st day adults, daf-2(e1370) or daf-2(m577) vs. daf-2; daf-16. Pools used, 5 biological 
replicates per genotype; 
Output: expression profile of daf-2 mutants (up, down); 
Fisher and Lithgow 
(2006) 
4 populations each of sterile strains containing daf-12(rh61rh411) or daf-12(rh273), 
assayed vs. mixed stage N2 reference RNA, with dye-flip for each sample; 
Output: expression profile of long-lived daf-12(rh273) and list of genes which are 
down in multiple long lived worms; 
Shaw et al. (2007) 
TGF-beta adults: comparison of the dauer-constitutive mutants daf-7(e1372), daf-
7(m62), and daf-1(m40) with dauer-defective mutants daf-3(mgDf90), daf-5(e1386), 
and daf-7(e1372);daf-3(mgDf90) double mutants at the permissive temperature, 20 C, 
on the first day of adulthood. Because daf-3 and daf-5 are epistatic to daf-7 and daf-1, 
these comparisons should identify targets that act downstream of this linear pathway; 
Output: expression profile of TGFeta adults, identification of the downstream tar-
gets; 
Evans et al. (2008) 
META-ANALYSIS 
daf- 2 summarized (Murphy et al., 2003 & McElwee et al., 2004); 
Output: pooled expression profile of daf-2 mutants (“broad daf-2 up”, “broad down 
in daf-2”); 
Studies addressing the polyphenolic action in C. elegans 
Viswanathan et al. 
(2005) 
Young adults, daf-16 or N2, resveratrol-treated worms vs. untreated, pools used, 4 
biological replicates per strain; 
Output: expression profile of N2 and daf-16 treated with resveratrol; 
Studies addressing the immune response of C. elegans 
Troemel et al. (2006) 
fer-15(b26)ts;fem-1(hc17); wildtype; PA14, or gacA mutant PA14; 
Output: expression profile of Pseudomonas aeruginosa infected nematodes 4 h 
and 8h after infection; 
daf-2 vs daf-2;pmk-1; 
Output: distinguishing targets either of PMK-1 (p38 MAPK) or DAF-16;  
Shapira et al. (2006) 
P. aeruginosa Infection; 
Output: expression profile of P. aeruginosa infected nematodes;  
Evans et al. (2008) 
META-ANALYSIS 
P. aeruginosa infection summarized (Shapira et al. 2006 & Troemel et al. 2006); 
Output: pooled expression profile of P. aeruginosa infected nematodes;  
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Overrepresented gene expression mountains according to Kim et al. (2001) 
Multiple components of the same intracellular regulatory pathway frequently display tight spatio-
temporal coregulation. Such organization in synexpression groups is thought to optimize the 
transcriptional control over regulatory pathways (Niehrs and Pollet, 1999; Zaslaver et al., 2004). 
Kim et al. (2001) assembled data from 553 C. elegans DNA-microarray experiments, including 
many growth conditions, mutants and developmental stages. From this, they compiled a three-
dimensional gene expression map, where highly co-regulated genes group together in terrain 
map mountains (also called mounts). Some of the mounts cluster genes together that are ex-
pressed in similar tissues, whereas other mountains group genes that have similar cellular func-
tions. Hence, 30 mountains could be assigned to a potential physiological importance, by show-
ing the enrichment of particular sets of genes. Table 19 displays all gene expression mountains, 
in which at least DEGs in either Qlongevity or Qall display overrepresentation (additional information 
about all 44 mountains, exact numbers of up- and down- regulated genes, RFs and statistics 
can be found in Supplementary Table 9).  
 
In a first comparison of the pooled groups Qlongevity and Qall the differences between the longevity 
promoting concentrations and the pre-lifespan extending dose have been determined (Table 19, 
top, compare light and dark grey boxes). Emanating that some modes of Q action can be found 
over the whole concentration range, but that they are not the mediators of Q provoked longevity, 
this comparison defines overrepresented gene expression mountains which are exclusively re-
gulated in Qlongevity. Gene expression structures, which are involved in lifespan prolongation, are 
suggested to be contained in these exclusively overrepresented gene expression mountains 
from Qlongevity. Obviously the overrepresentation of down-regulated genes in mounts 5 (no specif-
ic gene-groups assigned), 12 (no specific gene-groups assigned), 19 (enriched for genes from 
amino acid and lipid metabolism and CYPs), 22 (enriched for collagen) and 36 (enriched for 
heat shock genes), as well as up-regulated genes in mounts 6 (enriched for neuronal genes), 
15 (no specific gene-groups assigned), 19 (see above) and 21 (enriched for lipid metabolism 
genes) distinguishes the long-living concentrations, from the pre-lifespan extending one. Other 
gene expression patterns are shared throughout the whole concentration range: overrepresen-
tation of up-regulated genes in mounts 4 (sperm-enriched genes, protein kinases and phospha-
tases, MSPs), 8 (enriched for intestine-, protease-, carboxylesterase-, lipase-genes, antibacteri-
al proteins and UGTs), 16 (enriched for muscle and collagen genes), 17 (collagen enriched), 32 
(enriched for nucleosomal histone genes) and 35 (collagen enriched), and down-regulation of 
genes in mounts 1 (enriched for muscle, neuronal and PDZ genes), 14 (enriched for collagen) 
and 27 (enriched for genes assigned to Amino acid metabolism , energy generation).  
 
Secondly, to see parallels to longevity mutants, dauers, immune challenged and resveratrol 
treated nematodes, previously published datasets were evaluated regarding overrepresented 
gene expression mountains. For better clarity, Table 19 shows just RF values of mountains 
which are overrepresented in at least Qall and Qlongevity; the full analysis of literature datasets for 
all gene expression mountains can be found in Supplementary Table 10. Outstanding is a big 
overlap between Qlongevity on one side, with either daf-2 (Evans et al., 2008) or TGF-beta mu-
tants (Shaw et al., 2007); Qlongevity shares several longevity attendant prominent mountains, as 
well as the direction of regulation with these mutants. These findings confirm results from GO 
and KEGG pathway analysis, but also from daf-2 mutant lifespan assays. 
 
Strikingly, mountain 4 – overrepresented in Q treated nematodes throughout the whole concen-
tration range – is also overrepresented in daf-12(rh273) (Fisher and Lithgow, 2006) what points 
towards partly similar gene expression patterns (additional common overrepresented mounts 
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underpin this assumption). Interestingly resveratrol treated daf-16 mutants (Viswanathan et al., 
2005) display also overrepresentation in mountain 4, whereas their wildtype counterparts do not 
display this pattern. This result suggests that genes in mountain 4 are regulated in part by the 
absence of DAF-16 (because when daf-16 is missing, they are expressed). In general these 
findings show that the absence of DAF-12 or DAF-16 induces expression of genes in mountain 
4. Presumbly both palyers act in the same pathway to mediate this response. The results in Q 
treated nematodes suggest that Q interferes with this pathway. 
 
An overrepresentation of mount 1 in Q treated nematodes resembles a finding from dauers 
(Wang and Kim, 2003). The comparison to resveratrol treated N2 (Viswanathan et al., 2005), 
reveals only similarities in the overrepresentation of down-regulated genes in mountain 14 
(enriched for collagen), whereas resveratrol treated daf-16 mutants show higher similarities to Q 
treated worms (overrepresentation of up-regulated DEGs in mountains 4, 16, 17 and down-
regulated DEGs in 1, 14, 17). Noteworthy is the big difference in the regulated mountains in 
resveratrol treated daf-16 and N2 nematodes, which suggests that DAF-16 plays an inhibitory 
role for resveratrol-induced gene expression. Since resveratrol treated daf-16 mutants and Q 
treated nematodes share a notable amount of overrepresented mounts suggests that DAF-16 is 
suppressed due to Q treatment. 
 
The comparison to gene expression mountains regulated by PMK-1 (Troemel et al., 2006) re-
veals several similarities: all by PMK-1 regulated mounts are also regulated by Qlongevity. Regula-
tion in mountains 12, 15, 19 and 21 display even the same direction of regulation. This sug-
gests, that Q-induced transcriptional responses are, in parts, mediated by innate immunity 
pathways. 
 
No analogy can be assigned to overrepresentation in mount 35. All of these findings give first 
hints, that not just one genetic pathway mediates Q action in vivo, but rather the complex inter-
play of genetic structures, partly taken from classic genetic pathways, as ILS and TGF-beta, 
dauer related structures (which itself combines numerous pathways, as TGF-beta and ILS) and 
also immune-responsive patterns. A more detailed comparison of DEGs in these various condi-
tions (see below) will further concretize these results. 
 
Taken together, this comparison reveals that the lifespan prolonging transcriptional characteris-
tics of Q are included in mountains 5, 6, 12, 19, 21, 22 and 36. Interestingly, the very same 
gene expression mountains are also employed by various long-living mutants, suggesting a 
molecular basis set common to all longevity-promoting perturbations. 
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Table 19 Overrepresented gene expression mounts according to Kim et al. (2001). Shown are solely representa-
tion factors (RF) from overrepresented mounts (RF > 1) in each condition with statistical significance (*p < 0.05, **p < 
0.005, ***p < 0.001). Listed are all mounts in which at least DEGs in Qlongevity or Qall display overrepresentation. 
Additional information about RFs in all mountains from all conditions can be found in Supplementary Table 9 (for Q 
conditions) and Supplementary Table 10 (for references of datasets see Table 18). Bright grey fields mark mountains, 
which are oberrepresented in Qlongevity compared to Qall. Red RFs mark similar regulation in Qlongevity compared to the 
literature. 
 
   
mountains 
 
1 4 5 6 8 12 14 15 16 17 19 21 22 27 32 35 36 
Present study 
Qlongevity 
up  4,87  1,40 3,62   4,86 3,41 2,34 1,99 2,44   8,06 17,60  
 ***  * ***   *** *** ** * *   ** ***  
down 2,19  1,11   6,17 4,19    3,39  2,32 5,57   5,95 ***  *   *** ***    ***  *** ***   * 
Qall 
up  7,31   2,84    5,19 3,25     15,56 30,18  
 ***   ***    *** **     *** ***  
down 2,12      5,00       6,14    **      ***       *    
Overrepresented mountains in the literature-datasets 
daf-
12(rh273) 
up  14,36                
 ***                
down     4,18      23,25  3,94 7,29    
    ***      ***  * *    
daf-2 
up    2,63 3,91   7,43 1,42 4,06  2,62 2,78     
   *** ***   *** * ***  *** ***     
down   1,25  2,54      10,43 5,19 3,87 8,06    
  *  ***      *** *** *** ***    
TGF-beta 
adults 
up    2,40 3,44  2,43 1,69 6,40 2,29 2,98 2,20 3,22 6,63    
   *** ***  *** *** *** *** *** *** *** ***    
down   2,47   1,55         2,68   
  ***   *         **   
dauers all 1,71   2,35 2,12  7,94 3,29 5,26  4,86 4,92  6,34    ***   *** ***  *** *** ***  *** ***  ***    
P. aerugino-
sa infection 
up    1,56 5,09   6,14   12,85 5,78  4,85 5,61   
   * ***   ***   *** ***  *** *   
down     4,58  2,63  7,31  10,68 2,88 5,00 4,11    
    ***  **  ***  *** * *** *    
pmk-1 
up     2,54   3,77   22,01 6,25 4,52     
    *   *   *** ** *     down     4,07 9,46            
     ** *            
N2 + 
resveratrol 
up             7,16     
            ***     
down       3,40           
      ***           
daf-16 + 
resveratrol 
up  3,43     4,48  5,86 2,31   7,26    8,53 
 ***     ***  *** ***   ***    *** 
down 1,28   1,47   1,49 1,30  1,49 1,50 1,50      ***   ***   *** *  * * *      
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Overlapping DEGs in Qlongevity and selected datasets  
In the next step the numbers of overlapping DEGs from the datasets in the literature and Q 
treated nematodes were analyzed and significance of overlaps were defined for the same direc-
tion of regulation, as well as contrary regulation. Goal of this approach is to further constrain 
molecular mechanisms underlying the longevity promoting gene expression pattern in response 
to Qlongevity treatment (results for single concentrations as well as Qall, and comparison to all 13 
DNA-microarray studies can be found in Supplementary Table 11). Table 20 summarizes the 
number of overlapping DEGs, and the respective RF- and p-values between Qlongevity and the 
other conditions. All conditions - except resveratrol treated wild type nematodes – display signif-
icant overlaps with Q, a finding that further supports the conclusion drawn from gene expression 
mountain analysis. Therefore it is suggested, that major longevity assuring mechanisms are 
shared in Qlongevity and long-living mutants (daf-12, daf-2 and TGF-beta adults), as well as dau-
ers, and that these mechanisms also include immune responsive elements. Furthermore it can 
be concluded, that resveratrol- and Q-mediated longevity in wild type nematodes, are based on 
differing mechanisms. However, resveratrol treated daf-16 nematodes, which are also long-lived 
compared to untreated daf-16 controls, share DEGs with Q, suggesting that DAF-16 suppres-
sion is a consequence of Q treatment. However, since similar patterns have been assigned also 
to Q 50 µM, it is questionable whether these DAF-16 dependent mechanisms provoke the lon-
gevity effect. 
 
 
Table 20 Overview of overlapping DEGs, according RF- and p-values between Qlongevity and respec-
tive other conditions (datasets from the literature, listed in Table 18).  
  Qlongevity 
  up (620) down (1261) 
  genes RF p genes RF p 
daf-12(rh273) 
up (69) 38 17,77 0,00E+00 3 0,69 1,79E-01 
down (125) 8 2,06 2,50E-02 17 2,16 1,35E-03 
daf-2 
"broad up" (1155) 98 2,74 0,00E+00 76 1,04 4,51E-02 
"broad down" (905) 37 1,32 1,68E-02 131 2,30 0,00E+00 
TGF-beta adults 
up (1997) 132 2,13 0,00E+00 209 1,66 2,16E-14 
down (3728) 35 0,30 0,00E+00 86 0,37 0,00E+00 
dauers up/down (1663) 89 1,73 1,18E-07 211 2,01 0,00E+00 
P. aeruginosa infection 
up (446) 44 3,18 9,75E-12 86 3,06 0,00E+00 
down (263) 40 4,91 0,00E+00 26 1,57 6,84E-03 
pmk-1 
up (97) 7 2,33 2,06E-02 23 3,76 2,00E-08 
down (47) 2 1,37 2,52E-01 3 1,01 2,32E-01 
N2 + resveratrol 
up (118) 4 1,09 1,96E-01 2 0,27 1,42E-02 
down (196) 2 0,33 4,03E-02 14 1,13 9,88E-02 
daf-16 + resveratrol 
up (1028) 123 3,86 0,00E+00 55 0,85 2,35E-02 
down (2235) 51 0,74 2,80E-03 166 1,18 2,66E-03 
 
 
To gain deeper functional insights into aging-related genes, the significantly overlapping DEGs 
of Qlongevity samples and respective datasets were examined further with a GO- and InterPro- 
cluster analysis (Fig. 29, Supplementary Table 12). InterPro is a database which categorizes 
proteins in protein families, domains and functional sites. The GO- and InterPro-cluster analysis 
groups GO- and InterPro- terms together which are based on the same genes. Thus, it assigns 
a minimal number of biological functions and pathways to each group of overlapping DEG. Fig-
ure 29 depicts the relationship of transcriptional profiles either in Qlongevity to the other conditions 
and shows the results of the cluster analysis; for clarity, only the most significant proxy per 
Results 
85 
 
GO/InterPro- cluster is shown. Overlaps with datasets for dauers and resveratrol treated wild 
type have been excluded in this cluster analysis, since the direction of regulation for dauers 
could not be extracted from the literature and since resveratrol treated wild type do not signifi-
cantly overlap with Qlongevity. 
 
 
Comparing to studies addressing the genetic background of longevity mutants 
Comparing to daf-12(rh273): The RFs for overlapping genes (both up- and down-regulated) of 
Qlongevity and daf-12(rh273) are significantly enhanced (Fig. 29 A), suggesting that longevity ef-
fected by daf-12(rh273) as well as Qlongevity may share similar transcriptional mechanisms. Inte-
restingly, the commonly down-regulated section revealed eight DEGs (bre-1, clec-4, clec-66, 
dod-22, F35E12.5, F55G11.5, M02F4.7, pho-1), which were found also repressed in daf-2 and 
proposed to be down regulated in multiple longevity backgrounds (Fisher and Lithgow, 2006). 
The cluster analysis revealed one cluster in each significant intersection group (major sperm 
protein for commonly up-regulated genes and C-type lectin-like for commonly down-regulated 
genes). On the other hand, it is noteworthy that there also exists a significant group of eight 
genes, which were up-regulated in Qlongevity but down-regulated in daf-12(rh273) mutants. These 
contrary regulated genes are coding for CUB-like region proteins.  
Noteworthy at this point is that the locus daf-12 is very complex. DAF-12 is a nuclear hormone 
receptor that is required for regulating multiple stage-specific aspects of nematode development 
(Antebi et al., 2000; Snow and Larsen, 2000). It encods multiple alternatively spliced isoforms 
and thereby is capable of mutating to daf-d, daf-c and heterochronic phenotypes independently 
(Savage-Dunn, 2005). In the mutant lifespan assay performed in this study the daf-12 strain 
DR20 have been used, which carrys the mutation in the allele m20. This strain is dauer-
defective (daf-d) and short-lived (Larsen et al., 1995; Riddle et al., 1981). The DNA-microarray 
dataset used here have been evolved from the comparison of daf-d daf-12(rh61rh411) and daf-
c daf-12(rh273). Therefore the conclusion drawn from mutant lifespan assays (namely: daf-
12(m20) is not required for Q 200 µM provoked longevity, since mutants still had an extended 
mean lifespan) and the comparison of daf-12(rh273) evolved datasets to Qlongevity provoked tran-
scriptional output, have not compulsory be equal and thus, can divergate.  
 
Comparing to daf-2: Qlongevity shares a clear significant amount of down-, up- and a slightly signif-
icant amount of contrary (up in Qlongevity/down in daf-2) regulated DEGs compared to daf-2 mu-
tants (Fig. 29 B). The GO- and InterPro- cluster analysis of the intersection of up-regulated 
genes revealed five statistically significant clusters, such as determination of adult lifespan, lipid 
metabolic process and oxidoreductase activity (Supplementary Table 12). From the intersection 
with down-regulated transcripts emerge four clusters, as again determination of adult lifespan 
and UDP-glycosyltrasferase activity. These results suggest that the lifespan enhancement in 
Qlongevity arises, in parts, from similar mechanisms like in daf-2 mutants, indicated by an induction 
of the biotransformation system, changes in the metabolic status and up-regulation of longevity 
mediators as well as down regulation of longevity suppressors (cf Murphy et al., 2003; Supple-
mentary Table 11). Beside these similar modes of action, however, also other mechanisms exist 
(e.g. daf-2-contrarian), which may contribute to life extension as well.  
 
Comparing to TGF-beta mutant adults: The overlap between the gene lists for Qlongevity and TGF-
beta mutant adults is significant both in the up- and the contrary regulated section (Qlongevity 
down/TGF-beta mutants up) (Fig. 29 C). The cluster analysis from the up-regulated section re-
veals e.g. the terms catalytic activity and active transmembrane transporter activity, and from 
the opponent regulated intersection e.g. peptidase 28 and carbohydrate metabolic process  
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(Supplementary Table 12). These results suggest that Qlongevity may share up-regulation of par-
ticular genetic structures with TGF-beta mutants but also the inverse genetic mechanism (re-
pression of structures, which were up-regulated in TGF-beta). 45 genes out of the contrary in-
tersection are also down in daf-2, what hints towards an overlap of TGF-beta and ILS signaling, 
with opposing regulation of the same genes. 
 
 
Comparison to studies addressing the genetic background of induced immune response 
and pmk-1 
Comparing to P. aeruginosa infected nematodes: Findings from mutant lifespan assays with Q 
exposure (see section 3.6.1) revealed an involvement of the innate immunity p38 MAPK path-
way (represented by sek-1), suggesting that immune challenge might induce similar transcrip-
tional profiles as Q treatment. Hence, to check this assumption, DEGs resulting from Qlongevity 
treatment were matched to genetic profiles resulting from an immune response due to infection 
with a pathogenic bacteria (P. aeruginosa infection: Shapira et al., 2006; Troemel et al., 2006; 
summarized in Evans et al., 2008) (Fig. 29 D). Significant overrepresentation for DEGs in Qlongev-
ity could be noticed in all kinds of intersections (both up; up in Qlongevity/down in infection; both 
down; up in infection/down in Qlongevity). The cluster analyses of equally regulated sections reveal 
common up-regulation in e.g. lipid metabolic processes, monooxygenase activity, and genes 
coding for UDP-glucuronosyl/UDP-glucosyltransferase as well as a concurrent down-regulation 
in particular parts of catalytic activity. Contrary intersections contain genes coding for oxidore-
ductases and serin-peptidases (Qlongevity up/infection down) and for structural constitutes of cu-
ticle (Qlongevity down/infection up), respectively.  
 
Comparing to PMK-1 regulated genes: Troemel et al. (2006) identified specific immune re-
sponse genes, which are regulated by PMK-1 (p38 MAPK), an immune response pathway in C. 
elegans, which presumably works in parallel or down-stream of the ILS pathway. They com-
pared the genes determined as induced by PMK-1 to genes found regulated in P. aeruginosa 
infected nematodes and found a significant overlap. The evaluation of the overlap of Q treated 
nematodes with DEGs regulated by PMK-1 (Fig. 29 E) revealed significant overlap for Qlongevity in 
respective commonly up-regulated and contrary sections (down-regulated by Qlongevity/up due to 
PMK-1). To the gene classes which are contrary regulated belong CUB-like genes, ShKtoxins, 
C-type lectins, lysozymes, proteases and others.  
 
 
Comparing to resveratrol treated daf-16 mutants 
Both, the up- and down-regulated intersections, revealed significant RFs (Fig. 29 F). Four clus-
ters arose from the commonly up-regulated overlap, including major sperm proteins and nema-
tode cuticule collagen. The commonly down-regulated DEGs educed nine clusters, such as 
axon guidance, nervous system development, short-chain dehydrogenase and locomotion. The 
fact that just five genes out of these significant intersections of Qlongevity and resveratrol treated 
daf-16 mutants are also regulated in resveratrol treated wild type worms (Tables 22 and 23), 
suggests that resveratrol blocks the expression of these genes through DAF-16 in resveratrol 
treated wild type worms. When DAF-16 is absent, these transcripts were expressed. Viswana-
than et al. (2005) suggested that resveratrol blocks sir-2.1, which acts under normal conditions 
on longevity through differing pathways: (i) activation of DAF-16 responsive genes and (ii) re-
pression of abu-11 and other ER-stress-response genes. Due to resveratrol’s repression of sir-
2.1, the ILS pathway is blocked, but the ER stress-response pathway becomes de-repressed 
and leads to lifespan extension in wild type worms. Thus, resveratrol mediated longevity is in-
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dependent of the ILS, a finding that is confirmed by the life extension of daf-16 nematodes due 
to resveratrol.  
 
However, the significant overlaps of Qlongevity and resveratrol exposed daf-16 (in contrast to res-
veratrol treated wild type worms), in turn indicates that possibly DAF-16 is suppressed due to 
Qlongevity (at least in certain tissues) or that at least some events caused by resveratrol in daf-16 
mutants resemble structures in Qlongevity treated worms. 
 
 
Relationship between the various conditions and direction of regulation 
Since significant overlaps with various datasets from long-living mutants and other conditions 
could be shown for Qlongevity it was interesting to ask, how the transcriptional output is composed, 
how the genetic players adhere and what can be learned about their co-operation. Therefore it 
was first necessary to understand to which extent the single conditions cohere to each other. In 
the first step, it will systematically be analyzed to what extent the DEGs overlap for each combi-
nation of experimental conditions (Table 21; for RF- and p-values see Supplementary Table 13). 
The second part of the analysis will focus on the interdependency of Q-mediated pathways, and 
therefore investigate simultaneous overlap between Qlongevity and two other experimental condi-
tions, respectively (Tables 22 and 23, additional information about RF- and p- values in Sup-
plementary Tables 14 (Qlongevity up) and 15 (Qlongevity down)); this should, for example, reveal 
whether Q effects via daf-2 are dependent or independent of TGF-beta-mediated effects of Q.  
Table 21 reveals that a significant proportion of DEGs are shared between single conditions, 
both in common and contrary sections (numbers in red; see Supplementary Table 13 for addi-
tional information). This result is not surprising in light of the observation of overlapping gene 
expression mountains between conditions (see above). Moreover, all of the aforementioned 
conditions have been formerly described to display significant overlapping DEGs with at least 
one of the other conditions: (i) daf-2 and TGF-beta adults (Shaw et al., 2007); (ii) daf-2, dauers 
and daf-12(rh273) (Fisher et al., 2006); (iii) P. aeruginosa infection, pmk-1 (Troemel et al., 2006; 
Evans et al., 2008). To interpret and discuss the results, e.g., by considering all DEGs in the 
overlapping intersections, is beyond the scope of this work. Future studies should tie on this 
comparison, add additional datasets and thereby help to further clarify interlinks and mechan-
isms of genetic signaling. Just one notable aspect will be considered further in the following. 
 
Results for daf-2 mutants have been revealed in big parts due to the comparison of daf-2 single 
mutants vs. daf-2; daf-16 double mutants (Murphy et al., 2003; McElwee et al., 2004). It had 
been suggested that most of the obtained DEGs are DAF-16 targets. The finding that daf-2 mu-
tants and resveratrol treated daf-16 mutants display a slight significant overlap in commonly up- 
(67 genes) and down-regulated (126 genes) DEGs (Table 20) contradicts this assumption and 
underlines that DAF-16 is not the sole down-stream effector of DAF-2. If this would be true, both 
conditions (notwithstanding of the treatement of daf-16 with resveratrol) would not share this 
amount of commonly regulated DEGs. Therefore it is likely that another down-stream pathway 
exists, which is presumably affected by low ILS. Possibly, target genes that were so far thought 
to be controlled by DAF-16 are in fact (additionally or solely) regulated by other ILS effectors 
than DAF-16. Candidate mechanisms are yet to be identified players of the p38 MAPK pathway, 
a cross-regulation by TGF-beta, dependent or independent DAF-12 germline signaling but also 
another yet undefined pathway.  
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Fig. 29 Comparison of DNA-microarray data between Qlongevity with (A) daf12(rh273) mutants (Fisher 
and Lithgow, 2006); (B) daf-2 mutants (Evans et al., 2008); (C) TGF-beta mutant adults (Shaw et al., 
2007), (D) with P. aeruginosa immune responding C. elegans (Evans et al., 2008), (E) pmk-1 mutants 
(Troemel et al., 2006) and (F) resveratrol treated daf-16 mutants (Viswanathan et al., 2005) using Venn 
diagrams. The up- and down-regulated genes in respective datasets were compared with DEGs in Qlongev-
ity treatment. Significant overlap is indicated by RF values in brackets (*p < 0.05, **p < 0.005, ***p < 
0.001). Additional information about all RF values in single PP concentrations and with comparisons to 
additional publications can be found in Supplementary Table 11. The left section displays a GO- and In-
terPro- cluster analysis of overlapping DEGs in respective intersections, listed are the most significant 
term per cluster (IP: InterPro, MF: Molecular Function; BP: Biological Process; CC: Cellular Function). 
Gene names and p-values can be found in Supplementary Table 12. Red arrows indicate an origin in a 
commonly up-regulated intersection, green arrows originate in a commonly down-regulated intersection. 
(Note: no clusters were found in the comparison with pmk-1 mutants, due to the small number of DEGs; 
instead single terms are shown).  
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In the next step, the interdependency of Q-mediated pathways have been analyzed, and the 
number of overlapping DEGs of either Qlongevity up- or down-regulated genes with two conditions 
coevally have been determined (Tables 22 and 23). Although there are many interesting find-
ings, this study will be restricted to the interpretation of two aspects:  
 
Commonly regulated transcripts in daf-12(rh273), resveratrol treated daf-16 mutants and Qlongevi-
ty: When comparing daf-12(rh273) up-regulated transcripts with data from other studies, there do 
not exist noteworthy overlaps, except for resveratrol exposed daf-16 mutants (Table 20). From 
the 38 commonly regulated DEGs in Qlongevity and daf-12(rh273), 26 genes are also up-regulated 
in daf-16 exposed to resveratrol (Table 22), suggesting a molecular pathway common to all 
three conditions. Notably, 25 out of these 26 genes are members of gene expression mountain 
4, which contains sperm-enriched genes, protein kinases, protein phosphatases and major 
sperm proteins. Morover, most of the 26 genes are also induced by Tannic Acid, another lifes-
pan extending polyphenol investigated in our laboratory, which further supports their physiologi-
cal relevance (unpublished data).  
 
Gene expression mountain 4 is expressed throughout the whole concentration range of Q 
treated nematodes (and also Tannic acid treated nematodes), and thus also in non-lifespan 
extending exposures (e.g. Q 50 µM, Tannic acid 300 µM); this suggests that the 26 overlapping 
genes are presumably not responsible for lifespan extension. However, they could still be in-
volved in Q mediated action in vivo, even though not predominantely in life extension. Both daf-
12 and daf-16 are important players in longevity mediated through germline signaling (reviewed 
in Panowski and Dillin, 2009). Since sperm-enriched- and male-enriched genes out of gene ex-
pression mountain 4 are predominantely induced, suggests that this pathway could be also im-
portant for Q’s action. However, the full mechanism of germline signaling is not completely un-
derstood so far, thus, this assumption needs further clearance in the future.  
 
Commonly and contrary regulated genes in daf-12(rh273), daf-2, TGF-beta adults, P. 
aeruginosa infected, pmk-1 and Qlongevity: Owing to the huge overlaps of Q with either daf-
12(rh273), daf-2, TGF-beta, pmk-1 or infected nematodes (Table 20), it was interesting to know 
whether genes common to all conditions exist and, if yes, whether they exhibit the same direc-
tion of regulation. A large fraction of DEGs from the contradictory regulated intersection of Qlon-
gevity and P. aeruginosa infected nematodes (“up in infection/down in Qlongevity”, 86 genes, Table 
23) ‘is also down-regulated in daf-2 (37 genes) and daf-12(rh273) (10 genes); this again sug-
gests overlapping molecular pathways employed by different perturbation conditions. Among 
the 37 commonly regulated genes (“down in daf-2 and Qlongevity/up in P.aeruginosa infection”) 
are 7 CUB-like genes, 4 C-type lectins and 3 genes coding for aging relevant genes (Fig. 29, 
Supplementary Table 12). Interestingly, CUB-like genes were found also activated in induced 
immune response pathway modulated by PMK-1 (Troemel et al., 2006). Indeed, 15 genes out of 
the 86 gene overlap (“up in infection/down in Qlongevity”, Table 23) are also induced in pmk-1 mu-
tants, and belong to the CUB-like region genes, C-type lectins and Metridin-like ShK toxins. The 
proteins evolved from CUB-like genes could be involved in a diverse range of functions, includ-
ing complement activation, developmental patterning, tissue repair, axon guidance, angiogene-
sis, cell signaling, fertilization, haemostasis, inflammation, neurotransmission, receptor-
mediated endocytosis and tumor suppression (Abdul Ajees et al., 2006; Perry et al., 2007). Inte-
restingly, Troemel et al. (2006) found that some genes are commonly regulated by PMK-1 and 
DAF-16, but with inverse regulation. Into this group fall among others the CUB-like ones (which 
were found down-regulated due to Qlongevity exposure). They proposed a model where the PMK-
1 pathway on one hand and the DAF-2/DAF-16 pathway on the other, regulate common and 
exclusive immunity genes in parallel, some with contrary direction, but all contributing to im-
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munity and thereby to a prolonged lifespan. The ILS promotes longevity furthermore not just 
through specialized immunity genes, but also due to regulation of general stress response 
genes (more details can be found in the discussion section 4.6.1). Since Qlongevity display a nota-
bly amount of down-regulated CUB-like genes (down-regulation is shared with daf-2, while up in 
P. aeruginosa infection and pmk-1 mutants), it is suggested that DAF-16 represses these genes 
following Q treatment. On the other hand Qlongevity shows significant overlap with up-regulated 
genes in pmk-1 and therefore it is suggested, that the p38 MAPK pathway is also involved.  
 
Considering the other converse regulated intersection of Qlongevity and infected nematodes (“up in 
Qlongevity/down in infection”, 40 genes), there exist also extensive overlap with up-regulated 
genes in TGF-beta mutants (21 genes, Table 21) and in daf-2 (17 genes, whereof 12 together 
with TGF-beta). Among them are defense genes like spp-1, thn-1, thn-2, and biotransformations 
genes like sod-3, sodh-1, gst-4 and gst-29, collagens and others. This proves that a shared 
stress response (biotransformation, other defense genes) is commonly activated by Q, TGF-
beta signaling, and DAF-2.  
 
Considering the data presented here suggests that both, the ILS (through attenuated signaling 
and thus de-repression/activation of DAF-16) and the p38 MAPK pathway, play important roles 
in Q mediated longevity, and that a complex regulation determines, which genes are up- and 
which are down-regulated. Probably is that the TGF-beta pathway and germline signaling (both 
described acting partly through DAF-12), interfere to some extent also in this regulation.  
 
 
Table 21 Overlapping genes of single datasets from the literature (reference list see Table 18). Red 
numbers indicate significant overlaps (according RFs and p-values can be found in Supplementary Table 
13). 
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Table 22 Double overlaps of up-regulated genes in Qlongevity with two other conditions, 
respectively. (References of datasets can be found in Table 18; according RFs and p-values can be 
found in Supplementary Table 14). 
 
 
 
Table 23 Double overlaps of down-regulated genes in Qlongevity with two other conditions, 
respectively. (References of datasets can be found in Table 18; according RFs and p-values can be 
found in Supplementary Table 15). 
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Considering interesting aging relevant genes  
Given that distinct longevity phenotypes vary to a considerable extent in underlying genetic me-
chanisms but share single commonly regulated genes, it is arguable that these genes may play 
an important role in mediating lifespan extension by master-regulating subsequent genes. In the 
following, therefore a list of putative aging master regulator genes will be defined based on 
overlaps between various array studies.  
 
Datasets of life extended nematodes (daf-2, daf-12(rh273), TGF-beta mutants, resveratrol 
treated wild type and daf-16 nematodes) have been compiled and compared, as discussed in 
the previous sections. To enhance the possibility of success in extracting longevity associated 
genes, another dataset of polyphenol life-extended nematodes was included: Tannic acid (TA) 
has been shown to extend longevity in C. elegans, when applied in 100 µM or 200 µM (Saul et 
al., 2010). Transcriptome-wide microarray analysis was performed, an aging-related set of 
genes termed TAlongevity (pooled results of TA 100 µM and 200 µM) was defined and then com-
pared to Qlongevity treated nematodes (unpublished, publication in preparation). A list of putative 
aging-related 39 genes was compiled based on the following criteria (Table 24): (i) common up- 
or down-regulation in Qlongevity and TAlongevity and (ii) transcriptional regulation in one or more oth-
er longevity condition.  
 
Possibly Qlongevity influences the life-cycle by slowering the “rate of living”, thereby causing deve-
lopmental delays, and as a resulting consequence changes also life-cycle dependent gene ex-
pression. Expression variations of such genes relative to control could hence also be a conse-
quence of a slower life, instead of the cause. To rule out these artifacts the extracted genes 
have been further compared to a dataset of Hill et al. (2000) who addressed the gene-
expression changes during the life cycle. Specifically, it was analyzed whether the selected 
genes belong to the group of genes with varying expression profile during the lifecycle (Hill et 
al., 2000). If yes, the expression tendencies between 48 h and 60 h (1st day of adulthood/young 
adult stage due to maintaining at 25°C and therefore comparable with the stage of Qlongevity 
treated worms) in Hill et al. (2000) were compared to our data. This leads to determination of 
genes, whose expression values are potentially modified just due to simple developmental de-
lays. Genes with decreasing expression between 48 h and 60 h might be up-regulated in our 
study because of developmental delays. Contrarily, genes with increasing expression in Hill et 
al. (2000) would be down-regulated in our study and therefore presumably being a conse-
quence of a possible “slower” life caused by PPs. The 11 genes which do not match these crite-
ria of simple developmental delays are marked with an “x” in the last column of Table 24, and 
represent possible genetic players associated with longevity. Together with the genes, which 
did not alter gene expression during the life-cycle in Hill et al., the list comprises 23 interesting 
genes. Since many genes among them are not yet characterized and annotated, future tests will 
have to reveal the importance in aging in C. elegans, e.g. by knock-out mutants, by RNAi, or by 
overexpression. Several genes code for sperm-related proteins and nematode-specific pep-
tides, suggesting that these proteins play yet unknown roles beside sperm-specific action, pre-
sumably also in longevity mediation. Below follows a short description of some of these selected 
genes: 
 
C16E9.1 is a von Willebrand factor (vWF) protein. Although the majority of vWF-containing pro-
teins are extracellular (plasma proteins like complement factors, collagens and others; Bork, 
1991; Colombatti et al., 1993; Perkins et al., 1994), the most ancient ones, present in all euka-
ryotes, are intracellular proteins involved in transcription, DNA repair, ribosomal and membrane 
transport, and the proteasome. A common feature appears to be involvement in multi-protein 
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complexes. Proteins that incorporate vWF domains participate in numerous biological events 
(e.g. cell adhesion, migration, homing, pattern formation, and signal transduction), involving 
interaction with a large array of ligands (Colombatti et al., 1993). 
 
cex-1 is one of two predicted calexins in the C. elegans genome. Calexins, Ca2+ binding pro-
teins with an EF-hand motif, are involved in cellular mechanisms underlying associative learn-
ing, due to protein kinase C-dependent inactivation of voltage-dependent K+-channels (Alkon et 
al., 1998) and on the other via interaction and activation of ryanodine receptors (Nelson et al., 
1999). Furthermore, it could be shown that cex-1 is expressed in several muscular cell types 
and the AVB command interneuron. Overexpression can increase the rate of learning acquisi-
tion, functions in two serotonin-mediated behavioral responses, up regulation of pharyngeal 
pumping, and egg laying rate (Walker, 2005). 
 
far-7 is a fatty acid/retinol binding protein, which is positively regulated due to starvation. 
 
Very interesting for further analysis seems to be cpt-6/W01A11.5, coding for a carnitine palmi-
toyl transferase-1a, which is required for transport of fatty acyl-CoAs into mitochondria and 
therefore belongs to the conserved components of mitochondrial and peroxisomal β-oxidation 
pathways. The hypodermis, major sites of C. elegans fat storage, was determined as site of 
function (Srinivasan et al., 2008). The authors identified cpt-6 as involved in serotonergic regu-
lation of fat and feeding in C. elegans. cpt-6 was one of nine metabolic genes, which, when in-
activated by RNAi, partially blocked the fat-reducing effect of 5-HT and fully suppressed the 
increased oxygen consumption due to 5-HT and also abrogated the increased feeding rate of 5-
HT-treated animals, potentially due to accumulation of acyl-CoA moieties. How this picture fits 
with our results, as well as the results for the resveratrol treated animal and the longevity mu-
tants daf-2 and TGFbeta, needs further clearance. Both Q 200 µM (Pietsch et al., 2011), as well 
as TA 100 µM (Saul et al., unpublished) treated nematodes displayed significant decreased 
levels of fat content, and in Q 200 µM the pharyngeal pumping/feeding is significantly increased, 
while expression of cpt-6 is decreased. Presumably there are complex interactions. 
 
F35E12.5 is presumably responsible for a swelling response after infection (O’Rourke et al., 
2006). It is a member of the complement C1r/C1s, sea urchin epidermal growth factor-related 
protein, bone morphogenetic protein 1 (CUB) family of proteins (Bork and Beckmann 1993), 
with a DUF141 motif (O’Rourke et al., 2006). CUB-like proteins are involved in many diverse 
functions, including complement activation, inflammation, cell signaling, and many others. This 
specific CUB-like transcript has yet no known orthologs in higher organisms, and their exact 
function in C. elegans is not known. F35E12.5 was identified as p38MAPK/PMK-1 regulated 
gene (Troemel et al., 2006) and is thought to promote immunity. 
 
sur-5 encodes a protein with high similarity to H. sapiens Acetoacetyl-coenzyme A synthetase 
and is involved in Ras signaling, which is required for organismal viability and many other deve-
lopmental processes Because of the widespread roles of Ras signaling during development, 
mutations affecting the Ras pathway can cause many different pleiotropic defects. 
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Table 24 Genes which are regulated in diverse longevity scenarios identified by meta-analysis. 
Genes, identified as life-cycle changing genes (Hill et al., 2000), were further analyzed if expression in-
creased (↑) or decreased (↓) between 48 and 60 h of development, to see if changes due to PP treatment 
could be simply a consequence of a slower developmentally rate. Genes, whose expression changes in 
PP treatments cannot be explained by simple life-cycle effects, are marked with an “x” in the last row. 
Bright grey fields indicate induction; dark grey fields indicate repression of the gene in respective condi-
tion. “*“ highlights where respective gene was found regulated. 
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C16E9.1  Von Willebrand factor 
    
       C33F10.1              C45B2.1   * ↑ x         C45G9.12   * ↓          cex-1  CalEXcitin    *        col-118  * ↓          col-139  Collagens (type IV and type XIII) * ↓          cpt-6  Carnitine O-acyltransferase CPTI * ↓ x         F20A1.10  Uncharacterized protein * ↑ x * 
       F35E12.5  CUB-like gene * ↓ x         F58A6.9  major sperm protein * ↓          far-7 Fatty Acid/Retinol binding protein            lips-17 R07G3.2, Triacylglycerol lipase            msp-10  Major Sperm Protein * ↑ x         msp-142  Major Sperm Protein * ↓          msp-31  Major Sperm Protein * ↓          msp-38  Major Sperm Protein * ↑ x         msp-49  Major Sperm Protein * ↓          msp-50  Major Sperm Protein * ↓          msp-51  Major Sperm Protein * ↑ x         msp-56  Major Sperm Protein            msp-59  Major Sperm Protein * ↑ x         msp-76  Major Sperm Protein * ↑ x         msp-78  Major Sperm Protein * ↑ x         nspa-1  Nematode Specific Peptide family/group A            nspd-2  Nematode Specific Peptide family, group D * ↓          nspd-5  Nematode Specific Peptide family, group D * ↓          snf-9              sodh-1  SOrbitol DeHydrogenase family, Alcohol dehydrogenase, class V * ↓   
       srr-4 Serpentine Receptor, class R * ↓          ssp-11  Sperm-Specific family, class P            ssp-19  Sperm-Specific family, class P            sss-2  Sperm-Specific family, class S * ↓          sur-5  SUppressor of activated let-60 Ras, Acyl-CoA synthetase * ↓ x * 
       T26C5.4   * ↓          tag-32 Temporarily Assigned Gene name,  S-adenosylmethionine synthetase * ↓   
       Y59E9AL.3     
 
        ZK484.5  * ↓ 
 
        ZK596.1 Predicted alpha-helical protein             
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4 Discussion 
 
PPs are a potent substance class of phytochemicals, and some are capable of significantly ex-
tending the lifespan of C. elegans (examples are summarized in Supplementary Table 16; taken 
from Saul et al., 2009). They are able to induce a vast array of phenotypic responses, thus fur-
ther in-depth investigations are required to rule out artifacts associated with respective test-
designs and to decipher the exact underlying mechanisms that drive the observed effects. The 
applicability of using the model organism, C. elegans, to identify in vivo activities of natural 
compounds has certainly evolved and has become more differentiated (Gruber et al., 2009; Pun 
et al. 2010). This study aims to further our understanding regarding Q, CA, and RA mediated 
longevity and readdresses aforementioned challenges by answering the following questions: 
Does the observed longevity arise from hormesis? Are in vivo antioxidative properties responsi-
ble for causing the life extension? Do these PPs cause direct or indirect CR effects? Do antibac-
terial effects against the E. coli feeding strain lead to artifacts? Does the treatment with PPs 
cause physiological reallocations, which in turn provoke the prolonged lifespan in a disposable 
soma-like manner? Which genetic players and pathways are involved in longevity mediation 
respectively? 
 
 
4.1 Does the test design produce artifacts?  
 
Antimicrobial properties: Direct longevity effects can be discriminated from indirect antibacterial 
effects by feeding C. elegans with heat- or UV-killed OP50 (Patridge and Gems, 2007; Gruber 
et al., 2009). This study was able to prove that the antibacterial properties of Q and RA are in-
dependent entities and do, (if at all) influence their positive effect on lifespan extension in an 
ancillary range. An antimicrobial effect for CA could not be determined. Since RA administered 
with heat killed bacteria caused a more significant life extension compared to nematodes fed 
with living OP50, we can not exclude the possibility, that through E. coli metabolically altered 
and retired RA could also cause partly negative effects on C. elegans. The production of delete-
rious metabolites by proliferating bacteria can provoke harmful effects on C. elegans (Gems and 
Riddle, 2000; Garigan et al., 2002). Hence, it has been suggested that nematodes gain health 
benefits if the bacterial food source (the gram-negative E. coli OP50 feeding strain) is debilitated 
by antimicrobial substances.  
 
Transgenerational effects of PPs: Furthermore it was possible to exemplarily demonstrate for Q 
that transgenerational effects, which could provoke adaptive or additive effects on lifespan due 
to variations in differing exposure times, are negligible and therefore do not cause artifacts in 
the choosen test design. Since lifespan assays with whole-life-time Q-treated F1 nematodes 
revealed slightly higher statistical robustness than L4-onwards treated P0 nematodes, it was 
deemed adequate to choose the F1 scenario as standard exposure regime for all following ex-
periments. 
 
 
4.2 Is longevity promoted via hormesis? 
 
For all three PPs, the lifespan assays show a biphasic, inverted U-shaped concentration-effect 
relationship, similar to a classical hormetic dose response curve and therefore could be classi-
fied as hormetins (Rattan, 2008). The beneficial effects of mild stress on aging and longevity 
have been studied for several years (for review see Le Bourg, 2009), and this study addresses 
this aspect in fine detail. An important event in hormetical responses is the induction of one or 
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more stress response pathways, such as the stress responsive heat shock protein (HSP) path-
way(s) (Rattan, 2008). Increased levels of HSP can provide several benefits against crucial as-
pects of aging, including the protection against molecular damage. This study found that the 
expression of various HSPs is enhanced by Q and RA, suggesting that HSP induction may play 
an important role for the hormetic action of these PPs. In contrast, the HSP response was less 
pronounced for CA; however, it is important to note that the analysis was restricted to specific 
hsp-genes and other transcripts may have returned other results. In classical hormesis, stress 
response pathways are directly induced by hormetins. Alternatively, hsp-induction by Q and RA 
may be due to an indirect bactericidal effect on the OP50 feeding strain. Therefore, inhibition of 
bacterial growth could elicit the production of deleterious metabolites, which in turn would in-
duce the expression of hsp-genes. In this scenario, the observed effects would not be a direct 
hormetic response, but at most an indicator of indirect hormesis, or possibly an artifact of the 
experimental design. Addressing this question, for example via the use of heat- or UV-killed 
OP50, is clearly of importance as it will help to standardize handling procedures (Patridge and 
Gems, 2007; Gruber et al., 2009) and further define the suitability of C. elegans as a model or-
ganism for testing pharmacological compounds. 
 
 
4.3 Do direct or indirect CR effects contribute to life extension? 
 
The speed of pharynx contractions was determined to investigate whether PPs reduce food 
uptake and thereby impose a CR response; such an effect is thought to underlie longevity in 
slow-pumping eat-2 mutant (Lakowski and Hekimi, 1998). In accordance with previous reports, 
pharynx contractions declined gradually with increasing age (Huang et al., 2004). However, all 
three PPs resulted in an increased pumping rate at all three time points, thus excluding a CR 
response due to reduced food uptake. Indeed, the enhanced food intake observed in treated 
nematodes could indicate an increased availability of energy for respective nematodes. Un-
forced to prioritize, more energy could be distributed to various life processes, thus PPs treated 
nematodes would have advantages, without drastic disadvantages in major fields. 
 
Furthermore, another source of possible CR was investigated, namely the avoidance of food via 
a PPs based gustative distraction. Nematodes possess amphid and phasmid organs to distin-
guish between diverse odors and tastes, detect food, avoid toxic substances and find possible 
mating partners. Since none of the PP supplemented foods caused a significant repulsion, as 
tested by the attraction assay, the hypothesis of direct CR was rejected. The moderate (but in-
significant) tendency towards an avoidance of Q and RA supplemented bacterial spots could be 
correlated to the negative impact on the growth rate of E. coli, or due to modifications of the PPs 
by bacterial metabolism. This should be addressed in future tests. 
 
Having excluded PP induced alterations in food uptake, it was essential to investigate whether 
metabolic change by means of a sir-2.1 operation is affected by PPs. Indeed, CA and RA did 
not significantly prolong lifespan in sir-2.1 mutants which may be characterized by an intrinsic 
CR response (Tissenbaum and Guarente, 2001; Wood et al., 2004). Thus, it could be possible 
that both PPs activate an indirect CR response in the nematodes (for detailed discussion see 
section 4.6.2). Further experiments are called for in the future, to test this hypothesis in clearer 
detail.  
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4.4 Does disposable soma-like re-allocation of resources take place? 
 
According to the disposable soma theory (Kirkwood, 1977, 1988), the total amount of energy 
available to an organism is divided into maintenance, growth and reproduction. Therefore, it 
was analyzed whether an extension of lifespan by PPs result in trade-offs within other parts of 
physiology. Experimental support for the disposable some theory was obtained in mice and 
Drosophila melanogaster, where a reduction in body size correlates with longevity (Flurkey et 
al., 2001; Nielsen et al., 2008). Such trade-offs have also been observed in C. elegans, where 
Harrington and Harley (1988) noted a reduction of offspring in response to Vitamin E mediated 
longevity. Similarly, Saul et al. (2009, 2010) discovered that Catechin and Tannic acid mediated 
longevity was associated with an attenuation of growth. These findings encouraged the study of 
several fitness parameters to verify whether physiological trade-offs occur in C. elegans. 
 
First, PPs induce a delay in the onset of reproduction (though statistically significant only in RA 
exposed nematodes). Szewczyk et al. (2006) compared C. elegans grown on NGM with worms 
maintained on chemically defined minimal liquid medium (CeMM - C. elegans Maintenance Me-
dium) and observed that CeMM induced longevity and prolonged development and the repro-
ductive period, which implicates that longevity can be the result of slower rate of living. This 
could also be the case with PP treatment.  
 
Second, the growth of exposed and control worms was compared. PPs induce accelerated vo-
lumetric growth during the early larval development, followed by a reduction in growth in adult-
hood (CA, RA), which may increase the chance of survival within their native habitat. Indeed, 
alterations in the dynamics of growth may cause a reorganization and redistribution of energy, 
such that untreated worms allocate a large proportion of energy to development, while treated 
nematodes may spend more energy for maintenance and repair functions, thus delaying the 
aging process.  
 
Third, the intestinal fat deposition was tested (via the fluorescence dye Nile red) and a signifi-
cant reduction in the fluorescence intensity of Nile red in Q and CA exposed nematodes was 
found. Nile red (9-diethylamino-5H-benzo[α]phenoxazine-5-one), hailed in the past as an ideal 
marker for the in vivo detection of lipids in C. elegans, and has been a valuable tool to elucidate 
pathways of fat storage and metabolism (Ashrafi et al., 2003). It is well established that Nile Red 
has negligible effects on growth rate, brood-size, pharyngeal pumping, dauer formation and 
lifespan (Ashrafi, 2007). Recently, O’Rourke et al. (2009) suggested that the Nile red positive 
granules within the nematodes intestine are lysosome-related organelles (LROs) and possibly 
not the major site of neutral fat storage in C. elegans. However, since Nile red fluorescence is 
higher in short-lived mutants, such as daf-16, compared to long-lived mutants, e.g. daf-2, it was 
speculated that an increase in staining may be an indicator of decreased stress resistance and 
a shortened lifespan (O’Rourke et al., 2009). The results obtained in this study strongly support 
this assumption and suggest that LROs play a role at least in Q and CA induced longevity. Tak-
ing all of the fitness and physiological indices into account, these data suggest that the disposa-
ble soma theory may at least in part explain the observed longevity effects caused by Q, CA 
and RA.  
 
 
4.5  Are antioxidative properties in vivo responsible for longevity? 
 
The intracellular antioxidative capacity is a key parameter controlling cellular damage and or-
ganismic aging. However, experimentally measuring the antioxidative capacity of chemical 
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compounds in vivo is a laborious task. Specifically, antioxidant activity in biological systems 
cannot be inferred from in vitro tests (Trugo et al., 1984; Gazzani et al., 1998a,b). Moreover, 
antioxidative activity measured in vivo in one biological system may not be preserved in anoth-
er. Although all three PPs have repeatedly proven to possess antioxidant properties in vitro (for 
Review see Rice-Evans et al., 1996), very little exists about their in vivo absorption and poten-
tial, among them very few or none have been performed with C. elegans. Here we demonstrate 
in vivo antioxidant properties of Q, CA and RA in the model organism C. elegans and concretize 
its respective nature by distinguishing between four aspects: (i) impact on lifespan of internal 
oxidative stressed, hypersensitive mev-1 mutants; (ii) prevention against paraquat induced ma-
tricidal; (iii) TAC in worm homogenate after exposure with respective PP and (iv) fluorescence 
measurements of lipofuscin levels, as marker for the accumulation of oxidative damaged ma-
cromolecules and thus for aging. 
 
This work demonstrates that all three PPs possess in vitro antioxidative properties in both hy-
drophilic and lipophilic solvents (CA > RA > Q). The in vivo TAC of water-soluble substances 
derived from worm homogenates was significantly increased in Q and CA treated samples. The 
TAC of the worm homogenates reflects the sum of all (water- and/or lipid-soluble substances 
within the worm that are able to reduce oxygen radicals, which includes PPs metabolites as well 
as other antioxidants (e.g. glutathione). The comparably low TAC values in RA treated worm 
samples could be the result of reduced bioavailability and is also supported by the observation 
that lipofuscin levels are not significantly altered. Konishi et al. (2005) compared the bioavaila-
bility of CA and RA in rats. The absorption efficiency was approximately 9.7-fold higher for CA 
than RA, in accordance with data from human studies (Baba et al., 2005; for detailed review 
Lafay and Gil-Izquierdo, 2008). 
 
The TAC of lipid-soluble substances in Q, CA and RA treated nematodes, though not signifi-
cant, resemble trends not unlike those obtained from paraquat induced oxidative stress expo-
sures, suggesting that both phenomena may be interlinked. Since in vitro studies have pro-
posed that paraquat exerts its toxicity via redox cycling with the subsequent production of free 
radicals and oxidative damage to membrane lipids (Smith and Heath, 1976), lipid peroxidation is 
deemed to be the result of oxidative stress in paraquat exposed organisms (Yasaka et al., 1986; 
Ogata and Manabe, 1990).  Therefore, it is conceivable that Q has the potential to prevent 
worms from paraquat-induced matricide via lipid-peroxidation, a notion that is in agreement with 
the free radical theory of aging (FRTA, first proposed by Harman, 1956). Indeed, internal oxida-
tive stress may or may not (the controversy surrounding the FRTA is reviewed by Rattan (2006) 
and Muller et al., (2007)) resemble a self-amplifying vicious cycle, where the premature disrup-
tion of the oxidation chain decreases the risk and magnitude of injury. ROS generation following 
paraquat treatment takes place in the cytoplasm (Yanase et al., 2002). ROS production in mev-
1 mutants, however, is predominantly produced by a defective electron transport chain located 
in the mitochondria. This might explain the observed potential of PPs in combating oxidative 
damage, where differences in chemical nature defines their ability to cross cell membrane bar-
riers and/or their rate of clearance from cells. Indeed, the precise antioxidant properties of PPs 
in vivo will depend on their metabolic pathways within the gastrointestinal tract as well as the 
biochemical properties of the resulting metabolites. PPs have even been shown to process 
prooxidant properties (Makris and Rossiter, 2001) which emphasizes that the milieu, the relative 
amount and bioavailability, are important. Clearly further studies are warranted before the ob-
served effects can be fully interpreted and explained.  
 
Conceivably is furthermore that the observed thermal resistance of at least Q and CA treated 
nematodes can be explained partly by in vivo antioxidative properties: In Q treated animals, 
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thermal resistance may be also due to hormetic induction of some hsp-genes as well as other 
stress-responsive genes (as shown in the DNA-microarray data). But moreover, will the in vivo 
antioxidative properties (shown by lipofuscin decrease and TAC increase) provoke scavenging 
of heat-induced ROS, and thereby contribute to enhanced thermal resistance. CA also acts as 
an antioxidant in vivo, but only weakly induces HSP responses. It is conceivable that other CA 
target genes such as sir-2.1 or daf-16 could provoke thermal resistance by activating stress 
responses. In RA antioxidative properties in vivo apparently do not play a major role in stress 
resistance. However, hsp levels are strongly induced in all six tested genes, indicating hormetic 
overcompensation. Additionally, transcriptional stress responses may be mediated by sir-2.1 in 
RA exposed worms. 
 
Taking all findings concerning antioxidative properties together, it appears that  
(i) Q is an in vivo antioxidant. Following Q exposure the TAC of water-soluble sub-
stances in worm homogenate is significantly higher compared to controls. This find-
ing likely correlates with the attenuated lipofuscin levels, as it is thought that in vivo 
antioxidants diminish the rate of oxidative damage, which in turn reduces accumula-
tion of damaged products. The TAC of lipid-soluble substances was also increased 
and may contribute to preventing paraquat induced matricide. The lifespan of mev-1 
mutants was extended. 
(ii) CA is also a potent in vivo antioxidant. The highest TAC of water-soluble substances 
was observed following the exposure to CA, a result that is in agreement with lipo-
fuscin fluorescence being the lowest of all tested conditions. The TAC of lipid-soluble 
substances resembles control values, a finding that may be in line with results from 
paraquat challenge. 
(iii) RA, although in vitro a more potent antioxidant than Q, insignificantly enhanced the 
TAC of water-soluble substances, and likewise lipofuscin fluorescence was only 
marginally attenuated. The TAC of lipid-soluble substances rather diminished com-
pared to controls, a finding that may be interlinked to the increase in internal hatch, 
facing paraquat. It could therefore be argued that RA may act as a prooxidant in vi-
vo. Further work needs to be conducted before the observed prolonged mev-1 lifes-
pan can be fully interpreted.  
The present study demonstrates that the in vitro antioxidant properties of single compounds do 
not, by default, match up with an in vivo antioxidant impact, a statement that is in sync with Pun 
et al. (2010). Furthermore, the detection of in vivo antioxidant output depends, at large, on the 
chosen test design (compare for example the results for mev-1, TAC and paraquat challenge in 
RA treated nematodes) and the complexity of the in vivo system. Finally, the inclusion of infor-
mation related to bioavailability and metabolism of compounds would allow a more informed 
interpretation of results. 
 
 
4.6 Which genetic players promote longevity and stress-resistance? 
 
To investigate the molecular pathways of PP action, we analyzed the longevity promoting ef-
fects of PPs in mutant strains. Table 25 provides an overview of the mutants and summarizes 
known function(s) of mutated genes. Since this work focuses on Q, more mutant strains are 
tested in this condition. In total, 13 mutant strains were used for Q, 8 for CA and RA, each se-
lected for their involvement in well described stress and/or longevity pathways.  
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4.6.1 Genetic mechanisms of Q’s action  
Interpretation of results from mutant lifespan assays 
Four C. elegans mutants were identified where Q treatment did not prolong lifespan, nor in-
crease thermotolerance, namely age-1, daf-2, unc-43, and sek-1. Some of these results may be 
unexpected: For example, how is it possible that DAF-2 and AGE-1, both key players in ILS and 
inhibitors of DAF-16 seem to be responsible for Q-dependent lifespan extension, while daf-16 
isn’t? Similarly, why is daf-16 not involved, even though Kampkötter et al. (2007b, 2008) 
showed a significant nuclear translocation of the transcription factor DAF-16 following incuba-
tion with Q? daf-16 encodes the central forkhead FOXO transcription factor of the ILS pathway. 
It is the major downstream effector of DAF-2, the sole C. elegans insulin receptor (Tatar et al., 
2003). In general, the doubling of life span in daf-2 mutants is completely dependent on the 
gene daf-16 (Kenyon et al., 1993). Additionally to the impact on aging, DAF-16 triggering is cru-
cial for development, stress resistance, thermotolerance, pathogen resistance, metabolism and 
autophagy. The transcriptional targets of daf-16 include stress response, antimicrobial, and me-
tabolic genes, as well as many genes of unknown function (for detailed review see Landis and 
Murphy, 2010), some of which in turn impact aging (Murphy et al., 2003). The high specificity of 
DAF-16 functional output is in parts regulated by co-factors, which in turn determines which of 
the variety of DAF-16 targets will be induced (for detailed review see Berdichevsky and Gua-
rente, 2006). In this context, it has been also shown that nuclear translocation of DAF-16, 
though essential, remains insufficient for transcriptional induction of target genes if cofactors of 
DAF-16 are missing (Henderson et al., 2006). Thus, lifespan extension due to Q treatment and 
DAF-16 translocation (shown by Kampkötter et al., 2007b, 2008) coincide, but may not neces-
sarily be causally connected.  
 
In this scenario, alternative mechanisms would underlie the lifespan-prolonging activities of Q, 
e.g. the antioxidative properties (cf. discussion of mev-1 mutants). Short-lived daf-16 mutants 
are hypersensitive to both thermal and oxidative stress, because they lack the central ILS tran-
scription factor and must carry the burden of elevated internal oxidative stress and partly down-
regulated innate immune response (Chàvez et al., 2007). The elevated antioxidative activity of 
Q may attenuate the oxidative stress and thereby causes a physiological gain, resulting in a 
partial ‘‘rescue’’ to native lifespan levels. On the other hand, daf-2 as well as age-1 long-lived 
mutants are armed with robust stress-resistance machineries. It is conceivable that the positive 
effect of Q could be masked, since oxidative stress resistance and life extension may already be 
close to their maxima. But how does Q mediated longevity in akt-2 mutants fit into this picture? 
Because AKT-2 is located downstream of DAF-2 and AGE-1 in ILS, one may expect akt-2 mu-
tants not to respond to Q. Recent studies by Hertweck et al. (2004) and Tullet et al. (2008) offer 
a possible explanation: SGK-1 is a critical control factor in stress response and lifespan, which 
is activated by ILS independently of AKT/PKB kinase complex. While SGK-1 is the mediator for 
stress response, AKT/PKB is more important for dauer formation. Hertweck et al. (2004) show 
that akt-2 mutants are less stress-resistant than sgk-1 mutants and in consequence the anti-
oxidative property of Q may still expand the lifespan.  
 
The story is made even more complex by unc-43 and sek-1 as they seem to be involved with 
the molecular mechanism of the Q response. Although both genes were shown to be essential 
in blueberry polyphenol-derived longevity of C. elegans (Wilson et al., 2006), their function can-
not be explained by the antioxidative properties of the PPs alone. SEK-1, a MAP2K, is part of 
the MAP kinase pathway and acts downstream of TIR-1 (toll and interleucin receptor) and NSY-
1 (MAP3K). It phosphorylates the C. elegans p38-family MAP kinase PMK-1, which results in 
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elevated immune response to pathogen infection (Kim et al., 2002). NSY-1/SEK-1/PMK-1 cas-
sette also functions via SKN-1 to control resistance against arsenic (An and Blackwell, 2003). 
SEK-1 is also required for the resistance to oxidative stress by assisting the translocation of 
cytoplasmic DAF-16 into the nucleus (Kondo et al., 2005). UNC-43 displays a CaMKII 
(Ca2+/calmodulin-dependent protein kinase II). Mutations of the unc-43 gene result in diverse 
behavioral abnormalities by affecting locomotory activity, altering excitation of three muscle 
types, and changing the period of the motor output of a behavioral clock (Reiner et al., 1999). 
UNC-43, in association with voltage-activated calcium channels (UNC-2/UNC-36), presents a 
neuronal regulating signaling pathway upstream of TIR-1, NSY-1 and SEK-1, which is described 
to determine asymmetric str-2 expression in the AWC olfactory neurons (Sagasti et al., 2001) 
and thereby influences sensory perception. Sagasti et al. (2001) speculate that the CaMKII-
pathway could act in a variety of calcium-dependent processes, like regulation of other cell 
fates, physiological detection of stress, cell migration, axon guidance and neuronal plasticity. 
Thus, Q action in unc-43 and sek-1 mutants is most likely mediated through altered molecular 
signaling via the p38 MAP kinase pathway and by sensory perception through olfactory neurons 
and an up-grade of innate immunity. Further interpretation of these results will be provided in 
the microarray section. 
 
 
Global transcriptional output following Q treatment  
Q possesses a profound impact on transcriptional output and thereby alters the physiological 
status of C. elegans. By performing DNA-microarray experiments and comparing the resulting 
data with previously published gene expression profiles, an interlaced interplay of genetic path-
ways affected by Q was revealed. These findings rationalize results obtained in mutant lifespan 
assays. 
 
Concentration dependent transcriptional responses: The DEG numbers in Q 50, Q 100 and Q 
200 µM suggest that action of Q in C. elegans follows a non-linear mode: A lower concentration 
(Q 50 µM) regulates processes which potentially improve the health of the nematodes (e.g. the 
gene classes gsts, peroxidases, lysozymes; GO term: oxidoreductase activity; KEGG pathway: 
glutathione metabolism and metabolism of xenobiotics by cytochrome P450). In line, Q 50 µM 
induces enhanced thermal stress resistance (data not shown), though it is insufficient to extend 
the lifespan. For higher Q concentrations between 100 to 200 µM Q, a longevity phenotype is 
observed and the global transcriptional response of the worms changes substantially. The over-
representation of DEGs related to biotransformation (gene-classes: gsts, ugts, cyps; KEGG 
pathways: drug- and xenobiotic metabolism) in Qlongevity indicates, that enhanced catabolism of 
toxic intermediates contributes to the lifespan extension. Thus, Q action resembles predictions 
made by the green theory of aging, as supported by an additional enrichment of hsp expression 
levels in Q 200 µM. However, further mechanisms likely contribute to Q induced longevity, as 
indicated by overrepresentation of pdz genes, transcription factors and vitellogenins. The GO 
term (regulation of transcription, dauer entry, nucleosome and others) and KEGG pathway (Wnt, 
TGF-beta) results point towards extensive alterations in signaling pathways and transcription. 
Moreover, provide the alterations of the aminoacid metabolism and certain degradation 
processes in the lysosome possibilities to contribute to the longevity phenotype. 
 
Which conclusions can be drawn from this meta-analysis? The extensive literature comparison 
allows many conclusions. To address all possibilities is beyond the scope of this work and clear-
ly warrants further investigations. Here only a few aspects can be enlightend.  
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Qlongevity shares significant inducing and repressing transcriptional patterns with long-lived daf-
12(rh273), daf-2 and resveratrol treated daf-16 mutants as well as nematodes inducing immune 
response due to infection with P. aeruginosa (in parts PMK-1 induced genes). Moreover, Qlongevi-
ty shares further DEGs with these conditions, even though these genes were found contrarily 
regulated (up/down or down/up). With TGF-beta mutants, the significant overlap is restricted to 
induced and also contrary (up in Qlongevity/down in TGF-beta mutants) regulated genes, as is the 
case for pmk-1 mutants (down in Qlongevity/up in pmk-1). Additionally, Qlongevity shares overrepre-
sented gene expression mountains with all aforementioned conditions and additionally with 
dauers. (Noteworthy, since the dauer stage can be induced by ILS and TGF-beta signaling with 
DAF-12 being the final common target of dauer-regulatory pathways (Hu, 2007), it is not surpris-
ing that the transcriptional pattern provoked by Qlongevity also shares a significant overlap with 
dauers.) However, considering all of these results suggests that Q induces transcriptional res-
ponses through affecting a complex network of several parallel pathways (schematically de-
picted in Fig. 30). 
 
The results concerning the involvement of DAF-16 are somewhat contradictive and difficult to 
interpret: (i) On one hand the comparison with datasets suggests a repression of DAF-16, on 
the other hand stands the induction of DAF-16 by Qlongevity. (ii) Furthermore lifespan assays with 
Q treated daf-16 mutants revealed, that the lack of DAF-16 does not prevent life extension, 
whereas the lack of known upstream regulators of DAF-16 (daf-2 and age-1) does. Below follow 
some enlightening considerations: 
 
(i) A possible explanation for the finding of contrary regulation of DAF-16 (induced vs. re-
pressed) due to Qlongevity treatment, is a tissue specific modulation of genetic mediators. For ex-
ample, it is conceivable that ILS is diminished and thereby DAF-16 induction enhanced in the 
intestine, but repressed in the somatic gonad. Evans et al. (2008) described already that intes-
tinal and non-intestinal DAF-16 has antagonistic effects on host defense. Furthermore, ba-
lanced antagonistic effects on DAF-16 are observed in the context of signaling from the C. ele-
gans germline and somatic gonad that regulate aging. While signals from the germline normally 
suppress DAF-16 activity through ILS, the gonad signaling enhances DAF-16 activity in a paral-
lel pathway that does not require DAF-2 (Arantes-Oliveira et al., 2002). The output of this ba-
lanced signaling can be described as net aggregate effect (Evans et al., 2008). The complex 
regulation of DAF-16 with co-regulators which influence lifespan and stress resistance together 
with DAF-16 (Hsu et al., 2003; Wolff et al., 2006; Tullet et al., 2008), could possibly further ex-
plain this phenomenon. The exact mechanisms to which degree and in which tissue Qlongevity 
activates and represses DAF-16 activity should be addressed in future research.  
 
(ii) Q 200 µM was not able to extend the lifespan of daf-2 and age-1 mutants (Pietsch et al., 
2009). The corresponding proteins are key players of the ILS pathway and, obviously, also es-
sential for lifespan extension due to Q. Longevity in daf-2 mutants is thought to be largely de-
pendent on the lack of inhibiting DAF-16 (reviewed in Kurz and Tan, 2004). Surprisingly howev-
er, treatment with Q 200 µM provoked a robust life extension of 15% in daf-16 mutants, which 
even exceeds results for the wild type (+ 10%). Thus, despite of the big proportion of DAF-16 
dependent transcriptional responses due to Qlongevity in wild type worms (shown by regulated 
genes e.g. sod-3, sodh-1, other biotransformation genes and the significant overlap to daf-2 
mutants in general), it is suggested that DAF-16 mediated transcritption is not responsible for 
life extension. This phenomenon presumably becomes explainable by considering the p38 
MAPK-pathway as a further participating component, as proposed by Pietsch et al. (2009) due 
to missing lifespan extension following Q 200 µM exposure in sek-1 and unc-43 mutants, re-
spectively. This underlines the importance of p38 MAPK pathway, which is presumably mod-
Discussion 
104 
 
ulated by TGF-beta and ILS (Kurz and Tan, 2004) or others like DAF-12 or also germline/gonad 
signaling. The sek-1 gene encodes a MAPKK, part of the MAP kinase pathway, acting down-
stream of TIR-1 and NSY-1, which phosphorylates the p38-family MAP kinase PMK-1, resulting 
in elevated immune response to pathogen infection (Kim et al., 2002). Troemel et al. (2006) 
proposed this PMK-1 dependent pathway to act downstream of daf-2 and in parallel to ILS. In-
deed, DEGs up-regulated in response to P. aeruginosa infection correlate highly with genes 
determined as induced by PMK-1 (Troemel et al., 2006). Moreover, also Qlongevity DEGs show 
substantial overlap to genes being PMK-1 targets. All these results suggest that Q treatment 
regulates DAF-2 activity on the protein level, which in turn regulates DAF-16 and PMK-1 (possi-
bly already upstream of PMK-1, e.g. unc-43 and sek-1). DAF-16 modulates thereby rather the 
general stress response, whereas PMK-1’s activity leads to a stronger immune response. Both 
pathways concurrently provoke an interplay of induction and repression of their target genes, 
which partly overlap (e.g. CUB-like genes and C-type lectins, which are down-regulated in daf-2 
mutants but up-regulated following infection with P. aeruginosa). The fact that some CUB-like 
genes are also down-regulated in daf-12(rh273) points toward a regulatory role for DAF-12, too. 
Why CUB-like genes are down-regulated by DAF-16, even though they promote immunity, is 
unclear. Troemel et al. (2006) suggested that FOXO transcription factors have opposing roles in 
the immune response; while promoting certain kinds of immunity, inhibiting others. Possibly, this 
subtle down-regulation of certain immune responses contributes for the life prolonging effects of 
DAF-16 in daf-2 mutants grown on E. coli. Immune response proteins might be energetically 
costly and unnecessary when grown on a relatively non-pathogenic food source. This can be 
also the reason for the clear gain in mean lifespan due to Q 200 µM exposure in daf-16 mutants 
compared to wild type nematodes. The usually induced general stress response is partially 
turned off, while simultaneously the immune response through p38 MAPK (and probably other 
mechanisms) becomes activated. Conceivable, is the abolishment of this part extinction in the 
case of daf-16 mutants, which saves energy and prolongs lifespan over the limit of wild type 
nematodes (Pietsch et al., 2009). In this scenario, the suppression of CUB-like genes and other 
immune effectors by DAF-16 on one hand and the upregulation of other immune genes by 
PMK-1 counterbalance the optimal energy consumtion and protection against pathogens in this 
scenario. The regulation of gene expression by Q seems to be an array of several ancillary ac-
tivities, as an inactivation of ILS and an increase of stress resistance, an enhanced immune 
response and an involvement of DAF-12. In this way, Q action in C. elegans is an interesting 
example of how pathways interact, both in a cumulative and also in an antagonistic way; me-
chanisms which deserve closer attention in future investigations.  
 
However, as mentioned before, it is also conceivable that the lifespan results of daf-16 mutants 
are somewhat deceiving: Possibly the internal status of these short-living worms, lacking this 
important transcription factor, have a high ground level of stress and ROS and thus are highly 
susceptible for the antioxidative properties of Q. In this scenario, the antioxidative properties in 
vivo would overwhelm and mask the genetic effects of Q. In this case the commonly used inter-
pretation of lifespan results would be delusive. Furthermore, it should be noted that DNA-
microarray assays can also be erroneous and should be taken with caution. Mistakes in breed-
ing and harvesting of the worms and in RNA preparation, DNA-microarray hybridization and 
evaluation of the data can cause false results. Hence, the comparison of datasets from various 
studies therefore can be misleading. Confirming of found results by other tests like RNAi of in 
DNA-microarrays identified important genes, further mutant assays (lifespan and DNA-
microarrays) or overexpression experiments will have to be conducted in the future.  
 
Nevertheless, the regulation of gene expression by Q seems to be an array of several ancillary 
activities, as an inactivation and/or activation of ILS and an increase of stress resistance, an 
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enhanced immune response and an involvement of TGF-beta signaling, DAF-12, and further-
more presumably germline signaling. In this way, Q action in C. elegans is an interesting exam-
ple of how pathways get influenced by nutrition and how they obviously interact, both in a cumu-
lative and also in an antagonistic way. 
 
 
 
Fig. 30 Presumable model of Q’s lifespan extending genetic action in vivo. Dottet lines point out 
unknown types of interactions. 
 
 
4.6.2 Genetic mediators of CA’s and RA’s action: mutant lifespan assays 
 
The models in Fig. 31 A and B give a schematic overview about CA’s and RA’s action. As pre-
viously identified for Q, sek-1 and unc-43 are key players in CA and RA mediated longevity. In 
addition, osr-1 was shown to be required, a finding that resembles results obtained by Wilson et 
al. (2006) on blueberry polyphenol induced longevity. As far as known, OSR-1 regulates osmot-
ic stress response and survival in hyper-osmotic environments. Viability under osmotic stress 
depends on the activity of several proteins of the CaMKII pathway, where OSR-1 is coupled to 
SEK-1 through UNC-43 (Solomon et al., 2004). The re-occurring finding that osr-1, unc-43 and 
sek-1 are involved in PPs mediated lifespan extension provides compelling evidence that a, yet 
undefined, pathway exists, although there are notable exceptions: Neither osr-1, unc-43 nor 
sek-1 were shown to be responsible for lifespan enhancement in catechin exposed worms, nor 
osr-1 and unc-43 in tannic acid exposed nematodes (Saul et al., 2009; 2010). However, the CA 
and RA induced interplay of these three genes, presumably leads to  
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Table 25 Overview of genes tested in mutant lifespan assays for involvement in Q’s, CA’s and/or 
RA’s life extending action modes. Grey fields indicate genes that have been only investigated for Q’s 
involvement. Second column displays found involvement in respective PP action modes. 
age-1 Q 
- ortholog of the phosphoinositide 3-kinase (PI3K) p110 catalytic subunit  
- central component of the C. elegans ILS pathway, downstream of DAF-2/insulin receptor and upstream of both 
the PDK-1 and AKT-1/AKT-2 kinases and the DAF-16 forkhead type transcription factor  
- required for regulation of metabolism, life span, dauer formation, stress resistance, salt chemotaxis learning, 
fertility, and embryonic development 
- Mutations result in long-lived nematodes, due to missing inhibition of DAF-16 translocation  
akt-2  - Negative modulator of DAF-16 in ILS (Hertweck et al., 2004, Baumeister et al., 2006) 
daf-12 
(daf-d)  
- Promotes gonad-dependent adult longevity (Gerisch et al., 2007); tested was the daf-d m20 allell, which provokes 
a shorter lifespan than wild type 
daf-16 CA 
- central forkhead transcription factor of ILS, major downstream effector of DAF-2 (Tatar et al., 2003).  
- doubling of lifespan in daf-2 mutants is completely dependent on daf-16 (Kenyon et al., 1993) 
- crucial for development, stress resistance, thermotolerance, pathogen resistance, metabolism, and autophagy  
-  transcriptional targets: stress response, antimicrobial, and metabolic genes, many genes of unknown function (for 
detailed review see Landis and Murphy, 2010), some of them impact aging (Murphy et al., 2003)  
- regulated by co-factors, which determine its functional specificity (for detailed review see Berdichevsky and Gua-
rente, 2006).  
daf-2 Q 
- central player in ILS 
- predicted receptor tyrosine kinase that is the C. elegans insulin/IGF receptor ortholog;  
- required for a number of processes in C. elegans, including embryonic and larval development, formation the 
dauer larval stage, adult longevity, reproduction, fat storage, salt chemotaxis learning, and response to exogenous 
stressors such as high temperature or bacterial infection;  
- signals through a conserved PI 3-kinase pathway to negatively regulate the activity of DAF-16, by inducing its 
phosphorylation and nuclear exclusion  
- mutations result in long-lived nematodes, armed with a robust stress-resistance machinery due to missing inhibi-
tion of DAF-16 translocation, resulting in increased expression of its manifold target genes 
- negatively regulates the nuclear localization, and hence transcriptional activity of SKN-1 in intestinal nuclei  
jnk-1  - Post-translational positive regulation of DAF-16 (Wolf et al., 2008) 
mev-1  - Mutants showed significant PP-mediated gain in lifespan. This mutant is characterized by an elevated accumula-tion of endogenous ROS (Ishii et al., 1998) and provides a special test system to prove an antioxidative capacity.  
nhr-8  - active in the xenobiotic defense system (Lindblom et al., 2001) 
sek-1 
Q 
CA 
RA 
- MAP2K, part of the MAP kinase pathway, downstream of TIR-1 (toll and interleucin receptor) and NSY-1 (MAP3K) 
- phosphorylates the C. elegans p38-family MAP kinase PMK-1, which results in elevated immune response to 
pathogen infection (Kim et al., 2002). 
- NSY-1/SEK-1/PMK-1 cassette also functions via SKN-1 to control resistance against arsenic (An and Blackwell, 
2003) 
unc-43 
Q 
CA 
RA 
- CaMKII (Ca2+/calmodulin-dependent protein kinase II), mutations causes diverse behavioral defects by affecting 
locomotory activity, altering excitation of three muscle types, and changing the period of the motor output of a be-
havioral clock (Reiner et al., 1999).  
-  in association with voltage-activated calcium channels (UNC-2/UNC-36), presents a neuronal regulating signaling 
pathway upstream of TIR-1, NSY-1 and SEK-1, determines asymmetric str-2 expression in the AWC olfactory 
neurons (Sagasti et al., 2001) 
osr-1 CA RA 
- thought to be involved in the regulation of osmotic stress response and the survival in hyper-osmotic environ-
ments 
- is coupled to SEK-1 through UNC-43 (Solomon et al., 2004). 
sir-2.1 CA RA 
- NAD+-dependent deacetylases (North and Verdin 2004)  
- implicated in the regulation of aging and longevity across a wide variety of organisms(Tissenbaum and Guarente, 
2001).  
-  responsive to metabolic changes in the cellular environment, including nutrient/energy availability and cellular 
stress (Lin and Guarente, 2003).  
suggested working modes: 
- sir-2.1 requires daf-16 to extend the lifespan of C. elegans via ILS (Tissenbaum and Guarente, 2001) 
- SIR-2.1 and 14-3-3 act parallel to ILS in a stress-dependent pathway, activate DAF-16 and thus extends lifespan 
(Berdichevsky et al., 2006).  
- sir-2.1 may (Tissenbaum and Guarente, 2001; Wood et al., 2004) or may not (Houthoofd and Vanfleteren, 2006; 
Kaeberlein et al., 2006) promote longevity due to caloric restriction (CR); (there is sufficient evidence from yeast, 
fly and worm experiments that SIR2 is involved in lifespan extension by CR that is independent of the ILS pathway 
(Lin et al., 2000; Rogina and Helfand, 2004).  
- sir-2.1 and daf-16 have overlapping but also distinct roles in lifespan regulation (Wang and Tissenbaum, 2006).  
- Viswanathan et al. (2005) demonstrated that resveratrol mediates the lifespan extension of C. elegans through a 
sir-2.1-dependent ER stress pathway.,via the up-regulation of a family of stress response genes (especially abu-
11), which are thought to aid in protein folding within the endoplasmic reticulum (Urano et al., 2002) and thus is 
independent of daf-16. Resveratrol, in turn, inhibits SIR-2.1, which suppresses the expression of abu/pqn genes, 
thereby leading to de-repression of abu-11 and other abu/pqn genes. The result is an elevated level of protein 
folding surveillance within the ER and results in an increase of lifespan in the nematode. 
skn-1  
- Developmental transcription factor, responsible for the expression of various stress genes promoting oxidative 
stress resistance, shows striking similarities to DAF-16 mediated stress response, so far no regulatory link to IIS 
has been identified (An and Blackwell, 2003; Inoue et al., 2005; Baumeister et al., 2006) 
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longevity through different outputs: (i) an elevated immune response to pathogens, (ii) stress-
detection and stress-response and (iii) regulation of cell fates.  
 
In addition to the osr-1/unc-43/sek-1 pathway, daf-16 and sir-2.1 were also found to be involved 
in CA induced longevity, since no lifespan extension was observed in CA exposed daf-16 and 
sir-2.1 mutants. The Sir2 family of NAD+-dependent deacetylases (Imai et al., 2000; Landry et 
al., 2000; North and Verdin, 2004) has been implicated in the regulation of aging and longevity 
across a wide variety of organisms, including yeast, worms and flies (Kaeberlein et al., 1999; 
Tissenbaum and Guarente, 2001; Rogina and Helfand, 2004). SIR2 and its orthologs are res-
ponsive to metabolic changes in the cellular environment, including nutrient/energy availability 
and cellular stress (Lin and Guarente, 2003). In C. elegans, genetic analysis initially suggested 
that sir-2.1 extends life span via the ILS pathway and depends on daf-16 (Tissenbaum and Gu-
arente, 2001). Later, Berdichevsky et al. (2006) proposed the existence of a stress-dependent 
pathway in which SIR-2.1 and 14-3-3 act in parallel to the ILS pathway, but still emerge on and 
activate DAF-16, to extend life span. 14-3-3 proteins are highly conserved small acidic proteins, 
which bind phosphoserine and phosphothreonine residues in a context-specific manner (Du-
rocher et al., 2000) and rank among DAF-16 cofactors. Furthermore, although controversially 
discussed, sir-2.1 may (Tissenbaum and Guarente, 2001; Wood et al., 2004) or may not (Hou-
thoofd and Vanfleteren, 2006; Kaeberlein et al., 2006; Lee and Lee, 2006) promote longevity 
during caloric restriction (CR). Regardless, studies with certain yeast strains, flies and worms 
points toward an involvement of SIR2 in life span extension by CR, independent of the IIS 
pathway (Lin et al., 2000; Rogina and Helfand, 2004; Wang and Tissenbaum, 2006). Hence, it 
has been proposed that sir-2.1 and daf-16 play overlapping, as well as distinct roles in life span 
regulation (Wang and Tissenbaum, 2006). Moreover, acetylation and deacetylation of chroma-
tin-interacting proteins is central to the epigenetic regulation of genome architecture and gene 
expression. Due to the emerging realization of the pathogenetic role of histone deacetylation in 
human disorders, a great deal of effort has been evolved to detect chemicals that modulate his-
tone deacetylases activity (Johnstone, 2002; Grozinger and Schreiber, 2002). Howitz et al. 
(2003) showed that sirtuin activating compounds (STACs) like resveratrol – a polyphenol- and 
various other small molecules can promote the survival of human cells and extend the replica-
tive lifespan of yeast. Viswanathan et al. (2005) demonstrated in genomic and genetic analyses 
conducted with C. elegans, that resveratrol mediate lifespan extension through a sir-2.1-
dependent ER stress pathway. The mechanism involves up-regulation of a family of stress re-
sponse genes (especially abu-11), which are thought to aid protein folding in the endoplasmic 
reticulum (Urano et al., 2002) and thus is independent of DAF-16. Resveratrol evidently acts to 
inhibit SIR-2.1, which under normal conditions suppress the expression of abu/pqn genes, the-
reby leading to de-repression of abu-11 and other abu/pqn genes. The result is an elevated lev-
el of protein folding surveillance within the ER that, in turn increases the life span of the nema-
tode (Viswanathan et al., 2005). 
Given that the lifespan of daf-2 and age-1 mutants is positively affected by CA treatment, it is 
likely that CA operates through a SIR-2.1, 14-3-3 and DAF-16 pathway that is independent of 
ILS. CA may, in addition, promote longevity by means of a sir-2.1-dependent ER-stress re-
sponse pathway and/or the presumable CR-pathway. In contrast, RA triggered life extension is 
seemingly unconnected to daf-16 and presumably controlled by a sir-2.1-dependent ER-stress-
pathway, the putative sir-2.1-dependent CR-pathway, or through a yet to be discovered molecu-
lar switch.  
 
Three questions remain: (i) Why is CA’s but not RA’s life prolonging action dependent on daf-
16? Results obtained from rats suggest that RA is partially hydrolyzed to CA (Baba et al. 2004); 
it is therefore conceivable that CA may also be produced in C. elegans following the ingestion 
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and hydrolyzation of RA. Clearly, further metabolic and genetic investigations are needed to 
allow firm conclusions to be made. (ii) Why does CA exposure induce negative lifespan results 
in osr-1 and sir-2.1 mutants? (iii) If the mutants already have high base line levels of internal 
stress (due to their physiological status), would additional external influences (such as PP expo-
sure) not interfere with their ability to respond to stress? The latter question raises an important, 
and often overlooked, point: namely that the underlying internal physiology should not be neg-
lected when interpreting lifespan assays with mutant animals. 
 
 
 
 
Fig. 31 Presumable models of (A) CA’s and (B) RA’s genetic working modes 
. 
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4.7 Do Q, CA and RA use common or exclusive mechanisms?  
 
Table 26 summarizes the main results of this thesis and compares the effects of the three PPs. 
All three PPs share common but also display specific/exclusive mechanisms:  
 
Q, CA and RA all induce hormetic dose-responsive life extension in C. elegans. However, be-
cause of the differences in the underlying activation of stress responses (as defined by changes 
in hsp expression), only Q and RA are arguably classical hormetins. When taking into account 
the results from mutant lifespan assays, it is conceivable that CA provokes a sir-2.1 and/or daf-
16 dependent stress-response (ER-stress response or CR-stress response) in a hormetic sense 
and thus also could be classified as hormetin. 
 
The antimicrobial properties of Q and RA were not deemed to be the main reason for the life 
prolonging action, since the lifespan of wild type nematodes was still expanded when grown on 
heat killed E. coli supplemented with either Q or RA. CA did not display an antibacterial property 
at all. 
 
Furthermore, different in vivo antioxidative properties of all three PPs suggested the presence of 
distinct modes of action, presumably dependent on their metabolism, ability to cross cell mem-
brane barriers and clearance from cells. Further tests are needed to define the exact underlying 
mechanisms. 
 
Considering experiments in mutant strains revealed also common and distinct genetic mechan-
isms. All three PPs share the involvement of sek-1 and unc-43, what implicates the participation 
of the p38 MAPK pathway, as well as the CaMKII pathway. It is apparent that C. elegans recog-
nizes all three PPs and activates an immune response pathway previously thought to be limited 
to pathogen infection. CA and RA additionally employ OSR-1 and SIR-2.1; OSR-1 mediates 
resistance to hyperosmotic environments and SIR-2.1 was shown to activate stress response in 
the ER and possibly controls CR. DAF-16 appears to contribute to CA action (apparently inde-
pendent from ILS), but plays no role for RA. In contrast, Q presumably uses the ILS and the 
TGF-beta pathway by signaling through DAF-12, but the longevity phenotype is essentially in-
dependent of DAF-16.  
 
Neither Q, nor CA or RA provoke direct CR by effective lowering of food ingestion (as shown by 
the attraction assay and the pharyngeal pumping rates), but indirect CR by involvement of SIR-
2.1 cannot be excluded in the cases of CA and RA. A reallocation of energy takes obviously 
place due to all three PPs, but with varying implications.  
 
Overall, these findings point towards a complex variety of underlying mechanisms – some in 
common, some differing. 
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Table 26 Summary of results from conducted experiments with Q, CA and RA. If not otherwise stated 
experiments are performed with Q 200 µM, CA 300 µM and RA 200 µM at 20 °C. Changes were calcu-
lated compared to control (0 µM). “–“ indicates a decrease, “+” a increase, “/” stands for non-significant 
results. “(–)“ or “(+)” spotlight non-significant tendencies. 
 Experiment Additional informa-tion Q CA RA 
Artifacts due 
to test design 
Antimicrobial proper-
ties 
Lifespan extension on  
heat-killed OP50 
(change) 
1.09±0.01** 1.15±0.03** 1.22±0.02** 
Bacterial growth inhibi-
tion -** / -* 
Transgenerational  
effects 
Adaptive 
Additive 
/ 
/ N/A N/A 
Hormesis and 
stress resis-
tance 
Concentration-
dependence of lifes-
pan variations 
(change) 
50 µM 
100 µM 
200 µM 
250 µM 
300 µM 
600 µM 
1.02±0.00 
1.11±0.06** 
1.10±0.03** 
0.93±0.03* 
1.00±0.01 
1.09±0.05** 
1.07±0.04* 
 
1.11±0.02** 
1.06±0.03** 
1.02±0.01 
1.06±0.01 
1.10±0.03** 
 
1.08±0.03** 
0.94±0.01* 
Pinpointed genes 
responsible for PPs 
action 
Mutant lifespan assays 
age-1, 
daf-2, 
sek-1, 
unc-43 
daf-16, 
osr-1, 
sek-1, 
sir-2.1, 
unc-43 
osr-1, 
sek-1, 
sir-2.1, 
unc-43 
Presumable path-
ways 
Q: deduced from mi-
croarray and mutant 
lifespan results 
CA, RA: deduced from 
mutant lifespan assays 
TGF-beta 
ILS 
P38 MAPK 
CaMKII 
p38 MAPK 
CaMKII 
ER/CR 
stress re-
sponse 
p38MAPK 
CaMKII 
ER/CR 
stress re-
sponse 
Thermotolerance  +** +** +* 
hsp expression  4 up 2 down  
1 up 
5 down  6 up   
Antioxidative 
Capacities in 
vivo 
Paraquat assay: 
matricidal prevention 
(change) 
 4.8x** 1.2x 0.29x** 
Antioxidative capaci-
ty in worm homoge-
nate 
TAC water-soluble 
TAC lipid-soluble 
+* 
/ (+) 
+* 
/ 
/ 
/ (-) 
mev-1 lifespan 
extension (change)  1.10±0.06** 1.10±0.02** 1.08±0.04** 
Lipofuscin levels  -* -* / (+) 
Reallocation 
of resources 
Growth 
 
Heat-killed at the 6th 
day of old adults: length 
(µm) 
 
Alive larvae (0 - 36 h 
post-hatching): 
area (µm2) 
/ 
 
 
+* 
-** 
 
 
+** 
-** 
 
 
+** 
Lipid metabolism in 
LROs  -* -* / (+) 
Reproduction 
Total brood size 
 
Delay 
/ 
 
/ (-) 
/ 
 
/ (-) 
/ 
 
-* 
Direct and 
indirect CR 
effects 
Pharyngeal pumping 
on certain days of 
adulthood 
3rd  adult day 
6th  adult day 
10th adult day 
+** 
+** 
+** 
+** 
+** 
+** 
+** 
+** 
+** 
Attraction  / (-) / / (-) 
sir-2.1 lifespan 
(change)  1.08**±0.03 0.93*±0.00 1.03±0.01 
Lifespan without 
OP50 (change)  1.10**±0.03 N/A N/A 
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4.8 Is it possible to apply common aging theories to the results of this study? 
 
Different theories approach aging from different viewpoints (e.g. mechanistic vs. evolutionary). 
Nevertheless, aging theories frequently overlap in certain aspects and in the predictions made 
(or at least they do not contradict each other). It is thus difficult to experimentally discriminate 
between aging theories. Nevertheless, the following discussion tries to integrate findings of the 
present study into the framework of popular aging hypotheses. It will mainly focus on mechanis-
tic approaches (except the disposable soma theory), since evolutionistic theories are difficult to 
confirm and mainly based on processes which define the maximum lifespan of species, as op-
posed to individuals. Table 27 summarizes aging modulations and theories which can be uti-
lized to explain the working mode of each PP. Predictions made for hormesis embrace and re-
semble at large the Green theory of aging. Moreover, it is suggested that mechanisms which 
underlie CR can be explained by hormetic working modes (cf. Introduction) and thus, also follow 
statements made by the Green theory. In this context, hormesis and CR are discussed together 
with the applicability of aging theories. 
 
Green theory of aging, hormesis, xenohormesis, mitohormesis and indirect CR: All three PPs 
operate on hormetic working schemes. More exact as xeno-hormetins, since all derive from 
nutritional sources and produce stress responses in C. elegans and thereby provoke longevity 
phenotypes. Gene expression profiling supports that Q-induced longevity follows the Green 
theory of aging, since biotransformation - and hsp- genes are overrepresented in Q treated ne-
matodes. Likewise, induction of all inspected hsps by RA suggests that this PP might operate in 
a Green theory manner as well. Since CA brought no significant induction of examined hsps in 
this study and no other biotransformation genes have been examined, clear evidence for the 
application of the Green theory to CA’s action could not be found. The lack of lifespan extension 
in sir 2.1 mutants suggests that CA and RA may employ a sir 2.1 dependent signaling pathway 
to induce: (i) an indirect CR effect, thus acting as CR mimetic or (ii) stress responses, both pre-
sumably involving hormetic working modes, and thus could in turn confirm the Green theory of 
aging.  
 
However, it should be noted, that hormesis in its original sense implies that there are no nega-
tive side-effects of the actual positive effect. Since this study examined only a few parameters 
under standardized laboratory conditions, it cannot be excluded that major negative effects 
have been overlooked. In this context, it is not possible to estimate whether the observed altera-
tions in physiology of the nematodes (e.g. delayed reproduction, altered size, altered fat con-
tent) under laboratory conditions, could have negative influences on overall fitness in natural 
ecological environments. Therefore it is difficult to conclude that the inverted U-shaped dose-
response curves reflect true hormesis.  
 
Free Radical- and Mitochondrial theory of aging vs. Mitohormesis: Considering the fact that Qs’ 
and CAs’ antioxidative in vivo actions provoke a reduced lipofuscin level, and Q additionally 
diminishes paraquat pressure on reproducing hermaphrodites, one could state that both PPs 
decrease the internal ROS level and thereby promote longevity. This would confirm predictions 
made by the FRTA. It seems that the lifespan prolongation of mev-1 mutants results from dimi-
nished production of ROS by the mitochondria or enhanced ROS scavenging in the mitochon-
dria following treatment with all three PPs. Hence, this would be corroboration for the MTA. On 
the other hand, it could be argued that RA which acts as a prooxidant in vivo employs mitohor-
metic actions; by increasing ROS production in the mitochondria it might provoke an enhanced 
induction of stress responses and thereby promote life extension. Further studies are required 
to discriminate these hypotheses. 
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Diposable Soma like patterns: Since redistribution of resources occurs in Q, CA, and RA-treated 
animals, the Disposable Soma theory could be applied to all three PPs. Specifically, we ob-
served altered developmental time spans, altered adult growth (in CA and RA) and altered fat 
metabolism (Q and CA). It is conceivable that the PPs induce a shift of energy towards im-
proved maintenance functions (e.g. stress response, biotransformation) with concurrently taking 
a loss in subordinary parameters (like growth in adulthood); this would finally improve the repro-
ductive success by ensuring a better health status of the individual, and the enhanced longevity 
would merely be a side-effect of improved health.  
 
Table 27 Hypotheses about aging which can be applied to findings due to respective PP treatment 
Q CA RA 
Green theory of aging 
(Xeno-) Hormetic working modes 
- HSP Induction 
- Biotransformations genes in-
duced (cyps, gsts, ugts, sods) 
  
(Xeno-)Hormetic working modes 
- Indirect CR (by means of sir-2.1 
induced  ER or CR stress re-
sponse) 
(Xeno-)Hormetic working modes 
- HSP induction 
- Mitohormesis by prooxidatve prop-
erties (enhanced paraquat suscep-
tibility, slightly enhanced TAC of 
lipid-soluble substances) 
- indirect CR (by means of sir-2.1 
induced ER or CR stress response) 
Free Radical- and Mitochondrial theory of aging 
Antioxidative properties (FRTA; 
MTA) 
- Reduced lipofuscin levels 
- Enhanced TAC of water soluble      
substances in worm-homogenate 
- Reduction of paraquat induced 
“bagging phenotype 
- mev-1 lifespan extension 
Antioxidative properties (FRTA, 
MTA) 
- Reduced lipofuscin levels 
- Enhanced TAC of water soluble      
substances in worm-homogenate 
- mev-1 lifespan extension 
 
(Antioxidative properties (MTA) 
- mev-1 lifespan extension ) 
Disposable Soma 
Reallocation of resources 
- Larval growth increased 
- Slight delay of onset of reproduc-
tion 
- Reduced fat content in LROs 
Reallocation of resources 
- Larval growth increased 
- Adult growth decreased 
- Slight delay of onset of and shift 
during reproduction  
- Reduced fat content in LROs 
Reallocation of resources 
- Larval growth increased 
- Adult growth decreased 
- delay in onset and shift during 
reproduction 
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5 Conclusion  
 
5.1 What can be learned from this study? 
 
Studying phytochemical actions in C. elegans is the first step to understand the complexity of 
underlying mechanisms in a multicellular organism. Although further detailed investigations are 
required, results of this study provide first insights into Q’s, CA’s and RA’s multifaceted functions 
in vivo. Taken together, our findings suggest that the PPs are able to target aging throughout 
life, rather than just being limited to improving survival at old age. This theory is supported by 
the increase in pumping rates, which typically decline in older animals, the attenuated lipofuscin 
accumulation, the diminished Nile red fluorescence and the changes in reproductive timing. Q 
can be best classified as an in vivo antioxidant with strong hormetic potential. CA is also a po-
tent in vivo antioxidant, while RA more likely acts as a prooxidant with hormetic working mode.  
 
5.1.1 General working scheme of PP action 
This comparative study identified common and contrasting mechanisms underlying longevity-
promoting actions of Q, CA, and RA. By various bioassays and DNA-microarray analyses the 
PPs were shown to have a profound impact on the in vivo status of C. elegans. Various aspects 
of nematode life are measurably affected: stress resistance, lifespan, growth, development, fat 
metabolism, food up-take, the internal TAC levels and genetic signaling cascades. It is likely 
that Q, CA and RA affect additional physiological parameters, implying that further mechanistic 
studies are required to fully understand PP action. Similar, drastic physiological alterations were 
previously reported in C. elegans treated with other natural compounds and antioxidants (re-
viewed Gruber et al., 2009; Saul et al., 2009). In conclusion, it seems that many phytochemicals 
are able to reduce age-related declines and produce changes in physiological parameters, al-
though not all studies found life extension (summarized in Supplementary Table 16, taken from 
Saul et al., 2009). 
 
Figure 32 depicts a presumable general working scheme for PPs in vivo. To a different extent 
PPs act through genetic signaling, hormetic and antibacterial working modes, anti- or pro-
oxidative properties in vivo and by regulation of the metabolism. The relative contribution of 
each effect may depend on the generic structure and bioavailablility of respective PP, as well as 
the treated organism, its developmental and physiological state, the examined tissue and other 
external influences. The direct responses to PPs in turn influence each other, giving rise to a 
complex feedback and feed-forward network (Fig. 32). Future studies might refine the simplified 
model in Fig. 32 which is only a crude approximation of the real network. The present study did 
not address the hierarchy of events within this network, an aspect that deserves further investi-
gation  
 
As example, it is conceivable that PPs provoke a slight physiological stress when ingested, like 
environmental xenobiotics. Adequate genes will be induced through genetic signaling. These 
reactions will be also categorized as hormetic working modes, if the biotransformation system, 
stress response or immunity genes are involved. Some biotransformation genes play also roles 
in lipid metabolism (e.g. some cyp-genes) and their activation may provoke altering of the lipid 
content and thereby change the internal ROS level. When inducing immunity genes, the antimi-
crobial defense of the organism will increase. Vice versa can direct antimicrobial properties of 
the PP also upgrade the overall immunity, by straightforward combating invading microbes. 
Less pathogen stress will reduce in turn the ROS generation. Conceivable is also, that the 
prooxidant or antioxidant properties of the PP will exert direct or indirect effects on the oxidative 
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status: internal ROS will be increased or decreased. Enhanced levels of ROS can help also in 
pathogen defense and furthermore were shown to act as signaling molecules (Lamb and Dixon, 
1997), provoking presumably mitohormesis. Beside will parts of the metabolism convert the PP 
in its metabolites which can induce further genetic signaling, activate again parts of the metabol-
ism, induce again hormetic working modes what presumably can lead again to ROS increase or 
decrease and so forth. Conceivable are many more interlinks and feedback loops.  
 
Although all phytochemicals will employ one or several of the network branches in Fig. 32, the 
ultimate output is not necessarily life extension and stress resistance. For instance, during the 
course of this study other compounds were tested, including cumaric acid, vanillic acid and res-
veratrol (data not shown); no life extension could be shown for each of these agents over a 
broad concentration range. Thus, it is likely that the physiological response to phytochemicals is 
determined by the combination of molecular events. It will stay still a major challenge for future 
studies to further define the relation between molecular events and organismic aging.  
 
 
 
 
Fig. 32 General working scheme for PPs in vivo. 
 
 
5.1.2 Outlook and future directions 
This work showed that C. elegans can be used as a model system to define the impact PPs on 
a multicellular organism, and revealed underlying mechanisms. The next steps would be more 
detailed pharmacological analyses in C. elegans and confirmation of the findings in other model 
organisms and in humans. For example, the fact of altering the fat deposition and lipofuscin 
accumulation due to treatment with PPs could be initial point for pharmacological application of 
PPs in obesity, diabetes and neurodegenerative disorders. Sugaya et al. (2004) showed an in-
creased lipofuscin accumulation in neurons, when experimentally induced diabetes in rats. Lo-
wering the risk of diabetes by reducing the fat content, as well as lowering the lipofuscin accu-
mulation in neurons by slowing down the aging process could reduce these age-associated 
diseases. 
 
Furthermore, since there is a strong association between immune function and individual hu-
man lifespan (Ginaldi et al., 2001), the involvement of the p38 MAPK pathway in PPs action 
should be initial point for further research. The NSY-1/SEK-1/PMK-1 cassette is an evolutionari-
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ly conserved module used in defense against pathogenic attack. Mammalian innate immunity 
uses molecular pathways conserved with flies and nematodes, even though these invertebrate 
animals lack classic adaptive immune systems. This innate immunity pathway appears to be 
commonly affected by multiple PPs including Q, blueberry polyphenols (Wilson et al., 2006), 
Tannic Acid (Saul et al., 2010), CA and RA in C. elegans. Such a generalized genetic mechan-
ism is likely to be active in other organisms as well and may thus be used in medical issues to 
enhance pathogen resistance against infections such as pneumonia, influenza, nephritis and 
septicemia, which are among the ten top causes of death for people over 65 years old (Ander-
son and Smith, 2005).  
 
Moreover does the involvement of sir-2.1 in CA and RA action require further investigations: 
The acetylation and deacetylation of chromatin-interacting proteins is central to the epigenetic 
regulation of gene expression. Because of the emerging pathogenetic role of histone deacetyla-
tion in human disorders (like some cancers, reviewed in Glozak and Seto, 2007), a great deal of 
effort has been evolved to detect chemicals that modulate histone deacetylases activity (John-
stone, 2002; Grozinger and Schreiber, 2002). Howitz et al. (2003) showed that sirtuin activating 
compounds (STACs) like resveratrol and other small molecules can promote the survival of hu-
man cells and extend the replicative lifespan of yeast. It is likely that CA and RA also are capa-
ble to do so and therefore could be utilized as drugs.  
 
Furthermore, PPs could be used as small-molecule modulators in biomedical research to inves-
tigate yet unknown points of interactions and combinatorial downstream effects of well known 
genetic pathways. It is becoming increasingly clear that conserved pathways, like the TGF-beta, 
ILS and p38 MAPK signaling, which all serve in adapting the organism to the environment, play 
prominent roles in at least some PP’s mode of action. PPs activate and inhibit not just one sin-
gle pathway, but rather provoke a complex interplay of various structures in different pathways, 
presumably dependent on their metabolic usability and bioavailability. PP treatments in C. ele-
gans could be used to combinatorially activate such pathways and DNA-microarray analyses 
could provide insights of possible interactions. This may set the stage for rational design of RNA 
interference experiments, suitable mutant assay experiments and RT-PCR approaches as well 
as protein-based tests of genetic players. 
 
In addition to defining the working modes of individual phytochemicals, we need to investigate 
how a mixture of various phytochemicals, as existent in natural food, influence effects of one 
another and thereby the health and aging of the consumer. This requires highly standardized 
test designs among different laboratories and comprehensive data storage in databases. Fur-
thermore, integrative experimental design strategies including transcriptomics, proteomics and 
metabolomics platforms are called for to understand the systems-level properties of aging net-
works. This will in turn contribute to a better understanding of how nutrition affects organisms 
and processes which cause and counteract aging.  
 
From an ecological perspective it would be interesting to investigate how population dynamics 
can be influenced by ingesting special types of food. Mathematical models could estimate how 
PP mediated alterations in lifespan of individuals affect the behavior of the population as a 
whole. Experiments with closely related species (e.g. C. briggsae) that occupy the same niches 
evaluate the species-specific susceptibility to certain PPs and calculate if they have the poten-
tial of triggering a micro-evolution.  
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5.1.3 Critical review 
Standardization of handling methods, test regimes and data evaluation 
Even though C. elegans is undoubtedly a suitable model to study complex circumstances in 
vivo, investigations about the impact of compounds on life parameters need to adhere some 
basical important issues (as recently reviewed in Gruber et al., 2009). It is becoming increasing-
ly clear in the C. elegans research community that meticulously standardizing the handling me-
thods and laboratory conditions (especially for lifespan experiments) is of utmost importance. 
Lifespan assays are very susceptible for minimal external (and presumably also internal) varia-
tions, making it difficult to generate robust lifespan data, as shown in single trial variations in this 
study, but also in the case of resveratrol in the literature. While Wood et al. (2004), Viswanathan 
et al. (2005) and Gruber et al. (2007) found lifespan extension due to exposure to resveratrol, 
Bass et al. (2007) could not confirm this finding. Within the framework of this study, it was also 
tried to reproduce results found for resveratrol in our laboratory, but we also could not find any 
life extension, rather a diminishment (data not shown). Sources for deviations are manifold: Lit-
tle variations in room temperature, in the density and composition of the bacterial food (e.g. con-
taminations with other bacteria), the number of nematodes on the plates, the use of media and 
chemicals from differing firms and batches, as well as the humidity and thickness of the agar 
can provoke major discrepancies in results. In addition, genetic drift occurs when nematodes 
are maintained over many generations under laboratory conditions, if not regulatory refreshed 
from frozen stocks. Hence, resulting genetic differences can affect lifespan and other physiolog-
ical traits, which sensitize worms to a given stimulus in aberrant extent. Differences in the num-
bers and the physical constrain of the transfer, and the use of hypochloride to synchronize 
worms can affect the status of the worms. Observer’s bias can furthermore subconsciously in-
fluence the results. Therefore blinding of studies is necessary, but not always practicable due to 
colored compounds (like in this study). Moreover, there are issues about the handling of data, 
calculation of significances and the minimum sample sizes of an experiment, which all produce 
deviations in the results (for a very informative review be referred to Gruber et al., 2009).  
 
Hence, every new starting C. elegans researcher should strongly be advised to inform about 
above discussed issues and thereafter prepare a fixed working scheme which has to be the 
basis of all following experiments. It should contain regimes for generating stocks in advance to 
large experiments and refreshing of populations, transfer of nematodes, growing bacteria and 
adjusting the same density, for pouring and storage of plates, as well as coding of blinded 
plates and evaluation and pooling of data. The laboratories should furthermore guarantee con-
stant temperature, and have to be held close and clean to avoid contaminations, since the 
transfer of C. elegans cohorts in lifespan assays is time consuming and plates have to be han-
dled outside thermo-cupboards and lamina flows.   
 
 
Interpretation of results  
Results from lifespan assays in mutant strains need to be interpreted with caution. For example 
mev-1 mutants are usually used to determine antioxidative properties of compounds in vivo, due 
to their higher level of internal oxidative stress produced by the defective electron transport 
chain. A lack in lifespan prolongation due to a certain PP could be interpreted on one hand, as 
deficient antioxidant ability of the compound in vivo, but on the other, as mev-1 being a genetic 
mediator of PP’s longevity. The gain in life extension of mev-1 mutants due to PPs treatment is 
usually explained with in vivo antioxidative properties of respective PP. In contrast, life exten-
sion in a daf-16 mutant would be taken as evidence that daf-16 can be excluded as a genetic 
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mediator. These variations in possibilities to interpret raise the question if lifespan assays with 
different mutant strains can be compared and interpreted without considering specifics of the 
underlying internal physiology. Furthermore it is conceivable that different genes are functionally 
redundant and therefore effects are masked when using a single mutant. 
 
DNA-microarray studies allow to systematically measuring the genome-wide gene expression 
profile. However, an induction or repression of individual genes does not necessarily imply that 
they play a significant role in mediating a response. Moreover, other regulatory mechanisms 
(e.g. post-translational modifications) exist which modulate the activity of respective protein. 
Therefore it would have to be important to subsequently test on the protein level and further-
more on the metabolomics level to get deeper insights in the exact working patterns in vivo. 
 
 
Difficulty of identifying underlying working modes of compounds 
The present study revealed that only a broad spectrum of different tests can help to elucidate 
the in vivo actions of phytochemicals. For example, the in vitro antioxidant properties, are not 
necessarily associated to in vivo antioxidant properties (cf. Pun et al., 2010), and the in vivo 
antioxidant properties cannot always explain the full impact on the organism. Moreover, it has to 
be investigated to which extent direct or indirect CR effects, hormetic mechanisms and other 
events contribute to observed phenotypes. 
Furthermore, this study has shown that simply evaluating DNA-microarrays with prevalent me-
thods, like GO-term and KEGG pathway-analyses, is not always enough to understand underly-
ing genetic mechanisms. Functional insights rather require detailed comparison with published 
DNA-microarray studies in C. elegans, especially investigations about the global transcriptional 
response of certain mutant strains. This example shows the growing need for comparative da-
tabases which evaluate the congruence of certain datasets and hence allows drawing conclu-
sions on underlying genetic players beyond simple GO and KEGG adjustment. 
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Supplementary Table 1 List of Phytochemicals in food 
Phenolic com-
pounds 
Monophenols • Apiole 
• Carnosol  
• Carvacrol  
• Dillapiole. 
• Rosemarinol  
• parsley 
• rosemary 
• oregano, thyme 
• dill 
• rosemary 
 Flavonoids (PPs) Flavonols 
• Quercetin  
 
• Gingerol 
• Kaempferol  
 
• Myricetin 
• Rutin  
 
• Isorhamnetin 
 
• onions, tea, wine, apples, cranber-
ries, buckwheat, beans 
• ginger 
• strawberries, gooseberries, cranber-
ries, peas, brassicates, chives 
• grapes, walnuts 
• citrus fruits, buckwheat, parsley, 
tomato, apricot, rhubarb, tea 
  Flavanones 
• Hesperidin  
• Naringenin 
• Silybin 
• Eriodictyol 
 
• citrus fruits 
• citrus fruits 
• blessed milk thistle 
 
  Flavones 
• Apigenin  
• Tangeritin 
• Luteolin 
 
• chamomile, celery, parsley 
• tangerine and other citrus peels 
 
  Flavan-3-ols 
• Catechins  
 
 
• (+)-Catechin 
• (+)-Gallocatechin 
• (-)-Epicatechin 
• (-)-Epigallocatechin 
• (-)-Epigallocatechin gal-
late (EGCG)  
 
• (-)-Epicatechin 3-gallate 
• Theaflavin  
• Theaflavin-3-gallate 
Theaflavin-3'-gallate  
• Theaflavin-3,3'-digallate 
• Thearubigins 
 
• white tea, green tea, black tea, 
grapes, wine, apple juice, cocoa, 
lentils, black-eyed peas 
 
 
 
 
• green tea 
 
 
 
• black tea 
• black tea 
 
• black tea 
• black tea 
  Anthocyanins (flavonals) and 
Anthocyanidins  
• Pelargonidin  
• Peonidin  
 
 
 
• Cyanidin  
 
 
• Delphinidin  
• Malvidin  
• Petunidin 
e.g. red wine, many red, purple or blue 
fruits and vegetables 
• bilberry, raspberry, strawberry 
• bilberry, blueberry, cherry, cranber-
ry, peach, red apple & pear, bilber-
ry, blackberry, blueberry, cherry, 
cranberry, peach, plum, hawthorn, 
loganberry, cocoa 
 
 
 
• bilberry, blueberry, eggplant 
• bilberry, blueberry 
  Isoflavones (phytoestrogens) 
• Daidzein (formononetin)  
 
• Genistein (biochanin A)  
 
• Glycitein  
 
• soy, alfalfa sprouts, red clov-
er,chickpeas, peanuts, other le-
gumes 
• soy, alfalfa sprouts, red clover, 
chickpeas, peanuts, other legumes 
• soy 
Table continues on page 139 
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  Dihydroflavonols  
  Chalcones  
  Coumestans (phytoestro-
gens) 
• Coumestrol  
 
• red clover, alfalfa sprouts, soy, 
peas, brussels sprouts 
 Phenolic acids 
 
• Ellagic acid  
 
• Gallic acid  
• Salicylic acid  
• Tannic acid  
• Vanillin  
• walnuts, strawberries, cranberries, 
blackberries, guava, grapes 
• tea, mango, strawberries, rhubarb, 
soy 
• peppermint, licorice, peanut, wheat 
• nettles, tea, berries 
• vanilla beans, cloves 
 Phenolic acids 
 
• Capsaicin  
• Curcumin 
• chilli peppers 
• turmeric, mustard 
 Hydroxycinnamic 
acids 
 
• Caffeic acid  
 
• Chlorogenic acid  
 
 
• Cinnamic acid  
• Ferulic acid  
 
• Coumarin  
• burdock, hawthorn, artichoke, pear, 
basil, thyme, oregano, apple 
• echinacea, strawberries, pineapple, 
coffee, sunflower, blueberries 
• aloe 
• oats, rice, artichoke, orange, pi-
neapple, apple, peanut 
• citrus fruits, maize 
 Lignans (phy-
toestrogens)   
 
 
 
 
 
 
• Silymarin  
• Matairesinol  
 
 
 
• Secoisolariciresinol  
 
 
• Pinoresinol and lariciresinol  
• seeds (flax, sesame, pumpkin, sun-
flower, poppy), whole grains (rye, 
oats, barley), bran (wheat, oat, rye), 
fruits (particularly berries) and vege-
tables  
• artichokes, milk thistle 
• flax seed, sesame seed, rye bran 
and meal, oat bran, poppy seed, 
strawberries, blackcurrants, broccoli 
• flax seeds, sunflower seeds, se-
same seeds, pumpkin, strawberries, 
blueberries, cranberries, zucchini, 
blackcurrant, carrots 
• sesame seed, Brassica vegetables 
 
 Tyrosol esters 
 
• Tyrosol  
• Hydroxytyrosol  
• Oleocanthal  
• Oleuropein  
• olive oil 
• olive oil 
• olive oil 
• olive oil 
 Stilbenoids 
 
• Resveratrol  
 
• Pterostilbene  
• Piceatannol  
• grape skins and seeds, wine, nuts, 
peanuts 
• grapes, blueberries 
• grapes 
 Punicalagins   • pomegranates 
Terpenes (iso-
prenoids) 
Carotenoids 
(tetraterpenoids) 
 
Carotenes (orange pigments) 
• α-Carotene  
 
 
• β-Carotene  
 
• γ-Carotene 
• δ-Carotene 
• Lycopene  
 
• Neurosporene 
• Phytofluene  
• Phytoene  
 
• in carrots, pumpkins, maize, tange-
rine, orange 
• in dark, leafy greens and red, 
orange and yellow fruits and vege-
tables 
 
 
• Vietnam Gac, tomatoes, grapefruit, 
watermelon, guava, apricots, carrots 
 
• star fruit, sweet potato, orange 
• sweet potato, orange. 
Table continues on page 140 
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Terpenes (iso-
prenoids) 
Carotenoids 
(tetraterpenoids) 
 
Xanthophylls (yellow pig-
ments) 
• Canthaxanthin 
• Cryptoxanthin  
 
• Zeaxanthin  
 
 
• Astaxanthin  
 
• Lutein  
 
 
 
 
 
• Rubixanthin  
 
• paprika 
• mango, tangerine, orange, papaya, 
peaches, avocado, pea, grapefruit, 
kiwi 
• wolfberry, spinach, kale, turnip 
greens, maize, eggs, red pepper, 
pumpkin, oranges 
• microalge, yeast, krill, shrimp, sal-
mon, lobsters, some crabs 
• spinach, turnip greens, romaine 
lettuce, eggs, red pepper, pumpkin, 
mango, papaya, oranges, kiwi, 
peaches, squash, legumes, brassi-
cates, prunes, sweet potatoes, ho-
neydew melon, rhubarb, plum, avo-
cado, pear 
• rose hips 
 Monoterpenes 
 
• Limonene  
 
 
• Perillyl alcohol  
• oils of citrus, cherries, spearmint, 
dill, garlic, celery, maize, rosemary, 
ginger, basil 
• citrus oils, caraway, mints 
 Saponins   • soybeans, beans, other legumes, 
maize, alfalfa 
 Lipids 
 
Phytosterols  
 
 
• Campesterol  
• beta Sitosterol  
 
 
• gamma sitosterol 
• Stigmasterol  
e.g. almonds, cashews, peanuts, se-
same seeds, sunflower seeds, whole 
wheat, maize, soybeans, many vege-
table oils 
• buckwheat 
• avocados, rice bran, wheat germ, 
corn oils, fennel, peanuts, soy-
beans, hawthorn, basil, buckwheat 
 
• buckwheat 
  Tocopherols (vitamin E)  
 Lipids omega-3,6,9 fatty acids  
 
• gamma-linolenic acid  
e.g. dark-green leafy vegetables, 
grains, legumes, nuts 
• evening primrose, borage, blackcur-
rant 
 Triterpenoid 
 
• Oleanolic acid  
 
• Ursolic acid  
 
 
 
• Betulinic acid  
 
 
 
 
 
 
 
• Moronic acid  
• American pokeweed, honey mes-
quite, garlic, java apple, cloves, and 
many other Syzygium species 
• apples, basil, bilberries, cranberries, 
elder flower, peppermint, lavender, 
oregano, thyme, hawthorn, prunes 
• Ber tree, white birch, tropical carni-
vorous plants Triphyophyllum pelta-
tum and Ancistrocladus heyneanus, 
Diospyrol leucomelas a member of 
the persimmon family, Tetracera 
boiviniana, the jambul (Syzygium 
formosanum), and many other Sy-
zygium species. 
• Rhus javanica (a sumac), mistletoe 
Betalains 
 
Betalains 
 
Betacyanins 
• betanin  
• isobetanin  
• probetanin  
• neobetanin  
 
• beets 
• beets 
• beets 
• beets 
  Betaxanthins  
• Indicaxanthin  
• Vulgaxanthin  
 
• beets, sicilian prickly pear 
• beets 
Organosulfides Dithiolthiones 
(isothiocyanates) 
• Sulphoraphane  • Brassicates. 
Table continues on page 141 
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Continuation Supplementary Table 1 
 
 
Thiosulphonates 
(allium com-
pounds) 
• Allyl methyl trisulfide  
• Diallyl sulfide  
• garlic, onions, leeks, chives, shallots 
• garlic, onions, leeks, chives, shallots 
Indoles, gluco-
sinolates 
 
 • Indole-3-carbinol  
 
• sulforaphane  
• 3,3'-Diindolylmethane or 
DIM  
• Sinigrin  
• Allicin  
• Alliin  
• Allyl isothiocyanate  
• Piperine  
• Syn-propanethial-S-oxide  
• cabbage, kale, brussels sprouts, 
rutabaga, mustard greens 
• broccoli family 
• broccoli family 
• broccoli family 
• garlic 
• garlic 
• horseradish, mustard, wasabi 
• black pepper 
• onions 
Protein inhibi-
tors 
 Protease inhibitors  
 
• soy, seeds, legumes, potatoes, 
eggs, cereals 
Other organic 
acids 
 
 • Oxalic acid  
 
 
• Phytic acid (inositol hexa-
phosphate)  
• Tartaric acid  
 
• Anacardic acid  
• orange, spinach, rhubarb, tea and 
coffee, banana, ginger, almond, 
sweet potato, bell pepper 
• cereals, nuts, sesame seeds, soy-
beans, wheat, pumpkin, beans, al-
monds 
• apricots, apples, sunflower, avoca-
do, grapes 
• cashews, mangoes 
Source: From Wikipedia, the free encyclopedia 
http://en.wikipedia.org/wiki/List_of_phytochemicals_in_food 
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Supplementary Fig. 1 Nile Red staining of young adults and and 10 day old nematodes: repeatedly 
found artifacts. In young adults seemingly the eggs also get stained by Nile Red what provoke falsifica-
tions; and in 10 days old adults obviously loose the intestine structure its integrity, what leads to over-
staining. Since these events were observed frequently, the Nile Red measurements have been restricted 
to 3 and 6 days old adults. 
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Supplementary Table 3: GO Cluster analysis with significantly up-regulated transcripts in Q 100 
and 200 µM. DAVID, adjusted on "medium classification stringency", p < 0.05. Displayed is one signifi-
cant GO-term per cluster. 
Cate
gory Term Process p-value 
Q 100 µM up-regulated 
BP 
GO:0031497 chromatin assembly 1.84E-04 
GO:0044255 cellular lipid metabolic process 5.37E-03 
GO:0032787 monocarboxylic acid metabolic process 1.77E-03 
GO:0009451 RNA modification 2.89E-02 
GO:0008152 metabolic process 4.90E-02 
MF GO:0016788 hydrolase activity, acting on ester bonds 1.57E-03 
GO:0004497 monooxygenase activity 1.91E-03 
CC 
GO:0000786 nucleosome 1.26E-04 
GO:0016021 integral to membrane 3.47E-02 
GO:0005856 cytoskeleton 6.25E-04 
Q 200 µM up-regulated 
BP 
GO:0006629 lipid metabolic process 3.57E-05 
GO:0030259 lipid glycosylation 5.67E-03 
GO:0065004 protein-DNA complex assembly 5.40E-05 
GO:0007592 protein-based cuticle development 2.07E-02 
GO:0006633 fatty acid biosynthetic process 2.07E-03 
GO:0008152 metabolic process 9.42E-06 
GO:0006470 protein amino acid dephosphorylation 7.22E-03 
GO:0006189 'de novo' IMP biosynthetic process 4.11E-03 
MF 
GO:0042578 phosphoric ester hydrolase activity 9.78E-05 
GO:0004497 monooxygenase activity 1.77E-04 
GO:0004091 carboxylesterase activity 1.75E-02 
GO:0030246 carbohydrate binding 1.96E-02 
GO:0016705 
oxidoreductase activity, acting on paired donors, with incorporation or reduction 
of molecular oxygen 3.17E-02 
GO:0008237 metallopeptidase activity 3.45E-02 
CC 
GO:0000786 nucleosome 5.15E-05 
GO:0005764 lysosome 9.07E-02 
GO:0016021 integral to membrane 2.64E-02 
GO:0005856 cytoskeleton 6.51E-03 
 
  
 150 
 
 A
ppendix 
  
Supplementary Table 4: GO Cluster analysis with significantly down-regulated transcripts in Q 
100 and 200 µM. DAVID, adjusted on "medium classification stringency", p < 0.05. Displayed is one sig-
nificant GO-term per cluster. 
 
Cate
gory Term Process p-Value 
Q 100 µM down-regulated 
BP 
GO:0007399 nervous system development 3.11E-15 
GO:0007155 cell adhesion 2.06E-08 
GO:0006928 cell motion 7.73E-09 
GO:0040012 regulation of locomotion 1.32E-04 
GO:0009653 anatomical structure morphogenesis 5.72E-10 
GO:0040014 regulation of multicellular organism growth 9.08E-04 
GO:0050789 regulation of biological process 3.77E-05 
GO:0007179 transforming growth factor beta receptor signaling pathway 6.79E-03 
GO:0042074 cell migration involved in gastrulation 1.19E-03 
GO:0045137 development of primary sexual characteristics 8.84E-03 
GO:0033057 reproductive behavior in a multicellular organism 5.84E-05 
GO:0014018 neuroblast fate specification 1.61E-02 
GO:0048583 regulation of response to stimulus 3.79E-03 
GO:0022603 regulation of anatomical structure morphogenesis 8.38E-03 
GO:0043053 dauer entry 1.59E-02 
GO:0018988 molting cycle, protein-based cuticle 3.20E-02 
GO:0008361 regulation of cell size 3.83E-03 
GO:0006355 regulation of transcription, DNA-dependent 2.67E-04 
GO:0051252 regulation of RNA metabolic process 3.10E-04 
GO:0006357 regulation of transcription from RNA polymerase II promoter 2.43E-02 
GO:0009887 organ morphogenesis 9.71E-03 
GO:0065008 regulation of biological quality 5.23E-03 
GO:0045185 maintenance of protein location 2.77E-02 
GO:0048646 anatomical structure formation involved in morphogenesis 1.63E-03 
GO:0010646 regulation of cell communication 3.56E-02 
GO:0042464 dosage compensation, by hypoactivation of X chromosome 2.51E-02 
GO:0043067 regulation of programmed cell death 1.98E-02 
GO:0048523 negative regulation of cellular process 1.97E-02 
GO:0032787 monocarboxylic acid metabolic process 5.26E-02 
GO:0007154 cell communication 2.87E-02 
GO:0050793 regulation of developmental process 2.09E-02 
MF 
GO:0030528 transcription regulator activity 2.73E-05 
GO:0016862 intramolecular oxidoreductase activity, interconverting keto- and enol-groups 2.92E-02 
GO:0016706 oxidoreductase activity, acting on paired donors, with incorporation or reduction 
of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one 
atom each of oxygen into both donors 2.36E-02 
CC 
GO:0044459 plasma membrane part 2.64E-07 
GO:0043231 intracellular membrane-bounded organelle 1.55E-04 
GO:0030054 cell junction 5.04E-04 
GO:0045111 intermediate filament cytoskeleton 4.59E-03 
GO:0044421 extracellular region part 4.62E-03 
GO:0005788 endoplasmic reticulum lumen 2.83E-04 
GO:0005856 cytoskeleton 2.98E-02 
Q 200 µM down-regulated 
BP 
GO:0007399 nervous system development 2.02E-14 
GO:0007155 cell adhesion 5.61E-08 
GO:0016477 cell migration 6.18E-07 
GO:0040014 regulation of multicellular organism growth 1.06E-04 
GO:0040012 regulation of locomotion 8.35E-04 
GO:0033057 reproductive behavior in a multicellular organism 5.12E-05 
GO:0009653 anatomical structure morphogenesis 3.44E-11 
GO:0040008 regulation of growth 1.60E-03 
GO:0007179 transforming growth factor beta receptor signaling pathway 8.39E-03 
GO:0042074 cell migration involved in gastrulation 1.53E-04 
GO:0006355 regulation of transcription, DNA-dependent 7.47E-07 
GO:0048608 reproductive structure development 9.48E-03 
GO:0065008 regulation of biological quality 1.69E-04 
GO:0018988 molting cycle, protein-based cuticle 1.38E-02 
Table continues on page 151 
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Continuation of Supplementary Table 4 
 GO:0008361 regulation of cell size 1.16E-03 
BP 
GO:0045944 positive regulation of transcription from RNA polymerase II promoter 1.22E-02 
GO:0014018 neuroblast fate specification 1.80E-02 
GO:0048583 regulation of response to stimulus 6.11E-03 
GO:0043053 dauer entry 2.08E-02 
GO:0010646 regulation of cell communication 1.77E-02 
GO:0048513 organ development 1.68E-02 
GO:0045185 maintenance of protein location 3.36E-02 
GO:0006631 fatty acid metabolic process 3.35E-03 
GO:0042464 dosage compensation, by hypoactivation of X chromosome 2.94E-02 
GO:0050793 regulation of developmental process 7.91E-03 
MF 
GO:0030528 transcription regulator activity 1.09E-07 
GO:0016860 intramolecular oxidoreductase activity 2.41E-02 
GO:0016706 oxidoreductase activity, acting on paired donors, with incorporation or reduction 
of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one 
atom each of oxygen into both donors 2.70E-02 
CC 
GO:0043231 intracellular membrane-bounded organelle 2.56E-05 
GO:0005886 plasma membrane 1.07E-05 
GO:0030054 cell junction 3.04E-03 
GO:0045111 intermediate filament cytoskeleton 6.01E-03 
GO:0044421 extracellular region part 2.36E-02 
GO:0005788 endoplasmic reticulum lumen 4.03E-04 
GO:0005856 cytoskeleton 3.61E-02 
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Supplementary Table 5 Overrepresented KEGG pathways found in Q 100 µM treated nematodes. 
Further summarized are the DEGs and statistical proven expression values (FC), p-values and the Fold 
Enrichment. The numbers in italics show FC values without guarantee of statistical robustness.  
cel04142: Lysosome 
0.000 2.734 apm-3 0.86 0.75 0.65 Clathrin-associated protein medium chain 
  
asm-2 1.20 1.38 1.79 
Acid sphingomyelinase and PHM5 phosphate 
metabolism protein 
  
asm-3 0.60 0.71 0.95 
Acid sphingomyelinase and PHM5 phosphate 
metabolism protein 
  
C33G3.4 0.89 0.73 0.68 Predicted beta-mannosidase 
  
cpr-2 1.56 5.83 8.28 Cysteine proteinase Cathepsin L 
  
cpr-3 0.70 0.71 0.81 cathepsin B-like cysteine proteinase 
  
cpr-3 0.70 0.64 0.73 Cysteine proteinase Cathepsin L 
  
F32H5.1 1.10 1.57 1.92 Cysteine proteinase Cathepsin L 
  
F57F5.1 1.07 0.78 0.86 Cysteine proteinase Cathepsin L 
  
R07E4.4 0.88 0.73 0.78 Nucleoside phosphatase 
  
smf-3 0.79 1.30 1.16 ST.LOUIS) 
  
vha-15 0.87 0.77 0.75 Vacuolar H+-ATPase V1 sector, subunit H 
  
W07B8.4 2.61 3.57 4.11 thiol protease; C.elegans cDNA clone yk150b4 
  
Y16B4A.2 1.24 0.73 0.82 
Serine carboxypeptidases (lysosomal cathepsin 
A) 
  
Y4C6B.6 1.42 1.30 1.57 Beta-glucocerebrosidase 
  
nuc-1 0.83 0.83 0.94 
abnormal NUClease /// locus:nuc-
1/Deoxyribonuclease II 
  
ncr-1 0.58 0.83 0.74 
Cholesterol transport protein (Niemann-Pick C 
disease protein) 
  
Y40D12A.2 1.33 0.63 0.71 
Serine carboxypeptidases (lysosomal cathepsin 
A) 
cel04350: TGF-beta signaling pathway 
0.001 3.551 daf-1 0.89 0.79 0.73 C.elegans cDNA clone yk18f7 
  
skr-10 0.99 0.68 0.56 SCF ubiquitin ligase, Skp1 component 
  
skr-12 1.01 0.63 0.58 SCF ubiquitin ligase, Skp1 component 
  
skr-13 1.03 0.72 0.62 SCF ubiquitin ligase, Skp1 component 
  
skr-14 1.04 0.80 0.67 SCF ubiquitin ligase, Skp1 component 
  
skr-15 0.95 0.76 0.65 SCF ubiquitin ligase, Skp1 component 
  
skr-21 0.78 0.74 0.55 
RNA polymerase II elongation factor like; 
C.elegans cDNA clone yk98d5 
  
skr-21 0.78 0.72 0.52 SCF ubiquitin ligase, Skp1 component 
  
skr-7 1.02 0.68 0.61 SCF ubiquitin ligase, Skp1 component 
  
skr-8 0.98 0.71 0.57 SCF ubiquitin ligase, Skp1 component 
  
skr-8 1.00 0.69 0.57 
cyclin A-associated protein; C.elegans cDNA 
clone yk282d6 
  
skr-9 0.95 0.67 0.56 SCF ubiquitin ligase, Skp1 component 
  
skr-16 0.90 0.82 0.70 SCF ubiquitin ligase, Skp1 component 
cel00600: Sphingolipid metabolism 
0.001 4.648 asm-2 1.20 1.38 1.79 
Acid sphingomyelinase and PHM5 phosphate 
metabolism protein 
  
asm-3 0.60 0.71 0.95 
Acid sphingomyelinase and PHM5 phosphate 
metabolism protein 
  
sms-2 0.77 0.76 0.63 Uncharacterized conserved protein 
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Continuation Supplementary Table 5 
  
sptl-2 1.46 0.79 0.74 
serine palmtoyltransferase (ST.LOUIS) 
TR:Q20375 protein_id:AAA92303.1 
  
Y54E5A.1 0.88 0.78 0.80 (HINXTON) 
  
Y4C6B.6 1.42 1.30 1.57 Beta-glucocerebrosidase 
  
spl-1 1.07 0.80 0.86 
Glutamate decarboxylase/sphingosine phos-
phate lyase 
  
sptl-3 1.28 0.85 0.93 Serine palmitoyltransferase 
cel04310: Wnt signaling pathway 
0.001 2.712 cwn-2 0.85 0.75 0.65 Wnt family of developmental regulators 
  
dsh-1 1.01 0.71 0.65 cDNA clone:yk653h6 
  
dsh-1 0.75 0.69 0.61 dishevelled-like protein 
  
jnk-1 0.71 0.74 0.62 MAP kinase 
  
skr-10 0.99 0.68 0.56 SCF ubiquitin ligase, Skp1 component 
  
skr-12 1.01 0.63 0.58 SCF ubiquitin ligase, Skp1 component 
  
skr-13 1.03 0.72 0.62 SCF ubiquitin ligase, Skp1 component 
  
skr-14 1.04 0.80 0.67 SCF ubiquitin ligase, Skp1 component 
  
skr-15 0.95 0.76 0.65 SCF ubiquitin ligase, Skp1 component 
  
skr-21 0.78 0.74 0.55 
RNA polymerase II elongation factor like; 
C.elegans cDNA clone yk98d5 
  
skr-21 0.78 0.72 0.52 SCF ubiquitin ligase, Skp1 component 
  
skr-7 1.02 0.68 0.61 SCF ubiquitin ligase, Skp1 component 
  
skr-8 0.98 0.71 0.57 SCF ubiquitin ligase, Skp1 component 
  
skr-8 1.00 0.69 0.57 
cyclin A-associated protein; C.elegans cDNA 
clone yk282d6 
  
skr-9 0.95 0.67 0.56 SCF ubiquitin ligase, Skp1 component 
  
unc-43 0.74 0.72 0.82 
Ca2+/calmodulin-dependent protein kinase, EF-
Hand protein superfamily 
  
skr-16 0.90 0.82 0.70 SCF ubiquitin ligase, Skp1 component 
cel00980: Metabolism of xenobiotics by cytochrome P450 
0.005 3.576 alh-5 0.73 1.95 2.28 Aldehyde dehydrogenase 
  
gst-38 0.58 0.64 1.23 Glutathione S-transferase 
  
gst-4 1.97 1.72 1.97 Glutathione S-transferase 
  
gst-5 1.13 1.27 1.53 Glutathione S-transferase 
  
sodh-1 1.78 2.32 1.83 Alcohol dehydrogenase, class V 
  
F35H8.6 0.82 1.46 1.44 
UDP-glucuronosyl and UDP-glucosyl transfe-
rase 
  
ugt-50 1.43 0.78 0.99 UDP-glucuronosyltransferase 
  
ugt-50 0.89 0.71 0.60 
wEST00903 Early embryo, Stratagene (cat. no. 
937007)      cDNA clone CEESC45 similar to       
cDNA clone cm10b6, mRNA sequence. 
  
W01A11.1 1.23 1.26 1.25 
Predicted hydrolases or acyltransferases (al-
pha/beta hydrolase superfamily) 
cel00982: Drug metabolism 
0.005 3.576 alh-5 0.73 1.95 2.28 Aldehyde dehydrogenase 
  
fmo-2 0.69 3.22 4.47 Flavin-containing monooxygenase 
  
gst-38 0.58 0.64 1.23 Glutathione S-transferase 
  
gst-4 1.97 1.72 1.97 Glutathione S-transferase 
  
gst-5 1.13 1.27 1.53 Glutathione S-transferase 
  
sodh-1 1.78 2.32 1.83 Alcohol dehydrogenase, class V 
  
ugt-58 0.82 1.46 1.44 
UDP-glucuronosyl and UDP-glucosyl transfe-
rase 
  
ugt-50 1.43 0.78 0.99 UDP-glucuronosyltransferase 
  
ugt-50 0.89 0.71 0.60 UDP-glucuronosyltransferase 
Table continues on page 154 
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Continuation Supplementary Table 5 
Overrepresented KEGG pathways in Q 100 µM 
p-
va
lu
e 
Fo
ld
 
En
ric
hm
en
t 
C
G
C
 
Q
 5
0 
µM
 
(F
C
) 
Q
 1
00
 µ
M
 
(F
C
) 
Q
 2
00
 µ
M
 
(F
C
) 
Description 
cel00330: Arginine and proline metabolism 
0.011 3.099 alh-1 1.14 1.45 1.42 Aldehyde dehydrogenase 2 
  
C10C5.4 1.15 1.68 1.95 
Aminoacylase ACY1 and related metalloex-
opeptidases 
  
T09B4.8 0.83 0.74 0.78 aminotransferase 
  
dpy-18 1.13 0.70 0.63 cDNA clone:yk548g10 
  
dpy-18 1.05 0.67 0.61 Prolyl 4-hydroxylase alpha subunit 
  
F44G3.2 1.53 2.18 1.89 Creatine kinases 
  
F55G1.9 1.17 1.29 1.32 Pyrroline-5-carboxylate reductase 
  
phy-2 1.33 0.71 0.71 Prolyl 4-hydroxylase alpha subunit 
  
smd-1 2.31 0.67 0.59 Genomic Cluster 
  
smd-1 2.50 0.76 0.58 S-adenosylmethionine decarboxylase 
  
T22H6.2 1.29 0.73 0.69 
1-pyroline-5-carboxylate synthetase 
(HINXTON) SW:P54889 pro-
tein_id:CAA90672.1 
cel00270: Cysteine and methionine metabolism 
0.033 3.201 T09B4.8 0.83 0.74 0.78 aminotransferase 
  
C06E7.3 1.33 1.35 1.29 S-adenosylmethionine synthetase 
  
ldh-1 1.14 0.78 0.70 Lactate dehydrogenase 
  
smd-1 2.31 0.67 0.59 Genomic Cluster 
  
smd-1 2.50 0.76 0.58 S-adenosylmethionine decarboxylase 
  
tag-32 3.32 2.57 4.18 S-adenosylmethionine synthetase 
  
ZC373.1 0.67 0.63 0.64 Cystathionine beta-synthase and related en-zymes 
cel00350: Tyrosine metabolism 
0.047 3.510 alh-5 0.73 1.95 2.28 Aldehyde dehydrogenase 
  
T09B4.8 0.83 0.74 0.78 aminotransferase 
  
R119.3 0.90 1.28 1.23 Reductases with broad range of substrate spe-cificities 
  
sodh-1 1.78 2.32 1.83 Alcohol dehydrogenase. class V 
  
tbh-1 0.94 0.80 0.78 Dopamine beta-monooxygenase 
 
< 0.65 < 0.8 <…> > 1.25 > 2.5 
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Supplementary Table 6 Overrepresented KEGG pathways found in Q 200 µM treated nematodes. 
Further summarized are the DEGs and statistical proven expression values (FC), p-values and the Fold 
Enrichment. The numbers in italics show FC values without guarantee of statistical robustness.  
cel04350: TGF-beta signaling pathway 
Overrepresented KEGG pathways in Q 200 µM 
p-
va
lu
e 
Fo
ld
 
En
ric
hm
en
t 
C
G
C
 
Q
 5
0 
µM
 
(F
C
) 
Q
 1
00
 µ
M
 
(F
C
) 
Q
 2
00
 µ
M
 
(F
C
) 
Description 
0.000 3.718 daf-1 0.89 0.79 0.73 C. elegans cDNA clone yk18f7 
  
skr-10 0.99 0.68 0.56 SCF ubiquitin ligase, Skp1 component 
  
skr-12 1.01 0.63 0.58 SCF ubiquitin ligase, Skp1 component 
  
skr-13 1.03 0.72 0.62 SCF ubiquitin ligase, Skp1 component 
  
skr-14 1.04 0.80 0.67 SCF ubiquitin ligase, Skp1 component 
  
skr-15 0.95 0.76 0.65 SCF ubiquitin ligase, Skp1 component 
  
skr-16 0.90 0.82 0.70 SCF ubiquitin ligase, Skp1 component 
  
skr-21 0.78 0.74 0.55 
RNA polymerase II elongation factor like; 
C,elegans cDNA clone yk98d5 
  
skr-21 0.78 0.72 0.52 SCF ubiquitin ligase, Skp1 component 
  
skr-5 1.08 1.00 1.42 SCF ubiquitin ligase, Skp1 component 
  
skr-7 1.02 0.68 0.61 SCF ubiquitin ligase, Skp1 component 
  
skr-8 0.98 0.71 0.57 SCF ubiquitin ligase, Skp1 component 
  
skr-8 1.00 0.69 0.57 
cyclin A-associated protein; C.elegans cDNA 
clone yk282d6 
  
skr-9 0.95 0.67 0.56 SCF ubiquitin ligase, Skp1 component 
  
skr-16 0.90 0.82 0.70 SCF ubiquitin ligase, Skp1 component 
cel04310: Wnt signaling pathway 
0.001 2.574 cwn-2 0.85 0.75 0.65 Wnt family of developmental regulators 
  
dsh-1 1.01 0.71 0.65 cDNA clone:yk653h6 
  
dsh-1 0.75 0.69 0.61 dishevelled-like protein 
  
jnk-1 0.71 0.74 0.62 MAP kinase 
  
skr-10 0.99 0.68 0.56 SCF ubiquitin ligase, Skp1 component 
  
skr-12 1.01 0.63 0.58 SCF ubiquitin ligase, Skp1 component 
  
skr-13 1.03 0.72 0.62 SCF ubiquitin ligase, Skp1 component 
  
skr-14 1.04 0.80 0.67 SCF ubiquitin ligase, Skp1 component 
  
skr-15 0.95 0.76 0.65 SCF ubiquitin ligase, Skp1 component 
  
skr-16 0.90 0.82 0.70 SCF ubiquitin ligase, Skp1 component 
  
skr-21 0.78 0.74 0.55 
RNA polymerase II elongation factor like; 
C,elegans cDNA clone yk98d5 
  
skr-21 0.78 0.72 0.52 SCF ubiquitin ligase, Skp1 component 
  
skr-5 1.08 1.00 1.42 SCF ubiquitin ligase, Skp1 component 
  
skr-7 1.02 0.68 0.61 SCF ubiquitin ligase, Skp1 component 
  
skr-8 0.98 0.71 0.57 SCF ubiquitin ligase, Skp1 component 
  
skr-8 1.00 0.69 0.57 
cyclin A-associated protein; C. elegans cDNA 
clone yk282d6 
  
skr-9 0.95 0.67 0.56 SCF ubiquitin ligase, Skp1 component 
  
unc-43 0.74 0.72 0.82 
Ca2+/calmodulin-dependent protein kinase, EF-
Hand protein superfamily 
Table continues on page 156 
      
 
 
 
 
 
Appendix 
156 
 
 A
ppendix 
  
Continuations Supplementary Table 6 
 
Overrepresented KEGG pathways in Q 200 µM 
p-
va
lu
e 
Fo
ld
 
En
ric
hm
en
t 
C
G
C
 
Q
 5
0 
µM
 
(F
C
) 
Q
 1
00
 µ
M
 
(F
C
) 
Q
 2
00
 µ
M
 
(F
C
) 
Description 
cel00982: Drug metabolism 
0.005 3.195 alh-5 0.73 1.95 2.28 Aldehyde dehydrogenase 
  
F20G2.2 1.24 0.86 0.79 Predicted short chain-type dehydrogenase 
  
fmo-1 1.07 0.98 1.25 Flavin-containing monooxygenase 
  
fmo-2 0.69 3.22 4.47 Flavin-containing monooxygenase 
  
gst-10 1.29 0.99 1.28 Glutathione S-transferase 
  
gst-4 1.97 1.72 1.97 Glutathione S-transferase 
  
gst-5 1.13 1.27 1.53 Glutathione S-transferase 
  
sodh-1 1.78 2.32 1.83 Alcohol dehydrogenase. class V 
  
ugt-50 0.89 0.71 0.60 
wEST00903 Early embryo. Stratagene (cat. no. 
937007) cDNA clone CEESC45 similar to       
cDNA clone cm10b6. mRNA sequence. 
cel00480: Glutathione metabolism 
0.015 2.647 C11E4.1 1.52 1.32 1.51 glutathione peroxidase 
  
C11E4.2 0.54 0.84 0.77 Glutathione peroxidase 
  
F59B8.2 1.21 0.90 0.81 NADP-dependent isocitrate dehydrogenase 
  
gst-10 1.29 0.99 1.28 Glutathione S-transferase 
  
gst-36 1.06 0.85 0.85 Glutathione S-transferase 
  
gst-4 1.97 1.72 1.97 Glutathione S-transferase 
  
gst-5 1.13 1.27 1.53 Glutathione S-transferase 
  
M176.2 0.94 0.86 0.81 cDNA clone:yk639e6 
  
rnr-2 1.03 0.90 0.84 Ribonucleotide reductase, beta subunit 
cel00330: Arginine and proline metabolism 
0.020 2.745 alh-1 1.14 1.45 1.42 Aldehyde dehydrogenase 2 
  
alh-9 0.99 0.81 0.79 Aldehyde dehydrogenase 
  
dpy-18 1.26 0.85 0.77 prolyl 4-hydroxylase alpha subunit 
  
dpy-18 1.13 0.70 0.63 cDNA clone:yk548g10 
  
dpy-18 1.05 0.67 0.61 Prolyl 4-hydroxylase alpha subunit 
  
F44G3.2 1.53 2.18 1.89 Creatine kinases 
  
F55G1.9 1.17 1.29 1.32 Pyrroline-5-carboxylate reductase 
  
phy-2 1.33 0.71 0.71 Prolyl 4-hydroxylase alpha subunit 
  
smd-1 2.31 0.67 0.59 Genomic Cluster 
  
smd-1 2.50 0.76 0.58 S-adenosylmethionine decarboxylase 
  
T22H6.2 1.29 0.73 0.69 
1-pyroline-5-carboxylate synthetase 
(HINXTON) SW:P54889 pro-
tein_id:CAA90672.1 
cel04142: Lysosome 
0.026 1.968 apm-3 0.86 0.75 0.65 Clathrin-associated protein medium chain 
  
asm-2 1.20 1.38 1.79 
Acid sphingomyelinase and PHM5 phosphate 
metabolism protein 
  
C33G3.4 0.89 0.73 0.68 Predicted beta-mannosidase 
  
cpr-2 1.56 5.83 8.28 Cysteine proteinase Cathepsin L 
  
cpr-3 0.70 0.64 0.73 Cysteine proteinase Cathepsin L 
  
F32H5.1 1.10 1.57 1.92 Cysteine proteinase Cathepsin L 
  
mig-23 0.88 0.73 0.78 Nucleoside phosphatase 
  
ncr-1 0.58 0.83 0.74 
Cholesterol transport protein (Niemann-Pick C 
disease protein) 
  
 
   
Table continues on page 157 
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    Continuation of Supplementary Table 6 
  
vha-15 0.87 0.77 0.75 Vacuolar H+-ATPase V1 sector. subunit H 
  
W07B8.4 2.61 3.57 4.11 thiol protease; C.elegans cDNA clone yk150b4 
  
Y4C6B.6 1.42 1.30 1.57 Beta-glucocerebrosidase 
  
Y40D12A.2 1.33 0.63 0.71 
Serine carboxypeptidases (lysosomal cathepsin 
A) 
  
M05B5.4 0.85 0.87 0.81 
Lecithin:cholesterol acyltransferase 
(LCAT)/Acyl-ceramide synthase 
  
Y16B4A.2 1.24 0.73 0.82 
Serine carboxypeptidases (lysosomal cathepsin 
A) 
cel00980: Metabolism of xenobiotics by cytochrome P450 
0.033 2.772 alh-5 0.73 1.95 2.28 Aldehyde dehydrogenase 
  
F20G2.2 1.24 0.86 0.79 Predicted short chain-type dehydrogenase 
  
gst-10 1.29 0.99 1.28 Glutathione S-transferase 
  
gst-4 1.97 1.72 1.97 Glutathione S-transferase 
  
gst-5 1.13 1.27 1.53 Glutathione S-transferase 
  
sodh-1 1.78 2.32 1.83 Alcohol dehydrogenase. class V 
  
ugt-58 0.82 1.46 1.44 
UDP-glucuronosyl and UDP-glucosyl transfe-
rase 
  
ugt-50 0.89 0.71 0.60 
wEST00903 Early embryo. Stratagene (cat. no. 
937007) cDNA clone CEESC45 similar to       
cDNA clone cm10b6. mRNA sequence. 
  
alh-1 1.14 1.45 1.42 Aldehyde dehydrogenase 2 
cel00340: Histidine metabolism 
0.048 4.576 alh-5 0.73 1.95 2.28 Aldehyde dehydrogenase 
  
alh-9 0.99 0.81 0.79 Aldehyde dehydrogenase 
  
Y51H4A.7 0.98 1.10 1.28 Urocanate hydratase 
 
< 0.65 < 0.8 <…> > 1.25 > 2.5 
 
 
 
Supplementary Table 7 Overrepresented KEGG pathway found in Qall. Further summarized are the 
DEGs and statistical proven expression values (FC), p-values and the Fold Enrichment. The numbers in 
italics show FC values without guarantee of statistical robustness.  
 
< 0.65 < 0.8 <…> > 1.25 > 2.5 
Overrepresented KEGG pathways in Qall 
p-
va
lu
e 
Fo
ld
 
En
ric
hm
en
t 
C
G
C
 
Q
 5
0 
µM
 
(F
C
) 
Q
 1
00
 µ
M
 
(F
C
) 
Q
 2
00
 µ
M
 
(F
C
) 
Description 
 
cel00330: Arginine and proline metabolism 
0.005 10.765 F44G3.2 1.53 2.18 1.89 Creatine kinases 
  
phy-2 1.33 0.71 0.71 Prolyl 4-hydroxylase alpha subunit 
  
smd-1 2.50 0.76 0.58 S-adenosylmethionine decarboxylase 
  
T22H6.2a 1.29 0.73 0.69 1-pyroline-5-carboxylate synthetase 
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Supplementary Table 11 Comparison of datasets from Q 50, 100 and 200 µM as well as pooled data-
sets from Qlongevity and Qall with global gene expression studies from aging- and immune-relevant literature 
in C. elegans. Numbers in red indicate significant RFs. (RF < 1, p < 0.05). Parts are displayed in Fig. 29. 
R
ef
er
en
ce
  
Genotype / condition 
N
o.
tr
an
sc
ri
pt
s 
on
 a
rr
ay
 
N
o.
 D
EG
s 
in
 
re
fe
re
nc
e 
st
ud
y 
N
o.
 tr
an
sc
irp
ts
 
id
en
tif
ie
d 
on
 
pr
es
en
t a
rr
ay
  Q 50 µM Q 100 
µM 
Q 200 
µM 
Qlongevity Qall 
DEGs 
total 623 2050 2354 1885 380 
up 475 685 878 620 241 
down 148 1365 1476 1261 88 
Studies addressing the age-dependent expression changes in wild type C. elegans 
H
ill
 e
t a
l. 
(2
00
0)
   18791 4221 3595 all 257 806 885 748 167 
   
up 204 249 304 231 106 
   
down 53 557 581 517 37 
   
RFall 2.16 2.06 1.97 2.07 2.30 
   
p-value 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Lu
nd
 e
t a
l. 
(2
00
1)
 
sterile mutant strains  (fer-
15, spe-9;fer-15, and spe-
9;emb-27); 6 adult ages, 
pools used, three sterile 
mutant strains, 3-6 biologi-
cal replicates per age group 
   
maturity genes (expression changes on days 3 & 4) 
17871 34 30 all 9 16 17 15 8 
   
up 9 15 16 14 7 
   
down 0 1 1 0 0 
   
RFall 8.61 4.65 4.30 4.74 12.54 
   
p-value 4.93E-07 2.28E-08 1.99E-08 6.24E-08 1.43E-07 
   
aging genes (expression changes after day 4) 
 
164 151 all 7 26 29 25 6 
   
up 7 11 15 11 5 
   
down 0 15 14 14 0 
   
RFall 1.33 1.50 1.46 1.57 1.87 
   
p-value 1.17E-01 9.65E-03 9.44E-03 6.94E-03 6.08E-02 
Studies addressing the genetic background of longevity mutants and dauers 
M
ur
ph
y 
et
 a
l. 
(2
00
3)
 
Young adult daf-2 or age-1 
vs. control, N2, or daf-2; 
daf-16, 1-4 replicates per 
comparison. Pools used. 
Time course of sterile mu-
tant strain treated with daf-
2, or daf-2 +daf-16 RNAi, or 
control vector, one array per 
condition per time point. 
   
up in daf-2, longevity mediators class I 
18455 
 
240 all 31 63 77 53 16 
   
up 26 42 55 36 10 
   
down 5 21 20 14 1 
   
RFall 3.83 2.36 2.52 2.16 3.24 
   
p-value 1.18E-10 2.74E-11 2.51E-15 2.88E-08 2.96E-05 
   
RFup up 4.21 4.71 4.82 4.46 3.19 
   
p-value 5.55E-10 0.00E+00 0.00E+00 3.60E-14 9.35E-04 
   
RFup down 2.60 1.18 1.04 0.85 0.87 
   
p-value 3.13E-02 6.72E-02 9.17E-02 8.99E-02 3.67E-01 
   
down in daf-2, longevity suppressors class II 
  
229 all 12 68 66 62 8 
   
up 10 8 12 8 3 
   
down 2 60 54 53 1 
   
RFall 1.55 2.67 2.26 2.65 1.70 
   
p-value 4.09E-02 8.14E-15 4.64E-11 2.64E-13 5.37E-02 
   
RFdown down 1.09 3.54 2.95 3.39 0.92 
   
p-value 2.72E-01 0.00E+00 2.18E-13 0.00E+00 3.69E-01 
   
RFdown up 1.70 0.94 1.10 1.04 1.00 
   
p-value 3.75E-02 1.41E-01 1.12E-01 1.42E-01 2.27E-01 
M
cE
lw
ee
 e
t 
al
. (
20
03
) First day adults, daf-
2(e1370) vs. daf2(e1370); 
daf-16(m27). Pools used, 2 
biological replicates, 2 
technical replicates of each. 
   
putative daf-16 targets 
17871 35 34 all 7 6 8 6 5 
   
up 7 6 8 6 5 
   
down 0 0 0 0 0 
   
RFall 5.91 1.54 1.79 1.67 6.92 
   
p-value 1.26E-04 1.01E-01 4.18E-02 8.17E-02 6.37E-04 
M
cE
lw
ee
 e
t a
l. 
(2
00
4)
 
First day adults, daf-
2(e1370) or daf-2(m577) vs. 
daf-2; daf-16. Pools used, 5 
biological replicates per 
genotype 
   
up in daf-2 
19282 1108 1039 all 66 176 210 156 39 
   
up 52 93 126 84 25 
   
down 14 83 84 72 9 
   
RFall 1.97 1.59 1.66 1.54 1.90 
   
p-value 6.29E-08 6.65E-11 1.47E-14 1.05E-08 4.78E-05 
   
RFup up 2.03 2.52 2.66 2.51 1.93 
   
p-value 5.43E-07 0.00E+00 0.00E+00 2.84E-15 7.30E-04 
   
RFup down 1.76 1.13 1.06 1.06 1.90 
   
p-value 1.51E-02 2.42E-02 4.05E-02 4.38E-02 2.74E-02 
   
down in daf-2 
 
779 736 all 45 155 162 129 24 
   
up 34 42 44 30 8 
   
down 11 113 118 98 7 
Table continues on page 165 
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 RFall 
1.89 1.98 1.80 1.79 1.65 
   
p-value 1.76E-05 0.00E+00 1.09E-14 1.37E-11 5.29E-03 
   
RFdown down 1.95 2.17 2.09 2.04 2.08 
   
p-value 1.53E-02 0.00E+00 4.18E-15 5.78E-12 3.19E-02 
   
RFdown up 1.88 1.61 1.31 1.27 0.87 
   
p-value 1.85E-04 7.78E-04 1.23E-02 3.27E-02 1.31E-01 
W
an
g 
&
 
K
im
 (2
00
3)
 N2 dauer 
   
dauer 
  17088 
 
1663 all 106 332 370 302 52 
  
   
up 86 99 123 89 23 
  
   
down 20 233 247 213 29 
  
   
RFall 1.75 1.66 1.62 1.65 1.41 
  
   
p-value 3.16E-09 0.00E+00 0.00E+00 0.00E+00 2.68E-03 
Fi
sh
er
 &
Li
th
go
w
 (2
00
6)
 
4 populations each of sterile 
strains containing daf-
12(rh61rh411) or daf-
12(rh273), assayed vs 
mixed stage N2 reference 
RNA, with dye-flip for each 
sample 
 
225 194 up in daf-12(rh273) 
22490 
 
69 all 23 42 42 41 21 
   
up 23 38 39 38 21 
   
down 0 4 3 3 0 
   
RFall 12.03 6.68 5.82 7.09 18.01 
   
p-value 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
   
RFup up 15.78 18.08 14.48 19.98 28.40 
   
p-value 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
   
RFup down 0.00 0.96 0.66 0.78 0.00 
   
p-value 6.34E-01 2.01E-01 1.68E-01 2.05E-01 7.63E-01 
   
down in daf-12(rh273) 
  
125 all 9 27 29 25 4 
   
up 9 9 11 8 4 
   
down 0 18 18 17 0 
   
RFall 2.60 2.37 2.22 2.39 1.89 
   
p-value 5.54E-03 1.21E-05 1.88E-05 2.35E-05 1.01E-01 
   
RFdown down 0.00 2.37 2.19 2.43 0.00 
   
p-value 4.37E-01 3.56E-04 8.33E-04 4.05E-04 6.12E-01 
   
RFdown up 3.41 2.36 2.25 2.32 2.99 
   
p-value 1.04E-03 9.41E-03 6.25E-03 1.47E-02 3.45E-02 
   
down in multiple long lived worms 
  
13 all 0 5 5 5 0 
   
up 0 0 0 0 0 
   
down 0 5 5 5 0 
   
RFall 0.00 4.22 3.67 4.59 0.00 
   
p-value 6.94E-01 3.76E-03 6.66E-03 2.63E-03 8.01E-01 
   
RFdown down 0.00 6.34 5.86 6.86 0.00 
   
p-value 9.18E-01 6.39E-04 9.06E-04 4.47E-04 9.50E-01 
   
RFdown up 0.00 0.00 0.00 0.00 0.00 
   
p-value 7.58E-01 6.69E-01 5.96E-01 6.95E-01 8.69E-01 
Ev
an
s 
et
 a
l. 
(2
00
8)
 M
ET
A
-A
N
A
LY
SI
S 
daf- 2 summarized (Murphy 
et al., 2003 & McElwee et 
al., 2004) 
   
broad daf-2 up 
20000 1241 1155 all 81 201 235 175 44 
   
up 65 110 146 98 29 
   
down 16 91 89 76 9 
   
RFall 2.25 1.70 1.73 1.61 2.01 
   
p-value 3.19E-12 7.03E-15 0.00E+00 4.51E-11 4.99E-06 
   
RFup up 2.37 2.78 2.88 2.74 2.08 
   
p-value 5.06E-11 0.00E+00 0.00E+00 0.00E+00 8.65E-05 
   
RFup down 1.87 1.15 1.04 1.04 1.77 
   
p-value 6.38E-03 1.61E-02 4.13E-02 4.51E-02 3.70E-02 
   
broad down in daf-2 
 
964 905 all 51 197 203 169 29 
   
up 39 49 51 37 11 
   
down 12 148 152 131 7 
   
RFall 1.81 2.12 1.91 1.98 1.69 
   
p-value 1.68E-05 0.00E+00 0.00E+00 0.00E+00 2.07E-03 
   
RFdown down 1.79 2.40 2.28 2.30 1.76 
   
p-value 1.96E-02 0.00E+00 0.00E+00 0.00E+00 5.79E-02 
   
RFdown up 1.81 1.58 1.28 1.32 1.01 
  
 p-value 1.31E-04 4.60E-04 1.17E-02 1.68E-02 1.23E-01 
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Genotype / condition 
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 D
EG
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N
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 tr
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sc
irp
ts
 
id
en
tif
ie
d 
on
 
pr
es
en
t a
rr
ay
  Q 50 µM Q 100 
µM 
Q 200 
µM 
Qlongevity Qall 
DEGs 
total 623 2050 2354 1885 380 
up 475 685 878 620 241 
down 148 1365 1476 1261 88 
Sh
aw
 e
t a
l. 
20
07
 
TGF-beta adults (To identi-
fy the downstream targets of 
the TGF-beta pathway in 
adulthood, they compared 
the dauer-constitutive mu-
tants daf-7(e1372), daf-
7(m62), and daf-1(m40) with 
dauer-defective mutants 
daf-3(mgDf90), daf-
5(e1386), and daf-
7(e1372);daf-3(mgDf90) 
double mutants at the per-
missive temperature, 20 C, 
on the first day of adulthood. 
Because daf-3 and daf-5 
are epistatic to daf-7 and 
daf-1, these comparisons 
should identify targets that 
act downstream of this 
linear pathway.) 
   
up in TGF-beta adults 
20000 2181 1997 all 167 384 460 343 83 
   
up 139 141 206 133 16 
   
down 28 243 254 209 50 
   
RFall 2.68 1.88 1.96 1.82 2.19 
   
p-value 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2.85E-12 
   
RFup up 2.93 2.06 2.35 2.15 0.66 
   
p-value 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.88E-02 
   
RFup down 1.89 1.78 1.72 1.66 5.69 
   
p-value 3.79E-04 0.00E+00 0.00E+00 2.16E-14 0.00E+00 
   
down in TGF-beta adults 
 
4219 3728 all 18 134 160 121 8 
   
up 13 47 51 35 4 
   
down 5 87 109 86 3 
   
RFall 0.16 0.35 0.36 0.34 0.11 
   
p-value 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
   
p-value      
   
RFdown down 0.18 0.34 0.40 0.37 0.18 
   
p-value 1.77E-08 0.00E+00 0.00E+00 0.00E+00 1.68E-05 
   
RFdown up 0.15 0.37 0.31 0.30 0.09 
   
p-value 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Studies addressing the polyphenolic action in C. elegans 
Vi
sw
an
at
ha
n 
et
 a
l. 
(2
00
5)
 
Young adults, daf-16 or N2, 
resveratrol-treated worms 
vs. untreated, pools used, 4 
biological replicates per 
strain 
 
330 315 up in N2+resveratrol 
19282 
 
118 all 4 7 8 6 1 
   
up 4 4 5 4 0 
   
down 0 3 3 2 0 
   
RFall 1.05 0.56 0.56 0.52 0.43 
   
p-value 1.98E-01 3.07E-02 2.16E-02 2.83E-02 2.26E-01 
   
RFup up 1.38 0.95 0.93 1.05 0.00 
   
p-value 1.65E-01 1.98E-01 1.77E-01 1.98E-01 2.26E-01 
   
RFup down 0.00 0.36 0.33 0.26 0.00 
   
p-value 4.02E-01 2.02E-02 1.25E-02 1.14E-02 5.82E-01 
   
down in N2 + resveratrol 
  
196 all 5 16 19 16 2 
   
up 3 2 4 2 0 
   
down 2 14 15 14 1 
   
RFall 0.79 0.77 0.79 0.84 0.52 
   
p-value 1.52E-01 5.25E-02 5.17E-02 7.65E-02 1.56E-01 
   
RFdown down 1.33 1.01 1.00 1.09 1.12 
   
p-value 2.54E-01 1.10E-01 1.07E-01 1.04E-01 3.69E-01 
   
RFdown up 0.62 0.29 0.45 0.32 0.00 
   
p-value 1.50E-01 2.12E-02 3.29E-02 3.44E-02 8.39E-02 
 
3495 3250 up in daf-16 + resveratrol 
  
1028 all 95 185 223 178 77 
   
up 91 125 151 123 69 
   
down 4 60 72 55 4 
   
RFall 2.86 1.69 1.78 1.77 3.80 
   
p-value 0.00E+00 1.01E-13 0.00E+00 5.46E-15 0.00E+00 
   
RFup up 3.59 3.42 3.23 3.72 5.37 
   
p-value 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
   
RFup down 0.51 0.82 0.91 0.82 0.85 
   
p-value 5.78E-02 1.41E-02 3.58E-02 1.49E-02 1.89E-01 
   
down in daf-16 + resveratrol 
  
2235 all 58 233 250 218 39 
   
up 44 57 72 51 21 
   
down 14 176 178 166 10 
   
RFall 0.80 0.98 0.92 1.00 0.89 
   
p-value 9.82E-03 2.77E-02 8.03E-03 3.02E-02 4.81E-02 
   
RFdown down 0.82 1.11 1.04 1.14 0.98 
Table continues on page 167 
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p-value 7.87E-02 1.03E-02 2.80E-02 7.15E-03 1.33E-01 
   
RFdown up 0.80 0.72 0.71 0.71 0.75 
   
p-value 1.62E-02 9.75E-04 1.75E-04 1.22E-03 3.14E-02 
Studies addressing the immun response of C. elegans 
Tr
oe
m
el
 e
t a
l. 
(2
00
6)
 
fer-15(b26)ts;fem-1(hc17); 
wildtype; PA14, or gacA 
mutant PA14 
   
4 h after P. aeruginosa infection up 
20000 308 289 all 30 106 107 92 15 
   
up 18 38 42 33 4 
   
down 12 68 65 59 6 
   
RFall 3.33 3.58 3.15 3.38 2.73 
   
p-value 6.58E-09 0.00E+00 0.00E+00 0.00E+00 3.09E-04 
   
p-value      
   
RFup up 2.62 3.84 3.31 3.68 1.15 
   
p-value 1.37E-04 8.99E-13 6.30E-12 9.05E-11 1.91E-01 
   
RFup down 5.61 3.45 3.05 3.24 4.72 
   
p-value 1.43E-06 0.00E+00 0.00E+00 0.00E+00 1.45E-03 
   
4h after P. aeruginosa infection down 
 
119 112 all 31 38 38 29 12 
   
up 29 19 23 16 6 
   
down 2 19 15 13 1 
   
RFall 8.89 3.31 2.88 2.75 5.64 
   
p-value 0.00E+00 8.12E-12 4.58E-10 2.50E-07 1.28E-06 
   
RFdown down 2.41 2.49 1.81 1.84 2.03 
   
p-value 1.51E-01 1.32E-04 9.59E-03 1.33E-02 3.03E-01 
   
RFdown up 10.90 4.95 4.68 4.61 4.45 
   
p-value 0.00E+00 6.72E-09 4.23E-10 2.99E-07 1.96E-03 
   
8h after P. aeruginosa infection up 
 
268 244 all 18 89 91 78 13 
   
up 8 34 38 28 4 
   
down 10 55 53 50 5 
   
RFall 2.37 3.56 3.17 3.39 2.80 
   
p-value 4.27E-04 0.00E+00 0.00E+00 0.00E+00 5.83E-04 
   
RFup up 1.38 4.07 3.55 3.70 1.36 
   
p-value 9.69E-02 2.77E-12 7.78E-12 2.10E-09 1.67E-01 
   
RFup down 5.54 3.30 2.94 3.25 4.66 
   
p-value 1.21E-05 0.00E+00 5.09E-13 6.64E-14 3.74E-03 
   
8h after P. aeruginosa infection down 
 
231 216 all 55 64 72 53 23 
   
up 53 33 43 29 15 
   
down 2 31 29 24 1 
   
RFall 8.17 2.89 2.83 2.60 5.60 
   
p-value 0.00E+00 0.00E+00 0.00E+00 3.68E-11 2.27E-11 
   
RFdown down 1.25 2.10 1.82 1.76 1.05 
   
p-value 2.61E-01 4.05E-05 6.64E-04 2.53E-03 3.70E-01 
   
RFdown up 10.33 4.46 4.53 4.33 5.76 
   
p-value 0.00E+00 4.40E-13 0.00E+00 2.61E-11 5.13E-08 
daf-2 vs daf-2;pmk-1 
   
Induced by PMK-1 
20000 
 
98 all 10 33 36 31 8 
   
up 9 8 11 7 2 
   
down 1 25 25 24 3 
   
RFall 3.28 3.29 3.12 3.36 4.30 
   
p-value 7.20E-04 2.30E-10 1.05E-10 5.78E-10 4.57E-04 
   
RFup up 3.87 2.38 2.56 2.30 1.69 
   
p-value 4.28E-04 1.28E-02 2.58E-03 2.15E-02 2.16E-01 
   
RFup down 1.38 3.74 3.46 3.88 6.96 
   
p-value 3.54E-01 4.91E-09 2.28E-08 5.09E-09 8.35E-03 
   
Repressed by PMK-1 
  
47 all 3 8 5 5 2 
   
up 3 4 2 2 1 
   
down 0 4 3 3 0 
   
RFall 2.05 1.66 0.90 1.13 2.24 
   
p-value 1.22E-01 5.64E-02 1.80E-01 1.79E-01 1.65E-01 
   
RFdown down 0.00 1.25 0.86 1.01 0.00 
   
p-value 7.05E-01 1.85E-01 2.24E-01 2.32E-01 8.13E-01 
   
RFdown up 2.69 2.48 0.97 1.37 1.77 
   
p-value 7.54E-02 5.48E-02 2.77E-01 2.52E-01 3.25E-01 
Table continues on page 168  
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Continuation Supplementary Table 11 
R
ef
er
en
ce
  
Genotype / condition 
N
o.
tr
an
sc
ri
pt
s 
on
 a
rr
ay
 
N
o.
 D
EG
s 
in
 re
fe
r-
en
ce
 s
tu
dy
 
N
o.
 tr
an
sc
irp
ts
 
id
en
tif
ie
d 
on
 
pr
es
en
t a
rr
ay
  Q 50 µM Q 100 
µM 
Q 200 
µM 
Qlongevity Qall 
DEGs 
total 623 2050 2354 1885 380 
up 475 685 878 620 241 
down 148 1365 1476 1261 88 
Sh
ap
ira
 e
t a
l. 
(2
00
6)
 
P. aeruginosa Infection 
   
up after P. aeruginosa infection 
7308 195 181 all 24 76 72 64 11 
   
up 16 14 19 14 2 
   
down 8 62 53 50 4 
   
RFall 1.56 1.50 1.23 1.37 1.17 
   
p-value 8.69E-03 1.56E-05 5.85E-03 9.90E-04 1.09E-01 
   
RFup up 1.36 0.83 0.87 0.91 0.34 
   
p-value 4.95E-02 8.18E-02 7.90E-02 1.04E-01 4.25E-02 
   
RFup down 2.18 1.83 1.45 1.60 1.84 
   
p-value 1.93E-02 2.01E-07 8.68E-04 1.42E-04 1.07E-01 
   
down after P. aeruginosa infection 
 
33 33 all 7 17 12 11 1 
   
up 7 14 11 10 1 
   
down 0 3 1 1 0 
   
RFall 2.49 1.84 1.13 1.29 0.58 
   
p-value 1.36E-02 2.44E-03 1.26E-01 9.19E-02 3.11E-01 
   
RFdown down 0.00 0.49 0.15 0.18 0.00 
   
p-value 5.08E-01 7.17E-02 4.82E-03 1.31E-02 6.70E-01 
   
RFdown up 3.26 4.53 2.77 3.57 0.92 
   
p-value 3.58E-03 4.67E-07 8.49E-04 2.24E-04 3.73E-01 
Ev
an
s 
et
 a
l. 
(2
00
8)
 M
ET
A
-A
N
A
LY
SI
S 
Pseudomonas aeruginosa 
infection summarized (Sha-
pira et al. 2006 & Troemel et 
al. 2006) 
   
up after P. aeruginosa infection 
20000 482 446 all 46 154 154 130 22 
   
up 31 50 60 44 6 
   
down 15 104 94 86 8 
   
RFall 3.31 3.37 2.93 3.09 2.60 
   
p-value 8.26E-13 0.00E+00 0.00E+00 0.00E+00 3.23E-05 
   
RFup up 2.93 3.27 3.06 3.18 1.12 
   
p-value 7.52E-08 1.22E-13 6.80E-15 9.75E-12 1.58E-01 
   
RFup down 4.54 3.42 2.86 3.06 4.08 
   
p-value 9.52E-07 0.00E+00 0.00E+00 0.00E+00 6.26E-04 
   
down after P. aeruginosa infection 
 
281 263 all 63 80 86 66 25 
   
up 59 46 55 40 16 
   
down 4 34 31 26 2 
   
RFall 7.69 2.97 2.78 2.66 5.00 
   
p-value 0.00E+00 0.00E+00 0.00E+00 5.27E-14 3.61E-11 
   
RFdown down 2.06 1.89 1.60 1.57 1.73 
   
p-value 8.53E-02 1.35E-04 2.97E-03 6.84E-03 2.13E-01 
   
RFdown up 9.45 5.11 4.76 4.91 5.05 
   
p-value 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.13E-07 
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Su
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 T
ab
le
 1
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G
O
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rP
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- c
lu
st
er
 a
na
ly
si
s 
of
 s
ig
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w
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n 
D
EG
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 Q
lo
ng
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nd
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s 
fro
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 d
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-1
2(
rh
27
3)
 (F
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r a
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Li
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w
, 2
00
6)
, d
af
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 (E
va
ns
 e
t a
l.,
 2
00
8)
, T
G
F-
be
ta
 a
du
lts
 (S
ha
w
 e
t a
l.,
 2
00
7)
, P
. a
er
ug
in
os
a 
in
fe
ct
ed
 C
. e
le
ga
ns
 (E
va
ns
 e
t a
l.,
 2
00
8)
 a
nd
 re
sv
er
at
ro
l t
re
at
ed
 
da
f-1
6 
m
ut
an
ts
 (V
is
w
an
at
ha
n 
et
 a
l.,
 2
00
5)
. O
nl
y 
on
e 
si
gn
ifi
ca
nt
 (p
 <
 0
.0
5)
 p
ro
xy
 p
er
 c
lu
st
er
 a
nd
 a
cc
or
di
ng
 g
en
es
 a
re
 s
ho
w
n.
 G
re
y 
fie
ld
s 
in
di
ca
te
 th
e 
sa
m
e 
di
re
ct
io
n 
of
 re
gu
la
tio
n,
 w
hi
te
 fi
el
ds
 c
on
tra
ry
. (
M
F:
 M
ol
ec
ul
ar
 F
un
ct
io
n;
 B
P:
 B
io
lo
gi
ca
l P
ro
ce
ss
; C
C
: C
el
lu
la
r C
om
po
ne
nt
; I
P:
 In
te
rP
ro
). 
R
ef
er
s 
to
 F
ig
. 2
9.
 
Q
lo
ng
ev
ity
 
 
Category 
Te
rm
 
No. DEGs 
p-
va
lu
e 
G
en
es
 
Category 
Te
rm
 
No. DEGs 
p-
va
lu
e 
G
en
es
 
 
up
 
do
w
n 
da
f-2
 (m
et
a-
an
al
ys
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 E
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up 
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S
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, 
 
 
 
 
 
  
M
F 
G
O
:0
01
64
91
 
ox
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E
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1.
51
E
-0
2 
cy
p-
35
C
1,
 
cy
p-
35
A
2,
 
cy
p-
14
A
5 
B
P 
G
O
:0
00
83
40
 
de
te
rm
in
at
io
n 
of
 a
du
lt 
lif
e 
sp
an
 
6 
3,
14
E
-0
2 
do
d-
22
, d
od
-2
3,
 d
od
-1
9,
 
ifc
-2
, 
jn
k-
1,
 
pe
s-
2.
1,
 
pe
s-
2.
2 
 
  
 
 
 
 
 
IP
 
IP
R
00
07
42
 
E
G
F-
lik
e,
 ty
pe
 3
 
4 
3,
96
E
-0
2 
F2
8B
4.
3,
 
ni
d-
1,
 
T2
5C
12
.3
, Y
51
H
4A
.2
5,
  
  
 
 
 
 
  
C
C
 
G
O
:0
04
51
11
 
in
te
rm
ed
ia
te
 
fil
am
en
t 
cy
to
sk
el
et
on
 
3 
1,
55
E
-0
3 
ifc
-2
, i
fd
-2
, i
fd
-1
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C
on
tin
ua
tio
n 
Su
pp
le
m
en
ta
ry
 T
ab
le
 1
2 
 
 
 
 
 
 
Q
lo
ng
ev
ity
 
 
Category 
Te
rm
 
N
o.
 D
EG
s 
No. DEGs 
p-
va
lu
e 
ge
ne
s 
Category 
Te
rm
 
N
o.
 D
EG
s 
No. DEGs 
p-
va
lu
e 
ge
ne
s 
 
up
 
do
w
n 
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f-1
2(
rh
27
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 (F
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r a
nd
 L
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w
, 2
00
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 p
ro
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Supplementary Table 16 Studies with C. elegans exposed to natural substances (Saul et al., 2009). 
 
Substance Observations in C. elegans Supposed mechanisms References 
EGCG 
• No lifespan extension 
• Enhanced thermal & oxidative stress resistance  
• Enhanced chemotaxis index 
• Decreased H2O2 level in N2, but not in daf-16 mutants 
• Attenuated decline in pharyngeal pumping behavior 
• Delayed movement decline & Aβ-induced muscle paralysis 
• Up-regulation of sod-3, skn-1  & hsp-16.2 expression 
• Increase of energy 
expenditure 
• ROS scavenging activi-
ty  
• Up-regulation of sod-3, 
hsp-16.2 & skn-1 
Brown et al., 
2006; 
Zhang et al., 
2009 
• Increased lifespan of N2 & mev-1 mutants 
• Enhanced oxidative stress resistance 
• Reduced intracellular H2O2 level & juglone-induced expression of hsp-
16.2  
• Antioxidant properties 
Abbas & Wink, 
2008 
 
Quercetin 
• Enhanced resistance to oxidative & thermal stress 
• Increased lifespan in N2 & akt-2, daf-12, daf-16, jnk-1, mev-1, nhr-8, 
osr-1, sir-2.1 & skn-1 mutants 
• No increased lifespan in age-1, daf-2, sek-1 & unc-43 mutants 
• No effects on reproduction or body length 
• Antioxidant capacities 
• UNC-43/SEK-1 pathway 
Pietsch et al., 
2008; 
Saul et al., 2008 
• Increased thermal & oxidative stress resistance 
• Reduction of SOD-3 expression & lipofuscin accumulation 
• Reduction of generated ROS during thermal stress 
• Reduction of gst-4 promoter induction during juglone treatment 
• Translocation of DAF-16 from the cytosol to the nucleus 
• Antioxidant capacities 
• Modulation of DAF-16 
activity 
Kampkötter et 
al., 2007b, 2008 
Resveratrol 
• Increased lifespan in N2 & daf-16 mutants 
• No lifespan extension in sir-2.1 mutants 
• Stimulated deacetylation activity of SIR-2.1 
• Induced expression of cyp-13A6 & several abu & pqn genes 
• No lifespan extension in abu-11 RNAi assay 
• Modulation of stress 
response via SIR-2.1 & 
ABU-11  
 
 
 
Wood et al., 
2004; Viswana-
than et al., 2005 
 
• Increased lifespan & oxidative stress resistance 
• Changes in reproduction pattern, but unchanged overall progeny 
• No changes in pharyngeal pumping rate or body length 
• Delay of the onset of 
the exponential in-
crease in mortality 
Gruber et al., 
2007 
• Variable lifespan extension in N2 & sir-2.1 mutants • SIR-2.1 independently 
activation of phase 2 
drug detoxification  
• AMP kinase activation 
Bass et al., 2007 
Blueberry 
extract 
 
• Increased lifespan at 20°C & 25°C, but not at 15°C  
• Increased pharyngeal pumping rate & thermal (but not oxidative) stress 
resistance  
• Delayed age related changes in hsp expression 
• No lifespan extension in mev-1, osr-1, sek-1 & unc-43 mutants, but in  
sir-2.1,, daf-16 & skn-1 mutants 
• OSR-1/UNC-43/SEK-1 
pathway 
 
Wilson et al., 
2006 
Fisetin 
• Increased thermal resistance 
• Reduced ROS accumulation under heat stress 
• Translocation of DAF-16 from the cytosol to the nucleus 
• Modulation of DAF-16 
activity 
• Antioxidative capacity 
Kampkötter at 
al., 2007a 
Wisconsin 
Ginseng 
• No significant lifespan extension 
• Reduced age dependent declines of locomotory rate, pharyngeal 
pumping & body wall muscle cells 
 Cao et al., 2007 
Gingko Biloba 
(EGb 761) 
 
• Increased lifespan 
• Increased thermal & oxidative stress resistance in N2 & mev-1 mutants 
• Reduced ROS accumulation, gst-4 promoter activity & catalase tran-
scription 
• Reduced age dependent declines of locomotory rate, pharyngeal 
pumping & body wall muscle cells 
• Suppression of heat shock induced hsp-16.2 expression 
• Antioxidative properties 
• Modulation of hsp-16.2 
expression 
 
Wu et al., 2002;  
Strayer et al., 
2003;  Cao et 
al., 2007; Kamp-
kötter et al., 
2007c 
Vitamin E 
• Increased lifespan 
• Decreased & delayed reproduction 
• No lifespan extension in mev-1 
• No modulation of mitochondrial superoxide anion production in N2 & 
mev-1 
• Slow down of reproduc-
tion & development 
Harrington & 
Harley, 1988; 
Ishii et al., 2004 
Tocopherol 
• Lifespan extension with γ-tocopherol, but not  with α -tocopherol 
 
Adachi & Ishii, 
2000; Zou et al., 
2007 
Tocotrienol • Increased lifespan 
• Enhanced UVB stress resistance 
• Reduction of ROS 
mediated damage 
Adachi & Ishii, 
2000 
 
  
 Table continues on page 178 
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Coenzyme Q10 
• Increased lifespan in N2 & mev-1 mutants 
• Modulation of mitochondrial superoxide anion production in N2 & mev-1 
• Significant suppression of apoptosis in mev-1 embryos 
• Reduction of oxidative 
stress in mitochondria Ishii et al., 2004 
Kaempferol 
• Increased thermal resistance 
• Reduced ROS accumulation under heat stress 
• Reduced lipofuscin autofluorescence 
• Translocation of DAF-16 from the cytosol to the nucleus 
• Modulation of DAF-16 
activity 
• Antioxidative capacity 
Kampkötter et 
al., 2007a 
Rutin 
• No thermal stress resistance 
• Reduction of generated ROS during thermal stress 
• Reduced gst-4 promoter induction during juglone treatment 
• No significant effect on DAF-16 distribution 
• No altered lipofuscin accumulation 
 Kampkötter et al., 2007b 
Humic 
Substances 
• Lifespan extension in low to moderate concentrations 
• Up-regulation of stress-defense related genes 
• Hormesis 
• Modulation of stress 
defense system 
Steinberg et al., 
2007 
α-lipoic acid 
• Increased life extension 
• Attenuated H2O2 level in N2 & daf-16 mutants 
• No attenuation of the rate of decline in pharyngeal pumping behavior 
• Enhancement of the chemotaxis index 
• No lifespan extension in daf-16 mutants 
• No delay in Aβ-induced muscle paralysis 
• Insulin/IGF-1 pathway Brown et al., 2006 
Continuation Supplementary Table 16  
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HOW TO USE THE FILTERTABLE? - Short description 
 
The filtertable can be found online under following web-address:  
 
https://docs.google.com/leaf?id=0B-
ebpwy-
wEV6MNGQ1MzU1ZGYtYjZhYS00ZGY2LWIwNTYtMjM5MGE1M2ZhMzJi&hl=en_US&authk
ey=CNuBhcgP 
 
This filter table contains the full genome (22 548 transcripts) fold change expression values for 
Q 50, 100 and 200 µM treated wild type C. elegans relative to control. Statistical significance of 
genes is indicated by an “X” in the row “Statistical Significance”, labeled with respective concen-
tration. Additionally the filter table highlights the DEGs of 11 DNA-microarray studies formerly 
conducted in C. elegans. The genes which are regulated in respective study are marked with an 
“*” in according row. Furthermore there are rows for all 44 gene expression mountains (accord-
ing to Kim et al., 2001) and various gene-classes and gene groups. Genes that belong to re-
spective mountains or groups are marked with an “*”.  
Based on the filter function of Microsoft excel this table can help to compare the various condi-
tions with each other, determine overlaps and exclusively regulated genes. The numbers in the 
line "all DEGs in respective condition" display the total number of DEGs in respective filter con-
dition. This number does not change. The numbers in "regulated in filter conditions" varies de-
pendent on the filter adjustments; they show how many DEGs are contained in respective group 
(e.g. the overlap to other studies) Selected DNA-microarray studies on which will be mainly re-
sponded in the thesis are highlighted in grey 
 
1. To filter for a certain condition klick the filter sign on respective condition.  
 
 
 
 
 
2. For DEGs in a “microarray study”, “gene expression mountain” or “gene-class” or “-
group”:  
filter for "*",  
to exclude according DEGs filter for “Leere”,  
to delete a set filter klick “Filter löschen” 
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3. To show significant regulated genes in Q concentrations:  
filter for "X" in the row "Statistical Significance" 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. To filter for Fold change values in Q concentrations:  
use the “Zahlenfilter” and  
enter numbers: e. g. "> 1" or "< 1" 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. To search for single genes or descriptive words: 
use the “Textfilter” in “Annotations” row  
enter the word you are looking for in the filter. 
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  6. It is possible to filter in diverse conditions in parallel. 
 
 
 
7. The numbers above the table indicate:  
-"all DEGs in respective condition" displays the number of regulated DEGs in respec-
tive condition 
- "regulated in filter conditions" varies dependent on the filter adjustment; it shows 
how many DEGs are contained in the respective group under total filter calibrations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. For better overview, the table view can be reduced by marking the complete row which is 
not be needed, right klick with the mouse, klick "AUSBLENDEN"; later on information can be 
showed again with "EINBLENDEN"  
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